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ABSTRACT 
Introduction: Much evidence shows that the Mediterranean diet and the Dietary 
Approaches to Stop Hypertension (DASH) style diet are associated with risk reduction of 
cardiometabolic disease as well as lower risk of all-cause, cardiovascular disease (CVD), 
and cancer mortality. A subgroup of obese individuals (metabolically healthy obese 
(MHO) phenotype) and normal weight individuals (metabolically obese normal weight 
(MONW) phenotype) have been identified to have different cardiometabolic risks 
compared with their counterparts in the same category of body mass index (BMI). Scarce 
evidence exists demonstrating a relationship between adherence to Mediterranean diet or 
DASH style diets with MHO and MONW phenotypes, or on the role of MHO and 
MONW phenotypes as important effect modifiers of the relationship between 
Mediterranean and DASH style diets with mortality risk. In addition, it is unclear how 
much the adjustment for adiposity modifies or attenuates the association of the 
Mediterranean diet and DASH style diet with cardiometabolic risk. 
Methods: Data from adults aged 20-90 years were analyzed from participants of 
the National Health and Nutrition Examination Survey III, 1988–1994 with its mortality 
file linked until December 31, 2011. Mediterranean diet scores (MDS) and DASH index 
were calculated using food frequency questionnaires and the 24-hr dietary recall data. 
MHO and MONW individuals were identified using the criterion including high fasting 
glucose, insulin resistance, blood pressure, triglycerides, C-reactive protein, and low 
high-density lipoprotein-cholesterol. For aim 1, multiple logistic regression analyses
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were conducted to generate odds ratios (ORs) and 95% confidence intervals (CIs) to 
estimate the associations of tertiles of MDS and DASH index with the presence of MHO 
and MONW phenotypes. For aim 2, multivariable Cox proportional hazards regression 
models were used to estimate hazard ratios (HRs) and 95% CIs of mortality across the 
tertiles of MDS and DASH index and 1-SD increment of MDS and DASH index. For aim 
3, multiple linear regression analyses were applied using traditional and causal mediation 
analysis to estimate the regression coefficients between diet score, obesity parameters, 
and markers for insulin resistance and inflammation. 
Results: For aim 1, higher MDS was associated with higher odds of MHO 
phenotype (tertile 3 vs 1; OR, 2.57 [95% CI, 1.04-6.35]; P trend = 0.04), whereas higher 
DASH index was associated with lower odds of MONW phenotype (tertile 3 vs 1; OR, 
0.59 [95% CI, 0.38-0.93]; P trend = 0.03) only in the younger age group, after adjusting 
for potential confounders. For aim 2, in MHO individuals, the multivariable-adjusted HR 
of all-cause mortality in the highest tertile compared to the first tertile of MDS was 0.44 
(95% CI, 0.26-0.75; P for trend <0.001). The corresponding HR was 0.23 (95% CI, 0.02-
2.10; P for trend = 0.03) for cancer mortality. A 5-point increment in the adherence to 
MDS was associated with a 43% reduction in the risk of all-cause mortality (HR, 0.59; 
95% CI, 0.37-0.94). However, no risk reduction of all-cause, CVD, and cancer mortality 
was found in MUO phenotype. In MONW individuals, 1-SD increment in the adherence 
to DASH style diet was significantly associated with 23% reduction in the risk of all-
cause mortality (HR, 0.77 [95% CI, 0.66-0.90]), after adjustment for potential 
confounders. The corresponding HRs for CVD mortality were 0.70 (95% CI, 0.53-0.93). 
However, no association was observed in MHNW phenotype. For aim 3, waist 
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circumference mediated the association of MDS with log insulin, log HOMA-IR, fasting 
glucose, post-load glucose, HbA1c, log hs-CRP, white blood cell, and fibrinogen, with 
proportion of mediation ranging from 14.4% to 42.3%. In addition, the mediated effects 
of waist circumference were greater than those of BMI consistently in all markers in both 
traditional and causal mediation analysis. However, no mediation effect by adiposity was 
observed in the association of DASH style diet with the markers for insulin resistance and 
inflammation. 
Conclusions:  Adherence to Mediterranean diet or DASH style diet was 
associated with MHO and MONW phenotypes only in the younger age group, suggesting 
that potential dietary intervention to prevent cardiometabolic disease may be different by 
age group. Adherence to a Mediterranean dietary pattern appears to improve longevity in 
the MHO phenotype within an obese population, whereas higher DASH index was 
associated with a lower risk of mortality in MONW adults. Waist circumference 
mediated the association of the Mediterranean diet with insulin resistance and 
inflammation to a greater extent than BMI, suggesting that lowering abdominal obesity 
may be one of the pathways through which the Mediterranean diet reduces insulin 
resistance and inflammation.
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CHAPTER 1 
INTRODUCTION 
1.1 Statement of problem 
Obesity is associated with an increased risk of type 2 diabetes and cardiovascular 
disease (CVD) (Guh et al. 2009), but not all obese individuals are equally affected. Thus, 
even in the same category of body mass index (BMI), a subgroup of obese individuals 
with normal metabolic characteristics has been identified as “Metabolically Healthy 
Obese (MHO)”, compared with “Metabolically Unhealthy Obese (MUO)” (Kim, Kim, et 
al. 2014, Primeau et al. 2010, Karelis et al. 2004). In the same context, a subgroup of 
normal weight individuals who are susceptible to metabolic abnormalities due to their 
unfavorable body composition has been designated as “Metabolically Obese Normal 
Weight (MONW)” [also referred to as “Metabolically Unhealthy Normal Weight 
(MUNW)”], compared with their metabolically normal counterparts with the same 
normal category of BMI representing “Metabolically Healthy Normal Weight (MHNW)” 
(Kim, Han, et al. 2014, Choi et al. 2013, Lee et al. 2011, Yajnik and Yudkin 2004, 
Ruderman, Schneider, and Berchtold 1981). These metabolic phenotypes are determined 
by complex interaction between gene, environment, and life style characteristics 
(Teixeira et al. 2015, Samocha-Bonet et al. 2014, Oliveros et al. 2014, Phillips 2013). 
It is well known that the Mediterranean diet and the Dietary Approaches to Stop 
Hypertension (DASH) style diets are associated with lower risk of cardiometabolic
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disease and CVD mortality in both observational and intervention studies (Estruch et al. 
2013, Azadbakht 2013, Kastorini et al. 2011, Sofi et al. 2008). Underlying mechanisms 
for cardiovascular health benefits of Mediterranean diet and DASH style diets are 
complex, but can be explained by the improvement of metabolic profiles including 
insulin resistance, lipid profiles, blood pressure, and inflammatory markers (Grosso et al. 
2014). Therefore, it is plausible that adherence to Mediterranean diet and DASH style 
diets might be associated with a metabolically heathy phenotype. However, few studies 
have investigated the relationship of the Mediterranean diet and DASH style diet with 
MHO phenotype or MONW phenotype.  
The Mediterranean diet and DASH style diets seem to be independently 
associated with cardiometabolic risk after adjusting for adiposity (Kastorini et al. 2010). 
However, it is unclear how much the adjustment for adiposity modifies or attenuates the 
association of the Mediterranean diet and DASH style diet with cardiometabolic risk. 
Using mediation analysis, the role of adiposity underlying the relationship of the 
Mediterranean diet and DASH style diet with cardiometabolic risk could be clarified. 
However, no study has explored the mediator role of adiposity on the relationship of the 
Mediterranean diet and DASH style diet with cardiometabolic risk.  
To address this gap in the literature, we will evaluate the association of the 
Mediterranean diet and DASH style diet with MHO phenotype, MONW phenotype, and 
mortality risk, while examining adiposity as a potential mediator, using the National 
Health and Nutrition Examination Survey (NHANES) III and its linked mortality file. 
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1.2 Purpose and objectives 
In this dissertation, the following specific aims will be examined using the 
National Health and Nutrition Examination Survey (NHANES) III and its linked 
mortality file. 
Aim 1: Is the adherence to the Mediterranean diet or DASH style diet associated 
with metabolic health in both normal weight and obese populations?  
Hypothesis 1.1:  The adherence to the Mediterranean diet or DASH style diet will 
be positively associated with metabolic health in a representative US population. 
Hypothesis 1.2: The adherence to the Mediterranean diet or DASH style diet will 
be associated to a greater extent with the MHO phenotype in a representative US 
population.  
 Hypothesis 1.3: The adherence to the Mediterranean diet or DASH style diet will 
be associated to a lesser extent with the MONW phenotype in a representative US 
population.  
Aim 2: Does the adherence to the Mediterranean diet or DASH style diet reduce 
all-cause, CVD, and cancer mortality risk in the individuals with unfavorable metabolic 
phenotype in both normal weight and obese population?  
Hypothesis 2.1: The adherence to the Mediterranean diet or DASH style diet will 
be associated with lower all-cause, CVD, and cancer mortality risk in the NHANES III 
follow-up cohort.  
Hypothesis 2.2: The association between adherence to the Mediterranean diet or 
DASH style diet and lower mortality will be modified by MUO and MONW phenotypes 
in the NHANES III follow-up cohort.  
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Aim 3: Is adiposity a mediator of the influence of the Mediterranean diet or 
DASH style diet on the cardiometabolic risk? 
Hypothesis 3: The relation of the adherence to the Mediterranean diet or DASH 
style diet with cardiometabolic risk will be mediated by adiposity in a representative US 
population.  
1.3 Significance and relevance of the dissertation research 
Not all obese individuals are at an increased risk of metabolic disease (Karelis et 
al. 2004). Therefore, consideration of differential characteristics of subgroups of obese 
individuals may need to be considered in recommending guidelines for disease 
prevention or early treatment of obesity. Stratification of obese individuals based on their 
metabolic phenotype may be crucial in determining appropriate obesity management 
strategies (Primeau et al. 2010). Furthermore, a better understanding of metabolically 
healthy obese (MHO) phenotype will be helpful to develop targeted preventative 
strategies and evidence based public health approaches to reduce obesity-related 
morbidity and mortality, and associated medical costs (Stefan et al. 2008). 
A number of meta analyses have documented the association of adherence to the 
Mediterranean diet and DASH style diets with reduced risk of metabolic syndrome 
(Kastorini et al. 2011) and type 2 diabetes (Koloverou et al. 2014), in addition to 
modification of cardiovascular risk factors (Nordmann et al. 2011) and decreased 
inflammation and improved endothelial function (Schwingshackl and Hoffmann 2014). 
In addition, a systematic review suggested that there is a possible role of the adherence to 
Mediterranean diet in preventing overweight and obesity (Buckland, Bach, and Serra-
Majem 2008). However, the weakness of previous studies is not considering the 
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differential characteristics of a subgroup of obese individuals. Only one study found that 
higher dietary quality is positively associated with MHO phenotype in middle to old aged 
population, but it was not based on Mediterranean diet and DASH style diet. Additional 
weaknesses of this study were restricted age range and cross-sectional study design 
(Phillips et al. 2013). Our study will overcome these weaknesses using a nationally 
representative data that has both cross-sectional and longitudinal characteristics and a 
valid definition of metabolically healthy phenotype.  
While the inverse association of Mediterranean diet and the DASH style diets 
with all-cause mortality and cardiovascular mortality is well-known (Sofi et al. 2008), no 
other studies have explored the role of metabolic health as an important effect modifier of 
the relationship of Mediterranean diet and the DASH style diets with all-cause and CVD 
mortality. Consequently, this investigation will reveal how Mediterranean diet and the 
DASH style diets interact with MHO phenotype and MONW phenotype to predict all-
cause and CVD mortality. 
Research on methods for mediation analysis is a fast growing field in 
epidemiology (Richiardi, Bellocco, and Zugna 2013). Mediation analysis helps us to 
examine the mechanisms underlying an observed relationship between exposure and 
outcome, and investigate how they relate to a mediator. By exploring the role of adiposity 
as a mediator, we will be able to better understand the nature of the association of 
Mediterranean diet or DASH style diet with cardiometabolic risk and cardiovascular 
death. This dissertation is innovative because this approach has not been used to examine 
this particular hypothesis. Moreover, causal mediation analysis is a novel approach to 
determine controlled direct effect, natural direct effect, and natural indirect effect using 
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counterfactual approaches in which unbiased valid estimates of direct effect and indirect 
effect can be obtained (VanderWeele 2009). 
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CHAPTER 2 
BACKGROUND 
2.1 Characteristics of Mediterranean diet and the Dietary Approaches to Stop 
Hypertension (DASH) style diet 
2.1.1 Mediterranean diet 
The Mediterranean diet, representing the dietary pattern in the populations 
neighboring the Mediterranean Sea, has been documented as a model for healthy eating 
(Willett et al. 1995), and is characterized by high intake of olive oil (high  
monounsaturated/saturated fat), legumes, grains (including bread and potatoes), fruits, 
and vegetables; moderate intake of milk and dairy products, alcohol; and low intake of 
meat and meat products (Trichopoulou et al. 2003).  
It has been reported that adherence to the Mediterranean diet is related to a 
reduced risk of cardiovascular morbidity and mortality. Meta-analysis of 12 prospective 
cohort studies with 1,574, 299 subjects followed from three to 18 years showed that an 
increase in the adherence score was significantly associated with a reduced risk of 
mortality (pooled relative risk (RR) 0.91, 95% confidence interval (CI) 0.89 to 0.94) and 
cardiovascular mortality (pooled RR 0.91,0.87 to 0.95) (Sofi et al. 2008). A recently 
published multicenter trial of 7,447 individuals in Spain showed that both groups 
assigned to a Mediterranean diet with extra-virgin olive oil and a Mediterranean diet with
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nuts had a reduced incidence of major cardiovascular events (HR 0.70, 0.54 to 0.92; 0.75, 
0.54 to 0.96, respectively) (Estruch et al. 2013). 
The adherence to Mediterranean diet is known to be related to an improvement in 
cardiovascular risk factors and inflammatory profiles. Meta-analysis of 6 randomized 
controlled trials (RCTs) comparing Mediterranean to low-fat diets in 2,650 
overweight/obese subjects showed that those assigned to a Mediterranean diet had more 
favorable changes in cardiovascular risk factors and inflammatory markers including 
BMI, systolic blood pressure (BP), diastolic BP, fasting plasma glucose, total cholesterol, 
and high sensitivity C-reactive protein (hs-CRP) (Nordmann et al. 2011). In addition, a 
meta-analysis of 17 RCTs including 2300 individuals showed that high adherence to a 
Mediterranean diet is related to decreased inflammation and improved endothelial 
function such as decreased hs-CRP,  decreased interleukin-6 (IL-6), decreased 
intracellular adhesion molecule-1, increased flow mediated dilatation, and increased 
adiponectin) (Schwingshackl and Hoffmann 2014). 
It has been documented that the adherence to Mediterranean diet is related to a 
reduced risk of metabolic syndrome and type 2 diabetes. A meta-analysis of 50 clinical 
trials and observational studies including 534,906 individuals showed that the adherence 
to Mediterranean diet is associated with reduced risk of metabolic syndrome (log hazard 
ratio (HR): -0.69, -1.24 to -1.16) and its components (Kastorini et al. 2011). In addition, a 
meta-analysis of 10 clinical trials and prospective cohort studies including 136,846 
subjects showed that higher adherence to the Mediterranean diet was associated with a 
reduced risk of developing type 2 diabetes (combined RR  0.77, 0.66 to 0.89) (Koloverou 
et al. 2014). 
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There have been different approaches to evaluate the adherence to Mediterranean 
diet (Bach et al. 2006).  Created by positive or negative scoring of the components, 
‘Mediterranean Diet Score’ (MDS), is the most largely used index since it is easy to 
apply. Basically a score from 0 to 1 was assigned to the daily intake of each component 
of Mediterranean Diet in which the sex-specific medians of the sample were used as cut-
off points (Costacou et al. 2003). A point was given if the subject’s intake was over the 
sample median for the protective components such as legume, grains, vegetables and 
fruits below the median for non-protective components such as meat and dairy products. 
Therefore, MDS ranged 0 for minimal adherence to 8 for maximum adherence if the 
index had eight components. Usually, a score of 4 or more has been associated with 
adequate MDP adherence and better health outcomes. Another approaches to calculate 
the adherence to Mediterranean diet include an adherence index that adds or subtracts 
standardized components and a “Mediterranean Adequacy Index” based on a ratio 
between components were used (Bach et al. 2006). 
2.1.2 The Dietary Approaches to Stop Hypertension (DASH) style diet 
The DASH style diet that was originally developed to prevent hypertension has 
been reported as a healthy eating pattern (Champagne 2006, Appel et al. 1997). It is 
characterized by high intake of fruits, vegetables, nuts and legumes, low fat dairy 
products, and whole grains; and low intake of fat (total/saturated), sodium, sweets, and 
red meats (Sacks et al. 2001).  
It has been reported that the adherence to the DASH style diet is related to a 
reduced risk of cardiometabolic abnormalities. A meta-analysis of 6 prospective cohort 
studies with 260,011 subjects showed that the DASH style diet reduced the incidence of 
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CVDs (RR 0.80, 95%CI, 0.74 to 0.86), CHD (RR 0.79, 0.71 to 0.88), stroke (RR 0.81, 
0.72 to 0.92), and heart failure (RR 0.71, 0.58 to 0.88) (Salehi-Abargouei et al. 2013). In 
addition,  a meta-analysis of 9 RCTs showed that the DASH style diet reduced fasting 
insulin (mean difference -0.15, -0.22 to -0.08; P < 0.001) (Shirani, Salehi-Abargouei, and 
Azadbakht 2013). 
There have been different approaches to evaluate the adherence to the DASH diet 
index based on the composition of food and nutrients (Miller et al. 2013): 1) Mellen’s 
index is a completely nutrient-based DASH index with 9 components in which a better 
adherence is related to higher levels of protein, fiber, magnesium, calcium, and potassium, 
or lower levels of total fat, saturated fat, sodium, and cholesterol) (Mellen et al. 2008); 2) 
Fung’s index that is composed of  7 food groups and one nutrient with scoring system of 
quintile rankings using eating guide developed by the National Heart, Lung and Blood 
Institute (Fung et al. 2008); 3) Dixon’s index that is comprised of 8 food groups and one 
nutrient evaluating the adherence to the DASH Eating Plan in the 2005 Dietary 
Guidelines for Americans (Dixon et al. 2007); and 4) Günther’s index that is a food-
based index with 10 components evaluating the adherence to the DASH Eating Plan in 
the 2005 Dietary Guidelines for Americans (Gunther et al. 2009). 
2.2 Characteristics of MHO phenotype and MONW phenotype 
The risk of developing obesity-related complications corresponds to the degree of 
obesity (Guh et al. 2009). However, the existence of these obesity-related metabolic 
abnormalities varies extensively among obese individuals (Karelis et al. 2004).  In 
addition, although BMI is widely used as a simple measure of defining obesity and shows 
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a reliable association with adverse metabolic outcomes, it does not necessarily correlate 
with adiposity.  
Despite being outwardly obese, a subset of obese individuals appears to be 
protected or more resistant to the development of metabolic abnormalities associated with 
obesity. These individuals with MHO phenotype, namely benign or uncomplicated 
obesity demonstrate several favorable metabolic characteristics such as high insulin 
sensitivity, relatively low visceral fat, and no sign of dyslipidemia or hypertension (Kim, 
Kim, et al. 2014, Primeau et al. 2010, Karelis, Brochu, and Rabasa-Lhoret 2004). A few 
studies investigating the effect of lifestyle intervention on MHO phenotype consistently 
conclude that there is a potential benefit of distinguishing MHO phenotype and MUO 
phenotype.  
In addition, some non-obese subjects with MONW phenotype might be 
susceptible to insulin resistance, type 2 diabetes and CVD even though they are not 
outwardly obese (Ruderman, Schneider, and Berchtold 1981). Furthermore, MONW 
subjects display lower physical activity energy expenditure, a higher level of visceral 
adiposity, impaired insulin sensitivity, and a more atherogenic lipid profile, which 
together contribute to an increased risk of cardiometabolic disease (Kim, Han, et al. 2014, 
Choi et al. 2013, Lee et al. 2011, Yajnik and Yudkin 2004). 
Meig et al. (Meigs et al. 2006) proposed two different definitions for 
‘metabolically healthy’ phenotype: one is absence of metabolic syndrome components 
defined by the updated criteria from the Adult Treatment Panel III; the other one is 
absence of insulin resistance defined by being more than 75 percentile of HOMA-IR 
(homoeostasis model assessment of insulin resistance (HOMA-IR = fasting glucose 
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(mg/dl) x fasting insulin (lU/mL)/405).Individuals without metabolically healthy profiles 
within the same category of BMI were designated as the ‘metabolically unhealthy’ 
phenotype.  Wildman et al. (Wildman et al. 2008) defined ‘metabolically healthy’ 
phenotype as having 0 or 1 component among six cardiometabolic abnormalities.  Karelis 
and Rabasa-Lhoret (Karelis and Rabasa-Lhoret 2008) also proposed a similar definition 
of  ‘metabolically healthy’ phenotype as having 0 or 1 component among five 
cardiometabolic abnormalities (table 2.1). 
In normal weight population, the individuals who had over the highest tertile of 
percent body fat were designated as ‘Normal Weight Obesity’ that was also regarded as 
metabolically unhealthy phenotype (Romero-Corral et al. 2010). 
2.3  Relationship between diet and metabolic health 
Several studies have explored the association between dietary factors and 
metabolic phenotype. However, these reports have been limited to MHO phenotype 
(Camhi et al. 2015), without considering dietary pattern (Manu et al. 2012), or with 
specific age groups (Hankinson et al. 2013). A few studies have reported associations in 
MONW phenotype in non-US populations (Choi et al. 2012), but with limited 
generalizability (Suliga et al. 2015). Several studies demonstrated that dietary factors are 
related to metabolic phenotype in both obese and normal weight population (Phillips et al. 
2013), but only focused on women (Kimokoti et al. 2014), or single foods such as olive 
oil (Gutierrez-Repiso et al. 2014). 
A study in a multi-ethnic group of obese Americans aged 40–59 years showed 
that there was no difference in total energy or dietary macro/micro nutrient intake 
between MHO and MUO (Hankinson et al., 2012). However, there was a limitation of a 
15 
 
small sample size (n=149 for MHO; 19% of obese group) in this study. A study on US 
adults aged 20-79 years using the NHANES 1999-2004 showed that MHO, MUO, and 
MHNW males had similar energy intake and diet composition of micronutrients. 
However, MHO females consumed less fiber (Manu et al., 2012). A study in Ireland of 
adults aged 45-74 years showed that MHO and MUO individuals had similar total calorie 
intake, dietary macronutrient composition and dietary quality. However, it was shown 
that MHO individuals had better compliance with food pyramid recommendations 
(Phillips et al., 2013). A study on Korean adults > 20 years showed that MONW 
individuals had higher carbohydrate intake than MHNW individuals (Choi et al., 2012). 
2.4 Mediation analysis 
In epidemiological studies it is often necessary to unravel the pathways linking an 
exposure to an outcome (Richiardi, Bellocco, and Zugna 2013). Usually, confounding or 
mediator variables in epidemiologic studies are controlled by multivariate methods such 
as multivariable linear or logistic regression, depending on the objectives of the study 
and/or whether the dependent variable is continuous or dichotomous. Mediation analysis 
is a statistical procedure that can be used to explain the process underlying the 
relationship between the exposure and the outcome, and the extent to which this 
relationship can be mediated by a third variable (Baron and Kenny 1986).  
Commonly the purpose of mediation analysis is to determine the total effect of the 
exposure on the outcome, the effect of the exposure that performs through a given set of 
mediators of interest (indirect effect: shown as an indirect pathway with a broken arrow 
in Figure X) and the effect of the exposure unexplained by the same mediators (direct 
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effect: shown as a direct pathway with a solid arrow in Figure X) (Figure 2.1) (Richiardi, 
Bellocco, and Zugna 2013). 
Baron and Kenny proposed the following criteria to consider mediation: 1) the 
exposure variable is significantly related to the mediator; 2) the mediator is significantly 
related to the outcome variable; 3) the exposure variable is significantly related to the 
outcome variable; and 4) the association between the exposure and outcome variable is 
no longer significant when the mediator is included in the regression model (Baron and 
Kenny 1986). However, the third and fourth criteria have been called into question by 
other researchers.. For the third criteria, the effect of the exposure variable on the 
outcome variable may not be significant when direct and mediated effects have opposite 
sign. For the fourth criteria, when mediation is not complete, the path from the exposure 
to the outcome may still be significant even though the effect of the exposure on the 
outcome would be decreased (Valeri and Vanderweele 2013).  
2.4.1 Traditional approach to mediation analysis 
The approach to mediation analysis proposed by Baron and Kenny focused on 
comparing two regression models in which one model was conditioned on the mediator 
and the other one was not.  The exposure coefficient in the regression models would be 
interpreted as a direct effect in the model adjusted for the mediator, and as a total effect in 
the model unadjusted for the mediator (Richiardi, Bellocco, and Zugna 2013). In detail, 
the first step consists of regressing the outcome on the exposure and confounding factors 
to estimate the overall effect of exposure. In the next step, the mediator is also controlled 
to estimate the direct effect of exposure. Finally, the indirect effect by the mediator is 
estimated by calculating a) the difference of estimates between the coefficient of direct 
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effect and the coefficient of the overall effect (difference method); or b) the product of 
the coefficient of the path from exposure to mediator and the coefficient of the path from 
mediator to outcome (product method) (Baron and Kenny 1986).  
In addition, the structural equation modeling (SEM) focused on the path analysis 
has been used to estimate the direct and indirect effects by modeling covariance and 
correlation matrices (Valeri and Vanderweele 2013). 
2.4.2 Causal or counterfactual approach to mediation analysis  
The traditional approach to evaluate mediation tends to produce a bias due to 
incorrect statistical analysis and study design by not considering mediator-outcome 
confounding, exposure-mediator interaction, and mediator-outcome confounding affected 
by the exposure (Richiardi, Bellocco, and Zugna 2013).  
As unmeasured exposure-outcome confounders can generate confounding bias of 
estimates of total causal effects, unmeasured mediator-outcome confounders can generate 
bias of estimates of direct and indirect effects. This issue is also considered as a collider 
bias when the mediator is included as a covariate and mediator-outcome confounders 
were not adjusted simultaneously in a regression model (Figure 2.2) (Cole and Hernan 
2002) (VanderWeele 2009).  
In the traditional approach to mediation analysis, the direct effect is estimated by 
conditioning on the mediator. When the estimates of direct effect are different across 
various levels of the mediator, there should be an interaction between the exposure and 
the mediator in explaining the outcome. Thus, in the presence of exposure-mediator 
interaction, it is necessary to introduce another analytical framework to estimate the 
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effect of an exposure that is not explained by a mediator (Richiardi, Bellocco, and Zugna 
2013).  
To avoid collider bias, it is crucial to adjust for mediator-outcome confounding in 
regression models. However, when mediator-outcome confounding is also affected by the 
exposure, this adjustment will produces improper estimates. Figure X shows that L as an 
intermediate confounder is both a mediator-outcome confounder and a variable that exists 
on the direct path from the exposure to the outcome. Adjustment for L in traditional 
regression models would bias the estimate of the direct effect by blocking the path A → 
L  → Y, which would attenuate the direct effect and subsequently overestimate the 
indirect effect. Therefore, it is necessary to apply the counterfactual analytical framework 
in which the confounding effect of L can be adjusted without blocking the corresponding 
direct path from the exposure A to the outcome Y, and thus controlled direct effect can be 
obtained (Figure 2.3) (Richiardi, Bellocco, and Zugna 2013).  
To overcome these issues, counterfactual approaches as a causal mediation 
analysis can be made to determine controlled direct effect, natural direct effect, and 
natural indirect effect shown as the equations below (VanderWeele 2009) (Richiardi, 
Bellocco, and Zugna 2013).  
(1) controlled direct effect (a, a*;m) = Yam -  Ya*m : the controlled effect comparing 
exposure level A = a to A = a* ,with the mediator set to M = m. 
(2) natural direct effect (a, a*; a*) = YaM(a*) - Ya*M(a*) : the natural direct effect comparing 
exposure level A = a to A = a*, with the mediator set to M = M a*. 
(3) natural indirect effect (a, a*; a) = YaM(a) - YaM(a*) : the natural indirect effect 
comparing the effects M = Ma versus M = Ma*, with the exposure set to A = a. (here, 
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Ya : the counterfactual outcome (or potential outcome) Y for each individual under 
exposure A = a; Ya* : the counterfactual outcome (or potential outcome) Y for each 
individual under exposure A = a*; Yam : the counterfactual outcome (or potential 
outcome) Y for each individual if A were set to a and M to m) 
Controlled direct effect is the contrast between the counterfactual outcome if the 
subject were exposed at A =a and the counterfactual outcome if the same subject were 
exposed at A = a*, with the mediator set to a fixed value M=m. Natural direct effect is 
the contrast between the counterfactual outcome if the subject were exposed at A =a and 
the counterfactual outcome if the same subject were exposed at A = a*, with the mediator 
assuming whatever value it would have taken at the reference value of the exposure A 
=a*. Natural indirect effect is the contrast, having set the exposure at level A = a, 
between the counterfactual outcome if the mediator assumed whatever value it would 
have taken at a value of the exposure A = a and the counterfactual outcome if the 
mediator assumed whatever value it would have taken at a reference value of the 
exposure A = a* (Robins and Greenland 1992, Richiardi, Bellocco, and Zugna 2013). 
In addition to identifying the individual effects of natural direct effect, and natural 
indirect effect, and controlled direct effect, we can estimate the population average 
effects for each of them. Using this counterfactual framework, unbiased valid estimates 
of direct effect and indirect effect can be obtained and interpretation of mediation 
analysis will be improved (Robins and Greenland 1992, Richiardi, Bellocco, and Zugna 
2013).
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Table 2.1.  Comparison of definitions of metabolic healthy phenotype 
 
(Wildman 
et al. 2008) 
(Meigs et 
al. 2006) 
(A) 
(Meigs et 
al. 2006) 
(B) 
(Karelis 
and 
Rabasa-
Lhoret 
2008) 
High fasting glucose ≥ 100 mg/dL 
or antidiabetic medication use 
V V     
High blood pressure 
(systolic/diastolic blood pressure 
≥130/85 mm Hg)  or 
antihypertensive medication use 
V V     
High triglycerides (≥ 150 mg/dL) or 
on cholesterol-lowering medication 
V V   V 
Low HDL-C (< 40 mg/dL in men or 
< 50 mg/dL in women) or on 
cholesterol-lowering medication  
V V   V 
High waist circumference (≥102cm 
for men and ≥88 for women) 
  V     
High LDL-C  ( > 100  mg/dL)       V 
High hs-CRP ( > 90th pct) V     V 
High HOMA-IR (> 90th pct) V   
V (75th 
pct) 
V 
Criteria for metabolic health <2 <3 
HOMA-
IR <75th 
pct 
<1 
Abbreviations: HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density 
lipoprotein cholesterol; hs-CRP, high-sensitivity C-reactive protein; HOMA-IR, 
homoeostasis model assessment of insulin resistance. 
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Figure 2.1 Mediation model 
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Figure 2.2 Effect of adjusting for a mediator (M) on the estimate of 
an exposure (A)-outcome (Y) association in the presence of a 
mediator-outcome confounder (U) 
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Figure 2.3 Intermediate confounding 
C is affected by an exposure (A) and is also a mediator (M)-outcome 
(Y) confounder. 
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CHAPTER 3 
METHODOLOGY 
3.1 Statement of research aims and hypotheses 
The overall aim of the present study was to evaluate the association of the 
Mediterranean diet and DASH style diet with metabolic health in both normal weight and 
obese populations, and to investigate the differential association of the adherence to MD 
or DASH style diet with mortality risk reduction according to the metabolic phenotypes 
in both normal weight and obese populations using the National Health and Nutrition 
Examination Survey (NHANES) III and its linked mortality file. Furthermore, we 
examined the role of adiposity as a mediator of the association between adherence to the 
Mediterranean diet or DASH style diet and cardiometabolic risk factors.  
In specific aim #1, we investigated the association of Mediterranean diet and 
DASH style diet with MHO and MONW phenotypes in a cross-sectional study according 
to the two age groups exhibiting a substantially different in cardiovascular risk, based on 
being less than or greater than 45 years in men; before or after menopause in women. In 
specific aim #2, we assessed whether Mediterranean diet and DASH style diet would 
have a differential health benefit on mortality risk reduction in MHO individuals and 
MUO individuals as well as MONW individuals and MHNW individuals in a prospective 
study design. In specific aim #3, we examined the association of Mediterranean diet and 
DASH style diet with markers for insulin resistance and inflammation. In addition, we 
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investigated whether this association would be mediated by BMI and waist circumference, 
using both approaches in traditional mediation analysis and causal mediation analysis in a 
cross-sectional study.  
3.2 Study population 
We used data from the National Health and Nutrition Examination Survey 
(NHANES) III for the cross-sectional analyses and its mortality file linked until 
December 31, 2011 for the prospective analyses. The NHANES III was conducted 
between 1988 and 1994. A complex multi-stage stratified clustered probability sampling 
scheme was used to achieve a nationally representative sample of the civilian, non-
institutionalized US population. Collected data included personal interviews, physical 
examinations, and laboratory tests.  
Among the participants, we included adults aged 20 to 90 years with complete 
food frequency questionnaires (FFQ), 24-hour diet recalls, cardiometabolic parameters 
including fasting insulin, glucose, triglycerides, high-density lipoprotein cholesterol 
(HDL-C), hs-CRP, BP, and BMI for the aims #1 and #2, as well as waist circumference 
(WC) for the aim #3. Overall, we excluded pregnant or lactating women, those who 
reported implausible extreme energy intakes (<1st and >99th percentiles of energy 
intake/d in adults) and those with hs-CRP >10mg/dL, BMI < 18.5 kg/m2, BMI > 60 
kg/m2.  Additional exclusion criteria were different from each specific aim.  
To determine the mortality status, all subjects were linked to the National Death 
Index through 31 December 2011 using probabilistic matching. The underlying cause 
listed on the death certificate was applied to determine cause of death that was identified 
using the underlying Cause of Death-113 (UCOD-113) groups (International 
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Classification of Disease (ICD), 10th revision). Total mortality was defined as deaths 
with any underlying cause of death; CVD mortality was defined as circulatory-specific 
deaths (ICD-10: I00-I69); cancer death was defined as cancer-specific deaths (ICD-10: 
C00-C99). (NHANESIII) 
Follow-up for each subject for deaths continued from the date of the examination 
to the date of death or 31 December 2011. Thus, censoring occurred at the time of death 
from any cause for the total mortality outcome; or at the time of death for those who died 
from causes other than CVD for the CVD mortality outcome. Otherwise, the subjects not 
matched with a record of death were considered to be alive in terms of being right-
censored.  
3.3 Diet assessment 
3.3.1 Assessment of Mediterranean diet  
An 81-item food frequency questionnaires (FFQ) and the 24-hr dietary recall data, 
validated by the Nutrition Methodology Working Group (United States. National Center 
for Health Statistics. Plan and Operation of the Third National Health and Nutrition 
Examination Survey, 1988–94. US Department of Health and Human Services, Public 
Health Service, Centers for Disease Control and Prevention: Hyattsville, MD, 
Washington, DC, 1994), were used to assess dietary intake. Adherence to the 
Mediterranean diet was evaluated using the scoring methodology developed by 
Panagiotakos et al. (Panagiotakos, Pitsavos, and Stefanadis 2006, Panagiotakos et al. 
2007). In brief, scores 0 to 5 were assigned for the weekly consumption of food items 
assumed to be contributing to a Mediterranean dietary pattern, whereas scores on the 
inverse ordinal scale were assigned for the consumption of food items assumed to be 
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against the Mediterranean dietary pattern. For instance, the scores assigned to the weekly 
consumption frequencies of legumes were as follows: no servings, less than 1 serving, 1–
2 servings, 3–4 servings, 5–6 servings, and >6 servings were assigned scores of 0, 1, 2, 3, 
4 and 5, respectively. Similar score assignments were used for the food items of whole 
grains, potatoes, fruits, vegetables, fish, and olive oil. Reverse scores were assigned for 
the components of red meat and products, poultry and full-fat dairy products. For the 
alcohol consumption, a score of 5 was assigned for consumption of less than 300 ml (36g) 
of alcohol per day, 0 for no consumption or for consumption of >700 ml (84g) per day. It 
has been shown that MDS is highly associated with prevalent cardiometabolic diseases, 
10-year CVD risk, and inflammation and coagulation markers, in addition to capturing 
inherent characteristics of Mediterranean dietary pattern (Panagiotakos, Pitsavos, and 
Stefanadis 2006, Panagiotakos et al. 2007, Carter et al. 2010). 
The NHANES III FFQ applied a 1-month reference period without recording 
portion sizes. Thus, we calculated the MDS, assuming that the number of servings per 
week were equivalent to the number of times that a food item was consumed per week 
(Table 3.3). Potatoes were excluded in our MDS assessment, because the way potatoes 
are prepared in U.S. is quite different from European countries (Fung et al. 2005). The 
amount of alcohol consumed daily was estimated using the following assumption: 12.8g 
for 12-oz beer, 11g for 4-oz glass of wine, and 14g for an ounce of liquor based on the 
questionnaire provided. Additionally, gender-specific cut-offs were applied: a score of 5 
was assigned for consumption of less than 28g and 14 g of alcohol per day, 0 for no 
consumption or for consumption greater than 70g and 28g per day in men and women, 
respectively, and the cutoffs for subcategories between 0 and 5 were reassigned in even 
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intervals (Liangpunsakul, Crabb, and Qi 2010). Olive oil consumption was not measured 
in the NHANES III FFQ. Thus, we approximated olive oil consumption by calculating 
the ratio of total monounsaturated fatty acid to total saturated fatty acids using the 24-h 
dietary recall data, then dividing it into the six even intervals. Finally, the possible MDS 
ranged from 0 to 50, with higher values of this MDS indicating greater adherence to the 
Mediterranean diet. 
3.3.2 Assessment of DASH style diet  
The DASH style diets is characterized by high intake of fruits, vegetables, nuts 
and legumes, low fat dairy products, and whole grains; and low intake of fat 
(total/saturated), sodium, sweets, and red meats (Sacks et al. 2001). We used the 24-hr 
dietary recall data to calculate Mellen’s index which is one of the established DASH 
index scores (Miller et al. 2013), because NHANES FFQ did not provide information on 
servings. Mellen’s index, a nutrient-based index with 9 components including saturated 
fat, total fat, protein, cholesterol, fiber, magnesium, calcium, potassium, and sodium 
using target nutrient values used in clinical trials (Mellen et al. 2008), applied absolute 
targets on the basis of a 2100-kcal diet for both men and women. Individuals satisfying 
the goal for each component received 1 point, those who meet an intermediate goal, 
defined as the midpoint between the DASH diet goal and the nutrient content of the 
DASH control diet (Appel et al. 1997) received one-half of a point for the component, 
and those who meet neither goal received 0 points for the component. Finally, the 
possible DASH score ranged from 0 to 9, with higher values of this DASH score 
indicating greater adherence to the DASH style diet. 
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3.4 Assessment of metabolic health 
We determined metabolic health, using the metabolic parameters that were 
measured under quality control standards of Centers for Disease Control and Prevention. 
BMI was calculated as kg/m2; height was measured to the nearest 0.1cm and weight to 
the nearest 0.01 kg. Subjects were classified according to their BMI as obese (BMI 
≥30kg/m2) and normal weight (BMI <25kg/m2). WC was measured at the level of the 
right iliac crest. BP was averaged over five separate measurements. Glucose was 
measured in serum, using a modified hexokinase enzymatic method. Serum insulin was 
measured using a radioimmnuoassay (Pharmacia Diagnostics). HDL-C and triglycerides 
were measured using a Hitachi 704 analyzer (Boehringer-Mannheim Diagnostics). Serum 
CRP concentrations were measured by latex-enhanced nephlometry (Department of 
Laboratory Medicine, Immunology Division, University of Washington, Seattle). 
Metabolic health was defined when the individual had fewer than two cardiometabolic 
abnormalities (systolic/diastolic BP ≥ 130/85 mm Hg or antihypertensive medication use, 
triglycerides ≥ 150 mg/dL or on cholesterol-lowering medication, fasting glucose ≥ 100 
mg/dL or antidiabetic medication use, homoeostasis model assessment of insulin 
resistance (HOMA-IR = fasting glucose (mg/dl) x fasting insulin (lU/mL)/405) > the 90th 
percentile, hs-CRP > the 90th percentile, and HDL-C < 40 mg/dL in men or < 50 mg/dL 
in women or on cholesterol-lowering medication (Wildman et al. 2008). 
3.5 Assessment of covariates 
Potential confounders were included as covariates in multivariable logistic and 
Cox proportional hazards regression models. Participants’ sociodemographic 
characteristics, medical history, and lifestyle related characteristics were measured during 
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the personal interview. Sociodemographic variables included age, gender, race or 
ethnicity (non-Hispanic white, non-Hispanic black, Mexican American, or others), 
educational attainment (<12 years, 12 years, or >12 years of education), living with 
spouse, and level of income measured based on poverty income ratio (PIR) which is the 
ratio of household income to the appropriate poverty threshold (low (PIR ≤ 1.3), middle 
(1.3<PIR ≤ 3.5), and high (PIR>3.5)). Family history of coronary heart disease (CHD) 
and parental history of DM were self-reported. Smoking status was categorized as never, 
former, and current. The amount of alcohol consumed daily was estimated using the 
above mentioned assumption. Moderate alcohol use was defined as consumption up to 
28g and 14 g of alcohol per day in men and women (Liangpunsakul, Crabb, and Qi 
2010). Physical activity was categorized based on the recommended levels of physical 
activity (Haskell et al. 2007). Recommended physical activity was designated as a self-
reported leisure time moderate activity (3 ≤ metabolic equivalents (METs) <6) of five or 
more times per week or leisure time vigorous activity (METs ≥ 6) three or more times per 
week; physical inactivity as no reported leisure time physical activity; and insufficient 
physical activity as not meeting the criteria for recommended levels of physical activity 
but not inactive.  
3.6  Statistical methods 
We compared the baseline characteristics of participants by their tertiles for MDS 
or DASH index. Continuous variables were presented by mean (SE: standard error) and 
compared using linear regression analyses. Categorical variables were expressed by 
percentage with SE and were compared using Rao-Scott χ2 tests. We used two models 
according to degrees of adjustment: model 1 adjusted for age, sex, and race or ethnicity; 
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model 2 further adjusted for education, income, living with spouse, smoking, alcohol 
intake, physical activity, the presence of family history of CVD, parental history of DM, 
and total energy intake, and BMI. All analyses were conducted with SAS, version 9.4 
(SAS Institute, Inc) to take into account the complex survey design and the sampling 
weights used in NHANES III. For the subgroup analysis, domain analysis was applied to 
preserve the complex sampling design in which the entire samples were used for 
estimating the variance of subpopulations. All tests were two-sided, and P < 0.05 was 
considered statistically significant.  
For hypothesis 1.1, we expected that Mediterranean diet or DASH style diet 
would be favorable risk factors for metabolic health. Thus, we tested for the association 
of 1) continuous values and 2) the tertiles of MDS or DASH index with metabolic health 
using multivariable logistic regression analyses. In this model, we expect that the odds of 
being metabolic health will increase with increasing MDS and DASH index. The logistic 
regression model is described as follows. 
1)  𝑙𝑜𝑔𝑖𝑡 [𝜋(𝑥)] = 𝛼 +  𝛽1 ∗ (𝑀𝐷𝑆, 𝐷𝐴𝑆𝐻 𝑖𝑛𝑑𝑒𝑥) +  𝛽2 ∗ 𝐶𝑜𝑣1 +  𝛽3 ∗ 𝐶𝑜𝑣2 + ⋯ 
2)  𝑙𝑜𝑔𝑖𝑡 [𝜋(𝑥)] = 𝛼 +  𝛽1 ∗ 𝑄1 + 𝛽2 ∗ 𝑄2 + 𝛽3 ∗ 𝑄3 +  𝛽4 ∗ 𝐶𝑜𝑣1 +  𝛽5 ∗ 𝐶𝑜𝑣2 + ⋯ 
(𝑠𝑢𝑝𝑝𝑜𝑠𝑖𝑛𝑔 𝑡ℎ𝑎𝑡 𝑄1, 𝑄2, 𝑎𝑛𝑑 𝑄3 𝑎𝑟𝑒 𝑡𝑒𝑟𝑡𝑖𝑙𝑒𝑠 𝑜𝑓𝑀𝐷𝑆 𝑜𝑟 𝐷𝐴𝑆𝐻 𝑖𝑛𝑑𝑒𝑥) 
For hypothesis 1.2, we tested for the association of 1) continuous values and 2) 
the tertiles of MDS or DASH index with metabolic health using multivariable logistic 
regression analyses. In this model, we expected that the odds of being MHO would 
increase with increasing MDS and DASH index in obese population. 
For hypothesis 1.3, we tested for the association of 1) continuous values and 2) 
the tertiles of MDS or DASH index with metabolic health using multivariable logistic 
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regression analyses. In this model, we expected that the odds of being MONW would 
decrease with increasing MDS and DASH index in normal weight population. 
For hypothesis 2, cumulative mortality was estimated using Kaplan-Meier 
methods. Cox proportional hazards (PH) regression models were applied to estimate the 
hazard ratios (HRs) and 95% CIs for all-cause, CVD and cancer mortality. The 
proportional hazards assumption of the Cox models was evaluated with log of negative 
log survival curves based on Kaplan-Meier estimates for MDS tertile group as well as 
age, gender, and race/ethnicity. For Hypothesis 2.1, we tested the association of MDS and 
DASH index with all-cause, CVD, and cancer mortality using Cox proportional hazards 
(PH) regression analysis. In this model, we expected that hazard ratios for total, CVD, 
and cancer mortality risk would decrease with increasing numbers of MDS and DASH 
index as follows.  
3) ℎ(𝑡|𝑥) = ℎ0(𝑡) ∗ exp{𝛽1*(𝑀𝐷𝑆, 𝐷𝐴𝑆𝐻 𝑖𝑛𝑑𝑒𝑥) + 𝛽2 ∗ 𝐶𝑜𝑣1 +  𝛽3 ∗ 𝐶𝑜𝑣2 + ⋯} 
4) ℎ(𝑡|𝑥) = ℎ0(𝑡) ∗ exp{𝛽1*𝑄1 + 𝛽2 ∗ 𝑄2 + 𝛽3 ∗ 𝑄3 +  𝛽4 ∗ 𝐶𝑜𝑣1 +  𝛽5 ∗
𝐶𝑜𝑣2 + … } (𝑠𝑢𝑝𝑝𝑜𝑠𝑖𝑛𝑔 𝑡ℎ𝑎𝑡 𝑄1, 𝑄2, 𝑎𝑛𝑑 𝑄3 𝑎𝑟𝑒 𝑡𝑒𝑟𝑡𝑖𝑙𝑒𝑠 𝑜𝑓𝑀𝐷𝑆 𝑜𝑟 𝐷𝐴𝑆𝐻 𝑖𝑛𝑑𝑒𝑥) 
For hypothesis 2.2, we tested for interactions of 1) MDS and DASH index with 
being MHO or not in obese population by including the interaction terms in the Cox PH 
models based on Satterthwaite adjusted F tests as follows.  
5) ℎ(𝑡|𝑥) = ℎ0(𝑡) ∗ exp{𝛽1*(𝑀𝐷𝑆, 𝐷𝐴𝑆𝐻 𝑖𝑛𝑑𝑒𝑥) + 𝛽2 ∗ (𝑀𝐻𝑂 𝑜𝑟 𝑛𝑜𝑡) +  𝛽3 ∗
(𝑖𝑛𝑡𝑒𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑡𝑒𝑟𝑚𝑠) + 𝛽3 ∗ 𝐶𝑜𝑣1 + ⋯} 
6) ℎ(𝑡|𝑥) = ℎ0(𝑡) ∗ exp{𝛽1*(𝑀𝐷𝑆, 𝐷𝐴𝑆𝐻 𝑖𝑛𝑑𝑒𝑥) + 𝛽2 ∗ (𝑀𝑈𝑁𝑊 𝑜𝑟 𝑛𝑜𝑡) +  𝛽3 ∗
(𝑖𝑛𝑡𝑒𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑡𝑒𝑟𝑚𝑠) + 𝛽3 ∗ 𝐶𝑜𝑣1 + ⋯} 
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If the coefficient of this interaction terms was significant, we did a stratified 
analysis according to the status of being MHO or not, using the same model used in 3) or 
4).  This test also was applied to interactions of MDS and DASH index with being 
MONW or not in normal weight population. 
For hypothesis 3, we used two different approaches to explore the role of BMI 
and WC as a mediator in the association of Mediterranean diet and DASH style diet with 
markers for insulin resistance and inflammation. 
The traditional approach for mediation analysis included the following steps. First, 
linear regression analyses were applied to examine associations of Mediterranean diet 
and DASH style diet (the highest tertile vs. the first tertile, respectively) with BMI and 
WC, after adjusting for age, gender, race/ethnicity, educational attainment, living with 
spouse, income, smoking status, level of physical activity, family history of CHD, 
parental history of DM, and total energy intake, as well as alcohol consumption for the 
association of DASH style diet with BMI and WC (the estimate a in the Figure 3.1). 
Second, linear regression analyses were applied to examine the association of BMI and 
WC with markers for insulin resistance or inflammation, using the same covariates in 
addition to adjusting for MDS or DASH (the estimate b in the Figure 3.1). In this step, we 
added covariates to the model according to the characteristics of outcome variables (mean 
arterial pressure for markers for insulin resistance; multivitamin use for homocysteine). 
Third, the simple total effect of Mediterranean diet and DASH style diet was estimated 
by regressing the markers for insulin resistance or inflammation on MDS and DASH 
index while adjusting for the covariates used in the first step, but without adjusting for 
BMI or WC (the estimate c in the Figure 3.1). Fourth, BMI or WC was additionally 
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controlled in the model to estimate the direct effect of Mediterranean diet and DASH 
style diet on the markers for insulin resistance or inflammation (the estimate c in the 
Figure 3.1). Finally, the indirect effect by BMI or WC was estimated by calculating the 
product of the beta coefficient of the first regression model and the beta coefficient of the 
second regression model (the estimate a×b in the Figure 3.1) (Baron and Kenny 1986, 
Preacher and Hayes 2004). This approach also can be presented using the two 
models: 𝐸 [ 𝑀 ∣ 𝐴 = 𝑎, 𝐶 = 𝑐 ] =  𝛽₀ + 𝛽₁𝑎 + 𝛽₂′𝑐; 𝐸 [ 𝑌 ∣ 𝐴 = 𝑎, 𝑀 = 𝑚, 𝐶 = 𝑐 ] =
 𝜃₀ + 𝜃₁𝑎 + 𝜃₂𝑚 + 𝜃₄′𝑐 (a represents exposure, m represents mediator, and c represents 
confounders) in which the direct effect is evaluated by estimating 𝜃₁; the indirect effect is 
evaluated by estimating 𝛽₁𝜃₂ (Valeri and Vanderweele 2013). Then, we divided the 
indirect effect by its standard error and performed a z test under the null hypothesis that 
the indirect effect was equal to zero (Sobel 1982). In addition, proportion of mediation 
was calculated using the indirect effect as a numerator and the total effect as a 
denominator.  
BMI or WC was considered as a mediator if the estimates a and b were significant 
(Baron and Kenny 1986). Another criterion for determining a mediator would be whether 
or not the estimate c was significant (Preacher and Hayes 2004). However, we did not 
include this criterion in the present study, because the effect of Mediterranean diet and 
DASH style diet on the markers for insulin resistance or inflammation may not be 
significant when direct and mediated effects have opposite signs (Rucker et al. 2011, 
Valeri and Vanderweele 2013). 
In the causal mediation approach, we assessed the total, direct, and indirect effects 
of Mediterranean diet and DASH style diet on markers for insulin resistance or 
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inflammation with BMI or WC as a mediator, using the counterfactual framework 
(VanderWeele 2009, VanderWeele 2013). In this approach, total effect can be 
decomposed into direct effect (not mediated by BMI or WC) and indirect effect 
(mediated by BMI or WC). A causal directed acyclic graph (DAG) indicating these 
effects is presented in Figure 3.2. We applied the SAS macro developed by Valeri and 
VanderWeele to evaluate the natural direct effect, natural indirect effect, and marginal 
total effect of Mediterranean diet and DASH style diet on markers for insulin resistance 
or inflammation with BMI or WC as a mediator (Valeri and Vanderweele 2013).  
Natural direct effect and natural indirect effects can be evaluated conceptually as 
follows. For instance, natural direct effect is the contrast between the counterfactual 
outcome if the subject were exposed at the highest tertile of Mediterranean diet, and the 
counterfactual outcome if the same subject were exposed at the lowest tertile of 
Mediterranean diet, with BMI assuming whatever value it would have taken at the 
reference value of the lowest tertile of Mediterranean diet. Natural indirect effect is the 
contrast, having set the Mediterranean diet at level of the highest tertile, between the 
counterfactual outcome if BMI assumed whatever value it would have taken at a value of 
the highest tertile of Mediterranean diet, and the counterfactual outcome if the mediator 
assumed whatever value it would have taken at a reference value of the lowest tertile of 
Mediterranean diet. Based on these individual approaches, the average natural indirect 
and direct effects at the population level were estimated (Robins and Greenland 1992, 
Richiardi, Bellocco, and Zugna 2013). Survey procedures were not applied in the causal 
mediation analysis because a statistical tool was not developed yet for this procedure.  
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For this causal mediation analysis, we made four assumptions. First, there is no 
unmeasured confounding in the relation of Mediterranean diet and DASH style diet with 
the markers for insulin resistance or inflammation given confounders; second, there is no 
unmeasured confounding in the relation of BMI or WC with the markers for insulin 
resistance or inflammation; third, there is no unmeasured confounding in the relation of 
Mediterranean diet and DASH style diet with BMI and WC; fourth, there is no effect of 
Mediterranean diet and DASH style diet affecting confounders of the relationship of BMI 
and WC with the markers for insulin resistance or inflammation (VanderWeele 2009). 
Under these assumptions, natural direct effect, natural indirect effect, marginal total 
effect can be estimated using two separate linear regressions: the first regression of 
markers for insulin resistance or inflammation on the exposure (MDS or DASH index), 
the mediator (BMI or WC) and the confounding variables; and a second regression of 
BMI or WC on the MDS or DASH index and the confounding variables. Then, two 
regressions were combined to estimate natural direct and indirect effects. In this causal 
mediation analysis, we evaluated whether there is an interaction of MDS or DASH index 
with BMI or WC in the regression of the marker for insulin resistance and inflammation. 
When there is a significant interaction, controlled direct effect, natural direct effect, and 
natural indirect effect were estimated using the following models for change in MDS or 
DASH index from level a* to level a: controlled direct effect =(𝜃₁ + 𝜃₃𝑚)(𝑎 − 𝑎 ∗); 
natural direct effect = (𝜃₂𝛽₁ + 𝜃₃𝛽₁𝑎)(𝑎 − 𝑎 ∗); natural indirect effect =  (𝜃₁ + 𝜃₃ (𝛽₀ +
𝛽₁𝑎 ∗ +𝛽₂′𝑐))(𝑎 − 𝑎 ∗). When there is no significant interaction (𝜃₃ = 0), the controlled 
direct effect is equal to natural direct effect (Valeri and Vanderweele 2013). It is possible 
that the interaction may not be statistically significant due to low power. In addition, the 
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exposure-mediator interaction may be important in understanding the effects of mediation 
even when the interaction terms are not significant (VanderWeele 2015). Thus, we 
further evaluated whether there would be any substantial change in the magnitude of the 
natural indirect effect or the power to detect the natural indirect effect, with or without 
including the interaction terms of MDS or DASH index with BMI or WC in the model.  
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Table 3.1 Food items of food frequency questionnaires in NHANES III 
for assessing the Mediterranean diet 
 
Classification for 
Mediterranean diet    
Food item 
 
Grains 
 
Cereals: all-bran, etc 
  
Cereals: total, etc 
  
Cooked, hot cereals 
  
Dark breads and rolls 
  
Corn bread, muffins, tortillas 
Legume   Beans, lentils, chickpeas 
    Peanuts, peanut butter, etc 
Fruits 
 
Citrus fruits 
  
Melons 
  
Peaches, nectarines, etc 
   Any other fruits 
Vegetables 
 
Carrots 
  
Broccoli 
  
Brussel sprouts/cauliflower 
  
Tomatoes 
  
Spinach, greens, etc 
  
Tossed salad 
  
Cabbage, cole slaw, sauerkraut 
  
Hot red chili peppers 
  
Other peppers 
  
Any other vegetables 
Fish   Shrimp, clams, etc 
    Fish 
Olive oil 
 
 
Ratio of total saturated fatty acids (gm) to 
total monounsaturated fatty acids (gm) 
Alcohol  Beer and lite beer 
  
Wine, etc 
   Hard liquor 
Milk and dairy products 
 
Chocolate milk and hot cocoa 
  
Milk to drink or on cereal (Whole/regular; 
2% /low fat milk) 
  
Yogurt and frozen yogurt 
  
Ice cream, ice milk, milkshakes 
  
Cheese, all types 
  
Cheese dishes 
   Butter 
Red meat and products 
 
Bacon/sausage/processed meats 
  
Liver and other organ meats 
  
Beef 
  
Pork and ham 
Poultry 
 
Chicken and turkey 
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Table 3.2 Nutrient items of 24-h dietary recall in NHANES III 
for assessing DASH style diet index  
 
DASH style diet index   Nutrient 
Mellen’s index  
 
Protein (gm) 
  
Total fats (gm) 
  
Total saturated fatty acids (gm) 
  
Cholesterol (mg) 
  
Dietary fiber (gm) 
  
Calcium (mg) 
  
Magnesium (mg) 
  
Sodium (mg) 
    Potassium (mg) 
 
  
  
 
4
5
 
Table 3.3 Assessment of the Mediterranean Diet Score 
 
  Frequency of consumption (times/week or otherwise stated) 
Score 0 1 2 3 4 5 
Non-refined cereals (whole 
grain)  
Never 1-6 7-12 13-18 19-31 ≥32 
Legumes  Never <1 1-2 3-4 5-6 ≥7 
Fruits  Never 1-4 5-8 9-15 16-21 ≥22 
Vegetables  Never 1-6 7-12 13-20 21-32 ≥33 
Fish  Never <1 1-2 3-4 5-6 ≥7 
MUFA:SFA  
1st 
hexile 
2nd 
hexile 
3rd 
hexile 
4th 
hexile 
5th 
hexile 
6th 
hexile 
Score 5 4 3 2 1 0 
Red meat and products  ≤1 2-3 4-5 6-7 8-10 ≥11 
Poultry  ≤3 4-5 5-6 7-8 9-10 ≥11 
Dairy products  ≤10 11-15 16-20 21-28 29-30 ≥31 
Alcoholic beverages (g/d) 
<28g 
(men),  
<14g 
(women) 
Even intervals between two cutoffs 
0g or 
>70g 
(men),  
>28g 
(women) 
 
 
  
  
 
4
6
 
 
Figure 3.1 Traditional mediation model  
This model is based on the association of Mediterranean diet score and DASH style diet score with the 
markers for insulin resistance and inflammation as body mass index and waist circumference as a mediator. Path a 
represents the regression coefficient of the association of The Mediterranean diet score (MDS) and DASH diet 
score with BMI and WC. Path b represents the regression coefficient of the association of BMI and WC with the 
markers for insulin resistance and inflammation. The product of regression coefficients of path a and path b 
represents the mediated effect of BMI or WC (path a × path b). Path c’ represents the direct effect of MDS and 
DASH diet score with the markers for insulin resistance and inflammation, after the adjustment for BMI or WC. 
Path c represents the simple total effect of MDS and DASH diet score with the markers for insulin resistance and 
inflammation, without the adjustment for BMI or WC. 
  
 
4
7
 
 
 
 
 
 
 
Figure 3.2 Causal directed acyclic graph (DAG) describing relations of Mediterranean 
diet and DASH style diet (A) with the markers for insulin resistance and inflammation 
(Y) as BMI and waist circumference as a mediator (M)  
C1 and C2 include age, gender, race/ethnicity, educational attainment, income, 
living with spouse, smoking status, level of physical activity, family history of coronary 
heart disease, parental history of diabetes mellitus, and total calories (additionally 
adjusted for alcohol consumption in the model of DASH index).
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CHAPTER 4 
MEDITERRANEAN DIET, DIETARY APPROACHES TO STOP HYPERTENSION 
(DASH) STYLE DIET, AND METABOLIC HEALTH IN U.S. ADULTS 1
                                                 
1 Yong-Moon Mark Park, Susan E. Steck, Teresa T. Fung, Jiajia Zhang, Linda J. Hazlett, 
Kyungdo Han, and Anwar M. Merchant. To be submitted to Journal of Nutrition. 
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Abstract 
Background: There is little evidence on the relationship between Mediterranean 
diet, Dietary Approaches to Stop Hypertension (DASH) style diet, and metabolic health, 
especially in normal weight and obese population. 
Objective: To investigate the association of Mediterranean diet and DASH style 
diet with metabolically healthy obese (MHO) and metabolically obese normal weight 
(MONW) phenotypes in a representative U.S. population.  
Methods: Data from 2,767 adults aged 20-90 years without any prior diagnosis of 
cancer or cardiovascular disease were analyzed from the National Health and Nutrition 
Examination Survey III, 1988–1994. Mediterranean diet scores (MDS) and DASH index 
were calculated using food frequency questionnaires and 24-hr dietary recall data. MHO 
and MONW individuals were identified using criteria including high fasting glucose, 
insulin resistance, blood pressure, triglycerides, C-reactive protein, and low high-density 
lipoprotein-cholesterol. Logistic regression adjusting for potential confounders was used 
to examine associations for all participants and stratified by age groups (younger age 
group, <45 years for men or premenopausal women; older age group ≥45 for men or 
postmenopausal for women). 
Results: With increasing MDS, there was a higher prevalence of MHO phenotype, 
especially in the younger age group (P for trend = 0.01). Higher MDS was associated 
with higher odds of MHO phenotype (tertile 3 vs 1; odds ratio, 2.57 [95% confidence 
interval, 1.04-6.35]; P trend = 0.04), whereas higher DASH index was associated with 
lower odds of MONW phenotype (tertile 3 vs 1; 0.59 [0.38-0.93]; P trend = 0.03) only in 
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the younger age group. No significant association of MDS and DASH index with MHO 
and MONW phenotypes was observed in the older age group. 
Conclusions: Adherence to Mediterranean diet or DASH style diet was 
associated with MHO and MONW phenotypes only in the younger age group, suggesting 
that potential dietary intervention to prevent cardiometabolic disease differ by age group.  
Keywords: Mediterranean diet, Dietary Approaches to Stop Hypertension style 
diet, metabolically healthy obese, metabolically obese normal weight, National Health 
and Nutrition Examination Survey III 
Introduction 
Obesity is associated with an increased risk of type 2 diabetes and cardiovascular 
disease (CVD) (1), but not all obese individuals are equally susceptible to 
cardiometabolic risk. Within the same category of body mass index (BMI), a subgroup of 
obese individuals who have normal metabolic characteristics has been identified as 
metabolically healthy obese (MHO) phenotype, compared with metabolically unhealthy 
obese (MUO) phenotype (2-4). In addition, a subgroup of normal weight individuals who 
are susceptible to metabolic abnormalities has been referred to as metabolically obese 
normal weight (MONW) phenotype (5-8). 
It is well known that the Mediterranean diet and the Dietary Approaches to Stop 
Hypertension (DASH) style diets are associated with lower risk of cardiometabolic 
disease (9-12). Underlying mechanisms for cardiovascular health benefits of 
Mediterranean diet and DASH style diet are complex, but can be explained by the 
improvement of cardiometabolic profiles including insulin resistance, lipid profiles, 
blood pressure, and inflammatory markers (13). Therefore, it is plausible that adherence 
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to Mediterranean diet and DASH style diets might be positively associated with a 
metabolically healthy phenotype.  
Several studies have explored the association between dietary factors and 
metabolic phenotype. However, these reports have been limited to MHO phenotype (14), 
especially without considering dietary pattern (15), or with specific age groups (16). A 
few studies have reported associations in MONW phenotype in non-US population (17), 
but with limited generalizability (18). Several studies demonstrated that dietary factors 
are related to metabolic phenotype in both obese and normal weight population (19), but 
only focused on women (20), or single foods such as olive oil (21). However, limited data 
exist on the relationship of Mediterranean diet and DASH diet with metabolic phenotypes, 
especially for a potential differential association by age groups with substantially 
different cardiovascular risk.  
It has been suggested that the risk of developing coronary heart disease 
significantly increases after 45 years in men (22) and postmenopausal women (23). In 
addition, it is reported that the association between Mediterranean diet and 
atherothrombotic biomarkers is largely different between men <45 years and men ≥ 45 
years as well as premenopausal and postmenopausal women (24). Another study showed 
that the Healthy Eating Index score was associated with MHO phenotype only in younger 
age group (14). 
Therefore, we aimed to identify the association of Mediterranean diet and DASH 
style diet with MHO and MONW phenotypes in a nationally representative U.S. 
population, with a priori hypothesis that this association should be different according to 
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the two age groups exhibiting a substantial difference in cardiovascular risk; less than or 
greater than 45 years in men; before or after menopause in women.  
Methods  
Study population 
We used data from the Third National Health and Nutrition Examination Survey 
(NHANES III), 1988–1994 for this analysis. NHANES III was carried out using a 
complex multi-stage stratified clustered probability sample design to achieve a nationally 
representative sample of the civilian, non-institutionalized US population. The survey 
included personal interviews, physical examinations, and laboratory measurements. We 
included 3,858 normal weight (18.5 ≤ BMI < 25 kg/m2) and obese (BMI ≥ 30 kg/m2) 
adults aged 20-90 years with complete data on FFQ and 24-hour dietary recall, as well as 
the variables for defining metabolic health including fasting glucose, insulin, blood 
pressure (BP), triglycerides, high-density lipoprotein cholesterol (HDL-C), and high-
sensitivity C-reactive protein (hs-CRP) with at least 10 hours’ fasting. We applied the 
strict fasting criteria to minimize misclassification of metabolic health status. Because 
dietary habits might change due to chronic disease, we excluded those who reported a 
history of myocardial infarction, stroke, congestive heart failure, or any prior diagnosis of 
cancer (n=463).  To minimize reverse causation, we also excluded the participants who 
reported changing their dietary patterns due to any medical reason during the previous 12 
months (n=489). Furthermore, we excluded those who reported implausible extreme 
energy intakes (<1st and >99th percentiles of energy intake/d in adults), those with hs-
CRP >10mg/L, BMI > 60 kg/m2, or pregnant or lactating women (n=139). A total of 
2,767 individuals were analyzed in the present study where the younger age group 
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comprised men < 45 years and premenopausal women; and the older age group consisted 
of men ≥ 45 years and postmenopausal women. Women were designated as 
premenopausal if they reported having had a menstrual period during the previous 12 
months; and postmenopausal if they did not or if they had a history of surgery with both 
ovaries removed (25). 
Assessment of Mediterranean diet  
An 81-item food frequency questionnaire (FFQ) and 24-hr dietary recall data, 
validated by the Nutrition Methodology Working Group (26),  were used to assess dietary 
intake. Adherence to the Mediterranean diet was evaluated using the scoring 
methodology developed by Panagiotakos et al. (27, 28). In brief, scores 0 to 5 were 
assigned for the weekly consumption of food items assumed to be contributing to a 
Mediterranean dietary pattern, whereas scores on the inverse ordinal scale were assigned 
for the consumption of food items assumed to be against the Mediterranean dietary 
pattern. For instance, the scores assigned to the weekly consumption frequencies of 
legumes were as follows: no servings, less than 1 serving, 1–2 servings, 3–4 servings, 5–
6 servings, and >6 servings were assigned scores of 0, 1, 2, 3, 4 and 5, respectively. 
Similar score assignments were used for the food items of whole grains, potatoes, fruits, 
vegetables, fish, and olive oil. Reverse scores were assigned for the components of red 
meat and products, poultry and full-fat dairy products. For the alcohol consumption, a 
score of 5 was assigned for consumption of less than 300 ml (36g) of alcohol per day, 0 
for no consumption or for consumption of >700 ml (84g) per day. It has been shown that 
Mediterranean Diet Scores (MDS) are highly associated with prevalent cardio-metabolic 
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diseases, 10-year CVD risk, and inflammation and coagulation markers, in addition to 
capturing inherent characteristics of Mediterranean dietary pattern (24, 27, 28). 
The NHANES III FFQ applied a 1-month reference period without recording 
portion sizes. Thus, we calculated the MDS, assuming that the number of servings per 
week were equivalent to the number of times that a food item was consumed per week. 
Potatoes were excluded in our MDS assessment, because the way potatoes are prepared 
in U.S. is quite different from European countries (29). The amount of alcohol consumed 
daily was estimated using the following assumption: 12.8g for 12-oz beer, 11g for 4-oz 
glass of wine, and 14g for an ounce of liquor based on the questionnaire provided. 
Additionally, gender-specific cut-offs were applied: a score of 5 was assigned for 
consumption of less than 28g and 14 g of alcohol per day, score 0 for no consumption or 
for consumption of  greater than 70g and 28g per day in men and women, respectively, 
and the cutoffs for subcategories between 0 and 5 were reassigned with even intervals 
(30). Olive oil consumption was not measured in the NHANES III FFQ. Thus, we 
approximated olive oil consumption by calculating the ratio of total monounsaturated 
fatty acid to total saturated fatty acids using the 24-h dietary recall data, then dividing it 
into the six even intervals. Finally, the possible MDS score ranged from 0 to 50, with 
higher values of this MDS score indicating greater adherence to the Mediterranean diet. 
Assessment of DASH style diet  
We used 24-hr dietary recall data to calculate Mellen’s index which is one of the 
established DASH index scores (31), because the NHANES FFQ did not provide 
information on servings.  Mellen’s index, a nutrient-based index with 9 components 
including saturated fat, total fat, protein, cholesterol, fiber, magnesium, calcium, 
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potassium, and sodium using target nutrient values used in clinical trials (32), applied 
absolute targets on the basis of a 2100-kcal diet for both men and women. Individuals 
fulfilling the goal for each component received 1 point, those who met an intermediate 
goal, defined as the midpoint between the DASH diet goal and the nutrient content of the 
DASH control diet (33) received one-half of a point, and those who met neither goal 
received 0 points. The possible DASH score ranged from 0 to 9, with higher values of 
this DASH score indicating greater adherence to the DASH style diet. 
Assessment of Metabolic health 
We determined metabolic health, using the metabolic parameters that were 
measured under quality control standards of Centers for Disease Control and Prevention. 
BMI was calculated as kg/m2; height was measured to the nearest 0.1cm and weight to 
the nearest 0.01 kg. Waist circumference was measured at the level of the right iliac crest. 
BP was averaged over five separate measurements. Fasting glucose was measured in 
serum, using a modified hexokinase enzymatic method. Serum insulin was measured 
using a radioimmnuoassay (Pharmacia Diagnostics). HDL-C and triglycerides were 
measured using a Hitachi 704 analyzer (Boehringer-Mannheim Diagnostics). Serum hs-
CRP concentrations were measured by latex-enhanced nephlometry (Department of 
Laboratory Medicine, Immunology Division, University of Washington, Seattle). 
Metabolic health was defined when the individual had fewer than two cardiometabolic 
abnormalities [systolic/diastolic BP ≥ 130/85 mm Hg or antihypertensive medication use, 
triglycerides ≥ 150 mg/dL or on cholesterol-lowering medication, fasting glucose ≥ 100 
mg/dL or antidiabetic medication use, homoeostasis model assessment of insulin 
resistance (HOMA-IR = fasting glucose (mg/dl) x fasting insulin (lU/mL)/405) > the 90th 
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percentile, hs-CRP > the 90th percentile, and HDL-C < 40 mg/dL in men or < 50 mg/dL 
in women or on cholesterol-lowering medication] (34). Thus, obese individuals who had 
0 or 1 component were defined as MHO phenotype, whereas normal weight individuals 
who had 2 or more components were defined as MONW phenotype. 
Assessment of Covariates 
Participants’ sociodemographic characteristics, medical history, and lifestyle 
related characteristics were measured during the personal interview. Sociodemographic 
variables included age, gender, race or ethnicity (non-Hispanic white, non-Hispanic black, 
Mexican American, or others), educational attainment (<12 years, 12 years, or >12 years 
of education), living with spouse, and level of income measured based on poverty income 
ratio (PIR) which is the ratio of household income to the appropriate poverty threshold 
(low (PIR ≤ 1.3), middle (1.3<PIR ≤ 3.5), and high (PIR>3.5)). Family history of 
coronary heart disease (CHD) and parental history of DM were self-reported. Smoking 
status was categorized as never, former, and current. The amount of alcohol consumed 
daily was estimated using the above mentioned assumption. Moderate alcohol use was 
defined as consumption up to 28g and 14 g of alcohol per day in men and women (30). 
Physical activity was categorized based on the recommended levels of physical activity 
(35). Recommended physical activity was designated as a self-reported leisure time 
moderate activity (3 ≤ metabolic equivalents (METs) <6) of five or more times per week 
or leisure time vigorous activity (METs ≥ 6) three or more times per week; physical 
inactivity as no reported leisure time physical activity; and insufficient physical activity 
as not meeting the criteria for recommended levels of physical activity but not inactive.  
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Statistical Analysis 
Descriptive statistics were computed for the sample across the presence or 
absence of MHO phenotype and MONW phenotype in each age group. Continuous 
variables were presented by mean (SE: standard error) and compared using linear 
regression analyses. Categorical variables were expressed by percentage with SE and 
were compared using Rao-Scott χ2 tests. We used the appropriate survey procedures to 
account for the complex sampling design by using weights used in NHANES III. For the 
subgroup analysis, domain option was applied in survey procedure to preserve 
appropriate subsample in the complex sampling design, and it utilized the entire samples 
to estimate the variance of subpopulations.  
Multiple linear regression analyses were performed to test whether there is any 
difference in the consumption of Mediterranean diet, DASH style diet, and their 
components between metabolic phenotypes (Metabolically Healthy Normal Weight 
(MHNW) vs. MONW and MHO vs. MUO) after adjusting for educational attainment, 
income, living with spouse, smoking status, alcohol consumption, level of physical 
activity, family history of CHD, parental history of DM, total energy intake, and BMI. 
The consumption of dietary factors were also compared between MHO and MHNW 
phenotype. Considering multiple comparisons of Mediterranean diet and DASH style diet 
between metabolic phenotypes, a Bonferroni-corrected significance threshold (alpha = 
0.0167) was applied (36).  
Logistic regression analyses were conducted to generate odds ratios (ORs) and 95% 
confidence intervals (CIs) to quantify the associations of the tertiles of MDS and DASH 
score with the MHO and MONW phenotype. Since it was hypothesized that healthy 
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dietary patterns would be positively associated with MHO phenotype and inversely 
associated with MONW phenotype, the main outcomes of interest in the present study 
were MHO phenotype in the obese individuals and MONW phenotype in the normal 
weight individuals. For analyses in the obese population, the MUO phenotype was 
considered the referent group. For analyses in the normal weight population, the MHNW 
phenotype was designated as the referent group. Multivariable-adjusted model included 
age and total energy intake as continuous covariates; gender, race/ethnicity, educational 
attainment, income, living with spouse, smoking status, level of physical activity, family 
history of CHD, parental history of DM as categorical covariates. We evaluated age-, 
gender-, and race/ethnicity- adjusted ORs in model 1; further adjusted for the educational 
attainment, living with spouse, income, smoking status, level of physical activity, family 
history of CHD, parental history of DM, and total energy intake in model 2. Alcohol 
consumption as a categorical variable was added in the model in which the association 
between DASH index and metabolic health was assessed. Obesity parameters such as 
BMI or waist circumference were not included in the model, assuming that these may be 
on the causal pathway between healthy dietary pattern and metabolic health. 
All the statistical analyses were performed using SAS 9.4 software (SAS Institute 
Inc., Cary, NC, USA), using the P value of less than .05 was considered statistically 
significant.  
Results 
MHO and MONW phenotypes were observed in 40.5% and 10.2 % in the 
younger age group; 19.0% and 40.5% in the older age group, respectively. Table 4.1 
shows general and clinical characteristics according to the presence or absence of MHO 
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and MONW phenotypes in both age groups. MHO individuals were less likely to be non-
Hispanic white; had more favorable metabolic parameters in both age groups, but were 
less likely to have CHD family history and DM parental history in younger age group; 
were less likely to be smokers and more likely to be physically active in older age group, 
compared to MUO individuals. MONW individuals were older, and had less favorable 
metabolic parameters compared to MHNW in both age groups as expected given that the 
metabolic parameters were used in categorizing metabolic health status. MONW 
individuals in the younger age group were more likely to be men and smokers and have a 
parental history of DM than their MHNW counterparts. MONW individuals in the older 
age group had less education and were less likely to be physically active, compared to 
their MHNW individuals. 
Table 4.2 shows the distribution of weekly consumption frequencies of each 
component of Mediterranean diet according to the presence or absence of MHO and 
MONW phenotypes in both age groups. Overall, MDS was not very different between 
MHO and MUO; or between MONW and MHNW in either age group. MHO individuals 
consumed more grains and legumes than MUO individuals in the younger age group. 
MONW individuals consumed less fish in older age group. In addition, MONW 
individuals were less likely to consume fruits and poultry in younger age group; fruits 
and red meats in older age group, compared to MHNW individuals, all of which were 
marginally significant. When we compared MHO individuals with MHNW individuals in 
each age group, older MHO individuals consumed fewer vegetables. In addition, younger 
MHO individuals consumed fewer vegetables, whereas younger MHO individuals had 
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lower MDS and consumed more red meats; older MHO individuals consumed less dairy 
products, all of which were marginally statistically significantly different. 
Table 4.3 shows the distribution of each components of DASH style diet 
according to the presence or absence of MHO and MONW phenotypes in both age 
groups. Overall, no difference of DASH score was observed between metabolic 
phenotypes in either age group, although MONW individuals had a lower average DASH 
score compared to MHNW individuals in the younger age group which was marginally 
significant. MHO individuals consumed less cholesterol than MUO individuals in older 
age group. MONW individuals consumed less fiber and magnesium in younger age group, 
and less protein in older age group, compared to MHNW individuals. When we 
compared MHO individuals with MHNW individuals, MHO individuals had a lower 
average DASH score; consumed more total fat and saturated fat, and less fiber.  
Distribution of metabolic risk factors according to the tertiles of Mediterranean 
diet scores and DASH index by age group are shown in Table 4.4 for obese individuals 
and Table 4.5 for normal weight individuals, after adjusting for age, gender, and 
race/ethnicity. Overall, triglycerides tended to decrease with increasing MDS tertile in all 
subgroups; HDL-C was likely to increase with increasing MDS tertile, especially in older 
obese and younger normal weigh individuals. In contrast, triglycerides tended to increase 
with increasing DASH tertile although significant trend was observed only in young 
obese individuals. DBP tended to decrease with increasing DASH tertile except younger 
obese group. However, SBP was likely to increase with increasing MDS tertile in obese 
individuals; DBP increased in old obese individuals. BMI and waist circumference 
tended to decrease in younger obese individuals with increasing tertiles of MDS and 
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DASH index. Conversely, BMI tended to increase with increasing tertile of MDS in 
younger normal weight individuals. Decrease of hs-CRP was only observed in obese 
individuals. Total energy intake was decreased with increasing tertile of DASH index in 
all subgroups. 
Figures 4.1a through 1d show the prevalence of MHO and MONW according to 
tertiles of MDS and DASH scores in younger and older age groups. With increasing 
MDS, there was a higher prevalence of MHO phenotype, especially in young age group 
(P for trend = 0.01). No significant trend was observed in other results.  
Table 4.6 shows the association of MDS and DASH scores with MHO and 
MONW phenotypes in younger and older age groups. Among younger adults, those in 
the third vs. first tertile of MDS had higher odds of MHO phenotype (OR, 2.57 [95% CI, 
1.04-6.35], P trend = 0.04), whereas those in the third vs. first tertile of DASH index had 
lower odds of MONW phenotype (OR, 0.59 [95% CI, 0.38-0.93], P trend = 0.03), after 
multivariable adjustment. Although those in the third vs. first tertile of MDS among older 
adults had marginally significantly higher odds of MHO phenotype in age-, gender-, and 
race/ethnicity- adjusted model (OR, 1.84 [95% CI, 0.99-3.43], P trend = 0.06), this 
association was no longer significant after multivariable adjustment. Otherwise, no 
significant association of MDS and DASH index with MHO and MONW phenotypes was 
observed.  
Table 4.7 reports results of the logistic regression analyses examining whether 
level of physical activity was associated with MHO and MONW phenotypes. Individuals 
in the younger age group who reported getting recommended levels of physical activity 
had lower odds of MONW phenotype, whereas individuals in the older age group who 
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reported getting recommended levels of physical activity had both higher odds of MHO 
and lower odds of MONW phenotype. 
Discussion 
In this nationally representative sample of U.S. adults, the Mediterranean diet and 
DASH style diet were associated with metabolic phenotypes in the younger age group 
that included men < 45 years and premenopausal women. More specifically, MDS was 
positively associated with MHO phenotype, whereas the DASH index was inversely 
associated with the MONW phenotype, independent of a wide range of potential 
confounders. MDS and DASH index were not associated with MHO and MONW 
phenotypes in the older age group that included men ≥ 45 years and postmenopausal 
women, suggesting that healthy dietary patterns may be more effective in reducing the 
cardiometabolic risk among younger adults.  
Several epidemiological studies have explored the association of healthy dietary 
patterns with MHO and MONW phenotypes. Phillips et al. showed that higher 
compliance with food pyramid recommendations and DASH diet score were likely to be 
associated with metabolic health in obese and non-obese, respectively, Irish population 
aged 45-74 years. However, the results were not significant after multivariable 
adjustment (19). The age distribution of this study was similar to the older age group in 
our study in which no significant association of high dietary quality with metabolic health 
existed. Camhi et al. demonstrated that Healthy Eating Index 2005 scores were higher in 
MHO women aged 19-44 years compared with MUO women, but no difference was 
found in adults 45-85 years based on NHANES 2007-2010 data (14). Suliga et al. 
evaluated a normal weight Polish population aged 37-66 using the prudent dietary pattern, 
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characterized by a high consumption of fish and whole grains, and a low consumption of 
refined grains, sugar, sweets and cold cured meat, and found that higher scores of the 
prudent dietary pattern were associated with lower odds of MONW phenotype (18).  
Our study is unique in terms of assessing both Mediterranean diet and DASH 
style diet, measured by FFQ and 24 dietary recall, respectively, in the association with 
MHO and MONW phenotypes, according to age groups known to have distinct 
differential cardiovascular risk. Consistent with the findings from the previous research 
(14, 16, 19), the association between high diet quality and metabolic health was not 
apparent in older age group, although MDS was marginally significant with being more 
likely to be MHO phenotype in age-, gender-, and race/ethnicity- adjusted model. These 
findings suggest that other factors such as physical activity might be more important than 
diet in relation to metabolic abnormalities among older adults, which is supported by the 
fact that age-related changes in body composition, especially increase in visceral fat, may 
elevate the risk of cardiometabolic disease (37).  In our study, individuals in the older age 
group who reported getting recommended levels of physical activity had higher odds of 
MHO and lower odds of MONW phenotype (Table 4.7).  
Interestingly, the significant associations of MDS and DASH index with 
metabolic health in the younger age group differed according to MHO and MONW 
phenotypes; MDS was positively associated the MHO phenotype, whereas the DASH 
index was inversely associated with the MONW phenotype. The Mediterranean diet is 
rich in dietary fiber, antioxidant capacity, polyphenolic compounds, and magnesium (38), 
all of which are closely related to decreased insulin resistance, a key mechanism of 
metabolic abnormalities in obese individuals (39). We found that HOMA-IR, a surrogate 
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measure of insulin resistance, was significantly decreased with increasing MDS tertile, 
especially in younger obese individuals (Table 4.4). In addition, high intake of 
monounsaturated fatty acids (MUFAs), a key characteristic of the Mediterranean diet 
usually represented by olive oil consumption, contributes to lowering triglycerides and 
increasing HDL-C, two main components for determining metabolic health (40). 
Although intake of a single food cannot account for the underlying mechanism, higher 
consumption of legumes, another food source rich in MUFAs, in younger MHO 
individuals shown in Table 4.2 might contribute much to the association between higher 
MDS and MHO phenotype in the present population. Furthermore, the decreasing level 
of triglycerides with increasing tertile of MDS might support this association. In contrast, 
the increasing levels of triglycerides were observed with increasing tertiles of DASH 
index, indicating that a low fat diet may have an adverse effect on lipid profiles (Table 
4.4) (41, 42). 
In younger normal weight individuals, higher DASH index was associated with 
lower odds of MONW phenotype. MDS also showed the same direction with DASH 
index in the association with MONW, although it was not statistically significant. The 
DASH index used in the present study was developed based on the nutrient targets in the 
DASH trial (33). Among the components of DASH index, the consumption of fiber and 
magnesium was significantly lower in young MONW individuals, compared with their 
MHNW counterparts. Magnesium has been known to be associated with lower risk of 
metabolic syndrome (43) and type 2 DM (44). It is unclear whether dietary fiber and 
magnesium act synergistically or independently on decreasing the risk of metabolic 
disease such as type 2 DM (45). However, dietary fiber and magnesium are known to be 
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highly correlated (46), which may support our results that two factors were significantly 
different between MONW and MHNW phenotypes altogether.  
It has been argued that the MHO phenotype might not be a favorable condition, 
compared with MHNW phenotype (47). Few studies have compared dietary consumption 
between MHNW and MHO phenotypes. A study conducted among white and black 
women aged 45-98 years demonstrated that food intake was not different between two 
phenotypes after multivariable adjustment (20). The present study showed that MHO 
individuals consumed less vegetables and fiber, higher saturated fat and total fat, and had 
a lower DASH score, especially in younger age group, suggesting that MHO individuals 
are less likely to have healthy dietary habit compared with MHNW individuals.  
As expected, the prevalence and characteristics of MHO and MONW phenotypes 
were considerably different between younger and older age groups that were pre-defined 
by differential cardiovascular risk. The prevalence of MHO was relatively higher in 
younger age group whereas the prevalence of MONW was relatively higher in older age 
group, which also has been reported from other studies (34, 48). In addition, both MHO 
and MONW phenotypes were associated with DM parental history in younger age group; 
physical activity in older ager group altogether, suggesting that genetic factors in younger 
age group and lifestyle related factor in older age group might be predominantly related 
to metabolic health independent of obesity status.  
Our study has several strengths. First, we used data from a valid and reliable 
nationally representative study, based on extensive laboratory and physical examinations 
using standardized protocols to minimize the influence of measurement errors. Second, 
we assessed the association between healthy dietary patterns and metabolic health in a 
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comprehensive way consisting of normal weight and obese populations; younger and 
older age groups with distinct differential cardiovascular risk, using MDS and DASH 
score. Finally, the present study adjusted for a wide range of potential confounders in 
multivariable analyses. There are also several limitations. First, this cross-sectional study 
cannot imply a causal relationship between healthy dietary pattern and metabolic health, 
although we tried to minimize reverse causality using strict exclusion criteria. Second, 
since the information on “servings per week” was not available at NHANES III FFQ, we 
used “times per week” in assessing the consumption frequency for MDS calculation. This 
approach might cause exposure misclassification, but the direction would be non-
differential. In addition, we used nutrient data from the 24-hr dietary recall data in 
calculating DASH score, which might not be comparable to DASH score based on FFQ 
in other studies. However, we were able to compare the association between metabolic 
health and healthy dietary pattern in terms of food based approach and nutrient based 
approach. Third, there might be residual confounding due to not measuring the covariates 
in an objective way, such as self-reported physical activity and smoking status. 
In conclusion, the prevalence of MHO and MONW phenotypes and their related 
characteristics were distinctly different in younger and older age groups. Adherence to 
Mediterranean diet or DASH style diet is likely to be beneficially associated with MHO 
and MONW phenotypes in younger adults, suggesting that potential interventions to 
prevent cardiometabolic disease may need to be tailored by age group. Prospective 
studies evaluating relations between healthy dietary patterns and the risk of metabolic 
health are warranted. 
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Table 4.1 Comparison of general and clinical characteristics between the metabolic phenotypes in younger age 
group and older age group  
 
    Younger age group (men < 45 years and premenopausal women)   
Characteristics MHNW MONW 
P 
MHO MUO 
P 
    (n=1,096) (n=164) (n=284) (n=411) 
Age, years 31.1 ± 0.3 35.6 ± 0.5 <0.001 35.1 ± 0.6 36.1 ± 0.7 0.27 
Men, % 42.5 ± 1.8 61.0 ± 6.3 0.005 36.5 ± 4.6 53.5 ± 5.2 0.03 
Race/ ethnicity, % 
              
 
Non-Hispanic white 74.6 ± 3.0 70.7 ± 6.5 0.83 61.9 ± 5.1 66.1 ± 4.0 <0.001 
 
Non-Hispanic black 10.0 ± 1.2 9.8 ± 1.9 
 
27.0 ± 3.9 13.5 ± 2.4 
 
 
Mexican-American 4.8 ± 0.8 5.9 ± 1.4 
 
5.2 ± 1.1 11.0 ± 1.9 
 
 
Other 10.6 ± 2.1 13.6 ± 6.3 
 
5.9 ± 1.6 9.4 ± 2.9 
 
Educational attainment, % 
              
 
<12 years 15.7 ± 1.7 18.3 ± 4.5 0.80 19.2 ± 3.2 22.8 ± 4.5 0.75 
 
12 years 33.5 ± 2.4 29.6 ± 6.8 
 
44.7 ± 4.8 40.7 ± 5.3 
 
 
>=13 years 50.8 ± 2.4 52.2 ± 6.6 
 
36.1 ± 4.4 36.5 ± 5.6 
 
Income, % 
              
 
PIR=<1.3 19.5 ± 2.3 15.7 ± 3.6 0.14 23.2 ± 4.4 17.8 ± 2.3 0.41 
 
PIR=<3.5 40.2 ± 2.7 55.1 ± 8.6 
 
42.6 ± 5.2 51.2 ± 5.0 
 
 
PIR>3.5 40.3 ± 2.6 29.3 ± 7.8 
 
34.2 ± 5.1 31.0 ± 4.5 
 
Living with spouse, % 55.6 ± 2.4 64.2 ± 6.4 0.24 69.9 ± 4.2 67.4 ± 4.7 0.64 
Smoking status, % 
              
 
Never 50.5 ± 2.4 34.6 ± 4.4 0.02 51.8 ± 6.4 44.5 ± 4.7 0.08 
 
Former 18.4 ± 1.7 23.7 ± 4.7 
 
15.8 ± 4.0 29.9 ± 5.0 
 
 
Current 31.1 ± 2.5 41.7 ± 6.1 
 
32.4 ± 5.4 25.6 ± 2.9 
 
Drinking alcohol, % 
              
 
Never 33.7 ± 2.2 40.1 ± 6.6 0.28 39.1 ± 5.0 46.6 ± 4.9 0.47 
 
Moderate 63.8 ± 2.2 59.3 ± 6.6 
 
59.9 ± 5.0 52.6 ± 4.9 
 
 
Heavy 2.5 ± 0.5 0.6 ± 0.5 
 
1.1 ± 0.6 0.7 ± 0.5 
 
Physical activity, % 
              
 
Inactive 10.4 ± 1.7 13.0 ± 3.2 0.59 13.9 ± 2.2 12.1 ± 2.4 0.73 
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Insufficient activity 54.7 ± 2.6 57.0 ± 6.0 
 
64.4 ± 5.1 61.1 ± 4.7 
 
 
Recommended 
Activity 
35.0 ± 2.7 30.0 ± 4.9 
 
21.7 ± 4.7 26.8 ± 5.1 
 
CHD family history, % 16.0 ± 1.8 17.8 ± 4.0 0.68 12.4 ± 3.2 23.9 ± 3.6 0.05 
DM parental history, % 12.6 ± 1.6 21.4 ± 5.2 0.04 21.7 ± 4.5 35.8 ± 5.9 0.03 
DM, % 0.03 ± 0.03 2.3 ± 1.6 <0.001 0.00 ± 0.00 7.3 ± 2.1 NA 
Hypertension, % 3.2 ± 0.6 19.3 ± 4.9 <0.001 19.4 ± 5.0 35.5 ± 4.0 0.03 
BMI, kg/m2 22.0 ± 0.1 22.8 ± 0.1 <0.001 33.6 ± 0.2 35.4 ± 0.4 <0.001 
Waist circumference, cm 77.8 ± 0.2 84.8 ± 0.8 <0.001 104.1 ± 0.9 109.5 ± 1.0 <0.001 
Fasting glucose, mg/dl 89 ± 0.3 98 ± 1.0 <0.001 92 ± 0.5 103 ± 1.4 <0.001 
HOMA-IR 1.48 ± 0.03 2.32 ± 0.09 <0.001 2.62 ± 0.05 4.86 ± 0.31 <0.001 
SBP, mmHg 111 ± 0.4 122 ± 2.1 <0.001 118 ± 1.0 125 ± 0.7 <0.001 
DBP, mmHg 69 ± 0.5 77 ± 1.2 <0.001 74 ± 0.8 81 ± 0.8 <0.001 
hs-CRP, mg/dl 0.25 ± 0.01 0.40 ± 0.03 <0.001 0.43 ± 0.02 0.55 ± 0.04 0.003 
Triglycerides, mg/dl 79 ± 1.5 161 ± 6.0 <0.001 98 ± 3.6 181 ± 7.2 <0.001 
HDL-C, mg/dl 56 ± 0.7 43 ± 1.4 <0.001 50 ± 0.9 38 ± 0.8 <0.001 
 
 
Table 4.1 (Continued) 
    Older age group (men ≥ 45 years and postmenopausal women)    
Characteristics MHNW MONW 
P 
MHO MUO 
P 
    (n=244) (n=223) (n=69) (n=276) 
Age, years 59.0 ± 0.7 64.4 ± 0.8 <0.001 60.3 ± 0.6 58.4 ± 0.6 0.05 
Men, % 57.2 ± 4.0 54.7 ± 4.6 0.64 28.5 ± 6.7 50.2 ± 4.4 0.01 
Race/ ethnicity, % 
              
 
Non-Hispanic white 81.6 ± 3.0 73.2 ± 3.9 0.09 74.0 ± 6.2 80.5 ± 3.6 <0.001 
 
Non-Hispanic black 7.4 ± 1.8 10.8 ± 1.9 
 
21.5 ± 5.4 9.2 ± 1.4 
 
 
Mexican-American 2.0 ± 0.5 3.7 ± 1.0 
 
4.0 ± 1.4 4.1 ± 0.8 
 
 
Other 9.0 ± 2.2 12.3 ± 3.2 
 
0.5 ± 0.5 6.1 ± 3.4 
 
Educational attainment, % 
              
 
<12 years 24.2 ± 3.4 39.1 ± 4.3 0.01 19.2 ± 3.2 22.8 ± 4.5 0.75 
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12 years 28.2 ± 4.7 30.8 ± 4.5 
 
44.7 ± 4.8 40.7 ± 5.3 
 
 
>=13 years 47.6 ± 4.3 30.2 ± 4.0 
 
36.1 ± 4.4 36.5 ± 5.6 
 
Income, % 
              
 
PIR=<1.3 13.7 ± 3.0 22.4 ± 3.7 0.07 12.7 ± 6.6 18.4 ± 4.0 0.63 
 
PIR=<3.5 38.9 ± 4.1 42.3 ± 3.9 
 
43.0 ± 8.7 44.9 ± 3.8 
 
 
PIR>3.5 47.4 ± 4.5 35.3 ± 5.2 
 
44.3 ± 8.8 36.7 ± 4.3 
 
Living with spouse, % 68.4 ± 4.0 64.2 ± 4.1 0.39 75.5 ± 5.8 73.3 ± 3.5 0.74 
Smoking status, % 
              
 
Never 45.8 ± 3.8 49.1 ± 4.5 0.79 61.4 ± 6.9 38.2 ± 3.6 0.002 
 
Former 25.0 ± 3.5 22.3 ± 4.1 
 
32.8 ± 7.1 38.4 ± 4.0 
 
 
Current 29.1 ± 3.6 28.5 ± 3.5 
 
5.8 ± 3.1 23.4 ± 3.1 
 
Drinking alcohol, % 
              
 
Never 44.8 ± 4.9 48.7 ± 5.8 0.65 63.4 ± 8.5 58.0 ± 4.2 0.43 
 
Moderate 50.2 ± 5.0 45.3 ± 5.8 
 
32.2 ± 7.8 40.6 ± 4.5 
 
 
Heavy 5.0 ± 1.9 6.0 ± 2.4 
 
4.4 ± 4.3 1.4 ± 0.8 
 
Physical activity, % 
              
 
Inactive 10.3 ± 1.9 21.0 ± 3.8 0.02 16.8 ± 4.2 22.6 ± 3.0 0.02 
 
Insufficient activity 48.3 ± 4.4 37.4 ± 4.1 
 
36.9 ± 9.9 51.8 ± 3.8 
 
 
Recommended 
Activity 
41.4 ± 4.0 41.6 ± 4.4 
 
46.3 ± 9.0 25.7 ± 3.2 
 
CHD family history, % 9.9 ± 2.6 8.7 ± 2.7 0.72 10.1 ± 4.5 20.1 ± 3.4 0.11 
DM parental history, % 17.6 ± 4.5 13.8 ± 2.6 0.38 14.4 ± 5.2 29.3 ± 4.6 0.09 
DM, % 4.2 ± 2.0 15.4 ± 3.2 0.006 6.4 ± 2.8 29.9 ± 4.4 0.001 
Hypertension, % 24.9 ± 4.0 60.8 ± 4.8 <0.001 36.2 ± 7.7 61.3 ± 5.1 0.02 
BMI, kg/m2 22.4 ± 0.1 22.9 ± 0.1 <0.001 32.8 ± 0.2 34.2 ± 0.3 <0.001 
Waist circumference, cm 84.3 ± 0.5 87.5 ± 0.6 <0.001 104.8 ± 0.6 111.6 ± 0.7 <0.001 
Fasting glucose, mg/dl 93 ± 0.8 106 ± 1.6 <0.001 95 ± 0.6 121 ± 3.2 <0.001 
HOMA-IR 1.50 ± 0.03 2.29 ± 0.08 <0.001 2.59 ± 0.07 5.69 ± 0.41 <0.001 
SBP, mmHg 123 ± 1.0 140 ± 1.5 <0.001 129 ± 1.3 136 ± 1.1 0.000 
DBP, mmHg 73 ± 0.5 78 ± 0.9 <0.001 76 ± 1.0 79 ± 0.5 0.01 
hs-CRP, mg/dl 0.26 ± 0.01 0.36 ± 0.02 <0.001 0.42 ± 0.03 0.60 ± 0.03 <0.001 
Triglycerides, mg/dl 96 ± 3.1 173 ± 12.8 <0.001 108 ± 4.4 202 ± 7.6 <0.001 
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HDL-C, mg/dl 60 ± 1.5 49 ± 1.3 <0.001 58 ± 1.1 44 ± 1.2 <0.001 
Data are presented as means ± standard error or proportion (%) ± standard error.  
P values for continuous variables represent P for trend. 
Abbreviations: MHNW, metabolically healthy normal weight; MONW, metabolically obese normal weight; MHO, 
metabolically healthy obese; MUO, metabolically unhealthy obese; PIR, poverty income ratio; CHD, coronary heart 
disease; DM, diabetes mellitus, BMI, body mass index; HOMA-IR, homoeostasis model assessment of insulin resistance; 
SBP, systolic blood pressure; DBP, diastolic blood pressure; hs-CRP, high-sensitivity C-reactive protein; HDL-C, high-
density lipoprotein cholesterol. 
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Table 4.2 Comparison for each component of Mediterranean diet scores between the metabolic phenotypes in younger age 
group and older age group 
 
  Younger age group (men < 45 years and premenopausal women)     
 
MHNW MONW 
P 
MHO MUO 
P 
P (MHNW vs 
MHO)   (n=1,096) (n=164) (n=284) (n=411) 
Score range (12 - 41) (12 - 37) 
 
(13 - 38) (12 - 39) 
  
MDS  26.1 ± 0.2 26.0 ± 0.5 0.35 26.0 ± 0.4 25.2 ± 0.3 0.14 0.03 
Grains (times/wk) 3.9 ± 0.2 4.1 ± 0.5 0.87 4.1 ± 0.3 5.0 ± 0.7 0.01 0.79 
Legumes (times/wk) 2.7 ± 0.1 2.6 ± 0.2 0.33 2.9 ± 0.2 2.6 ± 0.2 0.005 0.92 
Fruit (times/wk) 5.4 ± 0.3 4.8 ± 0.3 0.04 4.7 ± 0.6 4.7 ± 0.4 0.72 0.12 
Vegetable (times/wk) 13.6 ± 0.5 14.2 ± 1.1 0.59 12.4 ± 0.5 12.1 ± 0.7 0.90 0.15 
Fish (times/wk) 1.5 ± 0.1 1.5 ± 0.2 0.99 1.6 ± 0.2 1.2 ± 0.2 0.18 0.61 
MUFA:SFA 1.20 ± 0.02 1.19 ± 0.03 0.59 1.18 ± 0.01 1.18 ± 0.02 0.38 0.41 
Red meats (times/wk) 5.3 ± 0.1 5.9 ± 0.4 0.18 5.6 ± 0.6 5.6 ± 0.4 0.28 0.02 
Poultry (times/wk) 2.2 ± 0.1 1.8 ± 0.1 0.03 2.1 ± 0.2 2.1 ± 0.1 0.36 0.59 
Dairy products (times/wk) 12.7 ± 0.4 11.0 ± 0.8 0.08 10.5 ± 0.9 11.8 ± 0.7 0.15 0.43 
Alcohol (g/d) 3.6 ± 0.3 4.0 ± 0.6 0.97 2.6 ± 0.3 2.4 ± 0.4 0.11 0.36 
Total energy intake, kcal 2316 ± 46 2152 ± 89 <0.001 2132 ± 82 2478 ± 110 0.12 0.07 
 
 
Table 4.2 (Continued) 
  Older age group (men ≥ 45 years and postmenopausal women)  
 
MHNW MONW 
P 
MHO MUO 
P 
P (MHNW vs 
MHO)   (n=244) (n=223) (n=69) (n=276) 
Score range (14 - 42) (16 - 40) 
 
(15 - 36) (15 - 40) 
  
MDS  27.5 ± 0.4 26.8 ± 0.4 0.64 26.2 ± 0.4 25.3 ± 0.4 0.47 0.34 
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Grains (times/wk) 5.4 ± 0.3 6.1 ± 0.5 0.98 7.1 ± 1.0 4.9 ± 0.4 0.22 0.61 
Legumes (times/wk) 3.1 ± 0.2 3.2 ± 0.3 0.16 2.3 ± 0.2 2.4 ± 0.2 0.78 0.41 
Fruit (times/wk) 8.5 ± 0.5 6.8 ± 0.6 0.03 7.2 ± 0.4 7.2 ± 0.4 0.16 0.18 
Vegetable (times/wk) 17.1 ± 0.7 16.0 ± 0.7 0.04 14.5 ± 0.8 13.5 ± 0.5 0.60 0.002 
Fish (times/wk) 1.7 ± 0.1 1.2 ± 0.1 0.003 1.4 ± 0.1 1.2 ± 0.1 0.10 0.73 
MUFA:SFA 1.22 ± 0.03 1.20 ± 0.03 0.57 1.23 ± 0.03 1.20 ± 0.03 0.34 0.36 
Red meats (times/wk) 5.0 ± 0.3 4.4 ± 0.3 0.02 4.4 ± 0.2 5.3 ± 0.3 0.20 0.16 
Poultry (times/wk) 2.1 ± 0.1 2.0 ± 0.1 0.18 2.0 ± 0.2 2.0 ± 0.2 0.93 0.31 
Dairy products (times/wk) 11.3 ± 0.4 10.7 ± 0.7 0.73 9.1 ± 0.7 11.6 ± 0.9 0.22 0.03 
Alcohol (g/d) 6.0 ± 1.1 5.0 ± 0.9 0.56 2.2 ± 0.3 2.7 ± 0.8 0.99 0.30 
Total energy intake, kcal 2051 ± 53 1914 ± 70 0.88 1690 ± 68 1955 ± 56 0.96 0.09 
Data are presented as means ± standard error.  
P values were obtained after adjusting for educational attainment, income, living with spouse, smoking status, alcohol consumption, 
level of physical activity, family history of CHD, parental history of DM, total energy intake, and body mass index. Alcohol 
consumption was excluded in the model for MDS and alcohol. Bold numbers indicate statistically significant differences between 
metabolic phenotypes, considering a Bonferroni-corrected significance threshold (alpha = 0.0167). 
Abbreviations: MDS, Mediterranean diet scores; MHNW, metabolically healthy normal weight; MONW, metabolically obese normal 
weight; MHO, metabolically healthy obese; MUO, metabolically unhealthy obese; MDS, Mediterranean Diet Score; MUFA, 
monounsaturated fatty acid; SFA, saturated fatty acid. 
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Table 4.3 Comparison for each component of DASH index between the metabolic phenotypes in younger age group and 
older age group 
 
  Younger age group (men < 45 years and premenopausal women)   
 
MHNW MONW 
P 
MHO MUO 
P 
P (MHNW vs 
MHO)   (n=1,096) (n=164) (n=284) (n=411) 
Score range (0 - 7) (0 - 6.5) 
 
(0 - 6.5) (0 - 8) 
  
DASH score 2.1 ± 0.1 2.0 ± 0.1 0.03 1.8 ± 0.1 1.8 ± 0.1 0.31 0.008 
Saturated fat, % energy 11.3 ± 0.2 11.0 ± 0.3 0.84 11.5 ± 0.4 12.1 ± 0.4 0.98 0.009 
Total fat, % energy 33.9 ± 0.5 33.0 ± 0.7 0.77 35.4 ± 0.8 36.7 ± 0.7 0.76 0.008 
Protein, % energy 15.1 ± 0.2 14.7 ± 0.5 0.05 15.4 ± 0.5 15.1 ± 0.3 0.35 0.16 
Cholesterol, mg 129 ± 4 125 ± 8 0.24 132 ± 7 133 ± 6 0.48 0.75 
Fiber, mg 7.4 ± 0.1 6.7 ± 0.3 <0.001 6.7 ± 0.2 7.3 ± 0.3 0.18 0.008 
Magnesium, mg 135 ± 2 127 ± 3 <0.001 126 ± 4 128 ± 3 0.76 0.03 
Calcium, mg 372 ± 12 347 ± 18 0.48 336 ± 17 371 ± 19 0.91 0.60 
Potassium, mg 1265 ± 16 1236 ± 31 0.08 1221 ± 38 1266 ± 23 0.58 0.99 
Sodium, mg 1621 ± 20 1581 ± 49 0.52 1711 ± 42 1709 ± 65 0.85 0.03 
 
 
Table 4.3 (Continued) 
  Older age group (men ≥ 45 years and postmenopausal women)  
 
MHNW MONW 
P 
MHO MUO 
P 
P (MHNW vs 
MHO)   (n=244) (n=223) (n=69) (n=276) 
Score range (0 - 8.5) (0 - 8) 
 
(0 - 7.5) (0 - 7.5) 
  
DASH score 2.8 ± 0.1 2.9 ± 0.2 0.93 2.5 ± 0.2 2.5 ± 0.2 0.56 0.12 
Saturated fat, % energy 10.2 ± 0.3 10.0 ± 0.4 0.66 11.2 ± 0.5 11.2 ± 0.3 0.56 0.33 
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Total fat, % energy 31.7 ± 0.6 30.5 ± 0.8 0.27 34.1 ± 0.8 33.9 ± 0.7 0.53 0.74 
Protein, % energy 16.1 ± 0.4 15.0 ± 0.4 0.01 16.1 ± 0.4 15.6 ± 0.3 0.46 0.23 
Cholesterol, mg 130 ± 11 129 ± 14 0.45 128 ± 6 136 ± 6 0.01 0.39 
Fiber, mg 9.5 ± 0.4 9.2 ± 0.5 0.34 8.5 ± 0.4 8.4 ± 0.3 0.89 0.08 
Magnesium, mg 162 ± 4 156 ± 5 0.13 149 ± 5 151 ± 4 0.71 0.18 
Calcium, mg 393 ± 13 410 ± 21 0.69 380 ± 20 412 ± 16 0.10 1.00 
Potassium, mg 1561 ± 36 1547 ± 45 0.64 1485 ± 50 1510 ± 28 0.90 0.10 
Sodium, mg 1639 ± 38 1675 ± 140 0.58 1773 ± 65 1679 ± 35 0.35 0.58 
Data are presented as means ± standard error. 
P values were obtained after adjusting for educational attainment, income, living with spouse, smoking status, alcohol 
consumption, level of physical activity, family history of CHD, parental history of DM, total energy intake, and body mass index. 
Bold numbers indicate statistically significant differences between metabolic phenotypes, considering a Bonferroni-corrected 
significance threshold (alpha = 0.0167). 
Abbreviations: MHNW, metabolically healthy normal weight; MONW, metabolically obese normal weight; MHO, metabolically 
healthy obese; MUO, metabolically unhealthy obese; DASH, Dietary Approaches to Stop Hypertension. The amount of each 
DASH dietary components are based on a 1,000 kcal diet. 
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Table 4.4 Comparison for metabolic risk factors according to the tertiles of Mediterranean diet scores and 
DASH index by age group in obese participants 
 
    Younger age group (men < 45 years and premenopausal women)       
  
MDS   DASH index   
Characteristics 
Tertile 1 Tertile 3 
P 
trend 
Tertile 1 Tertile 3 
P 
trend 
(n=385) (n=408)   (n=399) (n=381)   
Score range (12 - 23) (29 - 39) 
 
(0 - 1) (3 - 8) 
 
Index scores 20.6 ± 0.2 31.2 ± 0.1 <0.001 0.6 ± 0.0 4.0 ± 0.1 <0.001 
Age, years 35.4 ± 0.8 36.0 ± 1.0 0.85 35.7 ± 0.7 37.0 ± 0.7 0.23 
BMI, kg/m2 36.3 ± 0.5 34.1 ± 0.5 <0.001 35.0 ± 0.3 34.4 ± 0.5 0.10 
Waist circumference, cm 112 ± 1.2 105 ± 1.2 <0.001 109 ± 1.0 105 ± 1.3 0.03 
Fasting glucose, mg/dl 98 ± 1.4 100 ± 2.0 0.93 98 ± 0.7 100 ± 1.8 0.77 
HOMA-IR 4.36 ± 0.29 3.50 ± 0.19 0.002 3.74 ± 0.25 4.12 ± 0.36 0.54 
hs-CRP, mg/dl 0.52 ± 0.03 0.43 ± 0.05 0.02 0.53 ± 0.04 0.42 ± 0.04 0.001 
SBP, mmHg 123 ± 0.9 126 ± 2.0 0.002 122 ± 0.9 120 ± 1.4 0.57 
DBP, mmHg 79 ± 0.8 80 ± 1.1 0.49 78 ± 0.9 77 ± 1.5 0.78 
Triglycerides, mg/dl 170 ± 9.2 141 ± 10.5 0.02 129 ± 5.7 150 ± 9.6 0.001 
HDL-C, mg/dl 41 ± 0.9 44 ± 1.3 0.38 43 ± 1.4 45 ± 1.7 0.94 
Total energy intake, kcal 2520 ± 109 2279 ± 154 0.05 2599 ± 100 2028 ± 62 <0.001 
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Table 4.4 (Continued) 
    Older age group (men ≥ 45 years and postmenopausal women)  
  
MDS   DASH index   
Characteristics 
Tertile 1 Tertile 3 
P 
trend 
Tertile 1 Tertile 3 
P 
trend 
(n=125) (n=174)   (n=102) (n=221)   
Score range (15 - 23) (29 - 40) 
 
(0 - 1) (3 - 7.5) 
 
Index scores 20.3 ± 0.3 31.2 ± 0.3 <0.001 0.5 ± 0.0 4.2 ± 0.2 <0.001 
Age, years 58.6 ± 0.6 59.3 ± 0.7 0.07 59.9 ± 0.9 58.3 ± 0.7 0.25 
BMI, kg/m2 33.8 ± 0.3 34.0 ± 0.6 0.20 33.1 ± 0.3 33.3 ± 0.3 0.92 
Waist circumference, cm 111 ± 0.9 112 ± 1.3 0.66 108 ± 0.7 109 ± 1.0 0.87 
Fasting glucose, mg/dl 119 ± 5.6 114 ± 1.6 0.24 107 ± 2.2 123 ± 5.9 0.01 
HOMA-IR 5.60 ± 0.58 4.48 ± 0.29 0.21 3.99 ± 0.28 6.09 ± 0.66 0.12 
hs-CRP, mg/dl 0.55 ± 0.04 0.55 ± 0.03 0.04 0.56 ± 0.05 0.53 ± 0.06 0.53 
SBP, mmHg 131 ± 1.0 137 ± 2.5 0.02 135 ± 1.3 132 ± 1.5 0.14 
DBP, mmHg 77 ± 0.7 80 ± 1.2 0.009 79 ± 0.7 76 ± 0.7 <0.001 
Triglycerides, mg/dl 193 ± 10.2 176 ± 15.6 0.11 166 ± 8.6 193 ± 9.1 0.28 
HDL-C, mg/dl 44 ± 1.4 50 ± 2.8 0.007 47 ± 1.3 46 ± 2.1 0.58 
Total energy intake, kcal 1883 ± 64 1908 ± 125 0.68 2179 ± 87 1813 ± 94 <0.001 
Data are presented as means ± standard error.  
P values were obtained after adjusting for age, gender, and race/ethnicity. P values for HOMA-IR, hs-CRP, and 
triglycerides were calculated after log transformation of each observation due to their skewed distribution. 
Abbreviations: BMI, body mass index; HOMA-IR, homoeostasis model assessment of insulin resistance; hs-CRP, 
high-sensitivity C-reactive protein; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-
density lipoprotein cholesterol. 
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Table 4.5 Comparison for metabolic risk factors according to the tertiles of Mediterranean diet scores and 
DASH index by age group in normal weight participants 
 
    Younger age group (men < 45 years and premenopausal women)       
  
MDS   DASH index   
Characteristics 
Tertile 1 Tertile 3 
P 
trend 
Tertile 1 Tertile 3 
P 
trend 
(n=385) (n=408)   (n=399) (n=381)   
Score range (12 - 23) (29 - 41) 
 
(0 - 1) (3 - 7) 
 
Index scores 20.4 ± 0.2 31.7 ± 0.2 <0.001 0.7 ± 0.0 3.9 ± 0.0 <0.001 
Age, years 29.7 ± 0.5 33.6 ± 0.6 <0.001 29.9 ± 0.4 33.0 ± 0.6 <0.001 
BMI, kg/m2 21.8 ± 0.1 22.2 ± 0.1 0.007 21.9 ± 0.1 22.2 ± 0.1 0.21 
Waist circumference, cm 78 ± 0.6 78 ± 0.5 0.42 78 ± 0.4 78 ± 0.6 0.64 
Fasting glucose, mg/dl 90 ± 0.6 90 ± 0.6 0.40 90 ± 0.7 91 ± 0.6 0.96 
HOMA-IR 1.64 ± 0.05 1.51 ± 0.03 0.02 1.60 ± 0.06 1.52 ± 0.04 0.18 
hs-CRP, mg/dl 0.28 ± 0.01 0.27 ± 0.01 0.46 0.27 ± 0.01 0.25 ± 0.01 0.21 
SBP, mmHg 111 ± 0.8 112 ± 0.8 0.80 113 ± 1.0 112 ± 0.8 0.10 
DBP, mmHg 69 ± 0.6 70 ± 0.6 0.72 71 ± 0.6 70 ± 0.6 0.02 
Triglycerides, mg/dl 89 ± 3.0 87 ± 3.1 0.01 86 ± 2.4 88 ± 2.1 0.63 
HDL-C, mg/dl 53 ± 1.0 57 ± 1.1 0.006 54 ± 0.9 56 ± 1.3 0.44 
Total energy intake, kcal 2283 ± 75 2226 ± 78 0.23 2590 ± 75 2010 ± 64 <0.001 
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Table 4.5 (Continued) 
    Older age group (men ≥ 45 years and postmenopausal women)  
  
MDS   DASH index   
Characteristics 
Tertile 1 Tertile 3 
P 
trend 
Tertile 1 Tertile 3 
P 
trend 
(n=125) (n=174)   (n=102) (n=221)   
Score range (14 - 23) (29 - 42) 
 
(0 - 1) (3 - 8.5) 
 
Index scores 20.5 ± 0.2 31.7 ± 0.3 <0.001 0.6 ± 0.0 4.5 ± 0.1 <0.001 
Age, years 61.6 ± 0.9 61.7 ± 1.0 0.92 59.6 ± 1.2 64.3 ± 0.9 <0.001 
BMI, kg/m2 22.4 ± 0.2 22.6 ± 0.1 0.18 22.7 ± 0.1 22.5 ± 0.1 0.95 
Waist circumference, cm 87 ± 0.8 86 ± 0.5 0.40 87 ± 0.9 85 ± 0.4 0.23 
Fasting glucose, mg/dl 97 ± 1.5 98 ± 1.2 0.85 98 ± 0.9 99 ± 1.6 0.67 
HOMA-IR 1.81 ± 0.10 1.80 ± 0.07 0.58 1.85 ± 0.07 1.78 ± 0.08 0.14 
hs-CRP, mg/dl 0.31 ± 0.03 0.31 ± 0.02 0.91 0.32 ± 0.02 0.30 ± 0.01 0.29 
SBP, mmHg 130 ± 1.5 130 ± 1.7 0.78 130 ± 1.7 132 ± 1.5 0.36 
DBP, mmHg 75 ± 0.8 75 ± 0.6 0.49 76 ± 0.9 74 ± 0.5 0.06 
Triglycerides, mg/dl 141 ± 17.0 112 ± 4.0 0.001 123 ± 7.2 138 ± 10.9 0.07 
HDL-C, mg/dl 53 ± 2.0 57 ± 1.3 0.10 54 ± 1.5 55 ± 1.1 0.88 
Total energy intake, kcal 1938 ± 71 1986 ± 59 0.71 2226 ± 88 1737 ± 63 <0.001 
Data are presented as means ± standard error.  
P values were obtained after adjusting for age, gender, and race/ethnicity. P values for HOMA-IR, hs-CRP, and 
triglycerides were calculated after log transformation of each observation due to their skewed distribution. 
Abbreviations: BMI, body mass index; HOMA-IR, homoeostasis model assessment of insulin resistance; hs-CRP, 
high-sensitivity C-reactive protein; SBP, systolic blood pressure; DBP, diastolic blood pressure; HDL-C, high-density 
lipoprotein cholesterol. 
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Table 4.6 Adjusted odds ratios (ORs) of Metabolically Healthy Obese (MHO) and Metabolically Obese Normal Weight 
(MONW) phenotype according to the tertile categories in the Mediterranean diet score and DASH index 
 
  Younger age group  Older age group 
MHO 
phenotype 
 Tertile 1 
 
Tertile 2 Tertile 3 P 
trend 
Tertile 1 Tertile 2 Tertile 3 P 
trend 
 Mediterranean diet score,  
n (scores range) 
207  
(12 - 23) 
300 
(24 - 28) 
188 
(29 - 39) 
 103 
(15 - 23) 
124 
(24 - 28) 
118 
(29 - 40) 
 
 Age, gender, and 
race/ethnicity adjusted OR 
1.00 
(ref.) 
1.60  
(0.82-3.10) 
2.65  
(1.19-5.90) 
0.02 1.00 
(ref.) 
1.12  
(0.63-1.98) 
1.84  
(0.99-3.43) 
0.06 
 Multivariable adjusted OR* 1.00 
(ref.) 
1.57  
(0.83-2.95) 
2.57  
(1.04-6.35) 
0.04 1.00 
(ref.) 
0.78  
(0.43-1.41) 
1.07  
(0.56-2.06) 
0.82 
 DASH index,  
n (scores range) 
249 
(0 - 1) 
268 
(1.5 - 2.5) 
178 
(3 - 8) 
 75 
(0 - 1) 
131 
(1.5 - 2.5) 
139 
(3 – 7.5) 
 
 Age, gender, and 
race/ethnicity adjusted OR 
1.00 
(ref.) 
1.13  
(0.63-2.02) 
1.26  
(0.70-2.27) 
0.43 1.00 
(ref.) 
0.81  
(0.53-1.24) 
1.08  
(0.60-1.93) 
0.67 
 Multivariable adjusted OR* 1.00 
(ref.) 
0.95 
(0.59-1.54) 
1.10  
(0.72-1.67) 
0.75 1.00 
(ref.) 
0.95  
(0.53-1.72) 
1.18  
(0.55-2.51) 
0.63 
MONW 
phenotype 
 Tertile 1  Tertile 2  Tertile 3  P 
trend 
Tertile 1  Tertile 2  Tertile 3  P 
trend 
 Mediterranean diet score,  
n (scores range) 
385  
(12 - 23) 
467 
(24 - 28) 
408 
(29 - 41) 
 125 
(14 - 23) 
168 
(24 - 28) 
174 
(29 - 42) 
 
 Age, gender, and 
race/ethnicity adjusted OR 
1.00 
(ref.) 
0.86  
(0.52-1.40) 
0.69  
(0.41-1.18) 
0.17 1.00 
(ref.) 
1.06  
(0.59-1.92) 
0.75  
(0.45-1.24) 
0.17 
 Multivariable adjusted OR* 1.00 
(ref.) 
0.95  
(0.54-1.67) 
0.73  
(0.44-1.23) 
0.23 1.00 
(ref.) 
1.14  
(0.62-2.12) 
0.87  
(0.50-1.53) 
0.53 
 DASH index,  
n (scores range) 
399 
(0 - 1) 
480 
(1.5 - 2.5) 
381 
(3 - 7) 
 102 
(0 - 1) 
144 
(1.5 - 2.5) 
221 
(3 – 8.5) 
 
 Age, gender, and 
race/ethnicity adjusted OR 
1.00 
(ref.) 
0.79  
(0.43-1.43) 
0.67  
(0.42-1.09) 
0.11 1.00 
(ref.) 
0.85  
(0.42-1.70) 
0.90 
(0.50-1.64) 
0.81 
 Multivariable adjusted OR* 1.00 
(ref.) 
0.72 
(0.40-1.32) 
0.59 
(0.38-0.93) 
0.03 1.00 
(ref.) 
0.84  
(0.39-1.79) 
1.04  
(0.51-2.13) 
0.86 
Data are presented as odds ratio (95% confidence interval). 
Abbreviations: OR, odds ratio; DASH, Dietary Approaches to Stop Hypertension; MHO, metabolically healthy obese; MONW, 
metabolically obese normal weight. 
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* adjusted for educational attainment, income, living with spouse, smoking status, level of physical activity, family history of 
coronary heart disease, parental history of diabetes mellitus, and total calories (additionally adjusted for alcohol consumption 
in the model of DASH index). 
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Table 4.7 Multivariable adjusted odds ratios (ORs) of Metabolically Healthy Obese (MHO) and Metabolically 
Obese Normal Weight (MONW) phenotype according to the levels of physical activity  
 
  Younger age group  Older age group 
  Being 
inactive  
Insufficient 
activity 
Recommended 
Activity 
Being 
inactive  
Insufficient 
activity 
Recommende
d Activity 
MHO 
phenotype 
Multivariable 
adjusted OR* 
1.00 
(ref.) 
0.74  
(0.43-1.28) 
0.57  
(0.23-1.40) 
1.00 (ref.) 1.01  
(0.53-1.91) 
2.82  
(1.36-5.85) 
 Multivariable 
adjusted OR † 
1.00 
(ref.) 
0.67 
(0.34-1.33) 
0.56  
(0.21-1.52) 
1.00 (ref.) 1.02 
(0.55-1.89) 
2.81  
(1.35-5.83) 
MONW 
phenotype 
Multivariable 
adjusted OR* 
1.00 
(ref.) 
0.73  
(0.38-1.39) 
0.53  
(0.33-0.86) 
1.00 (ref.) 0.44  
(0.23-0.86) 
0.49  
(0.28-0.86) 
 Multivariable 
adjusted OR† 
1.00 
(ref.) 
0.72 
(0.38-1.36) 
0.53 
(0.33-0.86) 
1.00 (ref.) 0.45 
(0.22-0.91) 
0.49 
(0.26-0.89) 
Data are presented as odds ratio (95% confidence interval). 
Abbreviations: OR, odds ratio; MHO, metabolically healthy obese; MONW, metabolically obese normal weight. 
All models were adjusted for educational attainment, income, living with spouse, smoking status, family history of coronary 
heart disease, parental history of diabetes mellitus, and total calories.  
* Additionally adjusted for Mediterranean diet score.   
† Additionally adjusted for Dietary Approaches to Stop Hypertension (DASH) diet index and alcohol consumption.
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Figure 4.1 Prevalence of Metabolically Healthy Obese (MHO) and 
Metabolically Obese Normal Weight (MONW) phenotypes according to the 
tertiles of the Mediterranean diet scores (MDs) and the Dietary Approaches to 
Stop Hypertension (DASH) style diet index in younger and older age group 
 ((A) prevalence of MHO phenotype according to the MDS tertile, (B) 
prevalence of MHO phenotype according to the tertile of DASH index, (C) 
prevalence of MONW phenotype according to the MDS tertile, and (D) 
prevalence of MONW phenotype according to the tertile of DASH index). The 
error bars represent standard errors. Younger age group includes men < 45 
years and premenopausal women; older age group includes men ≥ 45 years and 
postmenopausal women.  In Figure 4.1a, the prevalence of MHO phenotype 
increases with increasing MDS in younger age group (P for trend = 0.01). 
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CHAPTER 5 
MEDITERRANEAN DIET AND MORTALITY RISK IN METABOLICALLY HEALTHY 
OBESE AND METABOLICALLY UNHEALTHY OBESE PHENOTYPES1 
                                                 
1 Yong-Moon Mark Park, Susan E. Steck, Teresa T. Fung, Jiajia Zhang, Linda J. Hazlett, 
Kyungdo Han, and Anwar M. Merchant. To be submitted to JAMA Internal Medicine. 
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Abstract 
IMPORTANCE: The Mediterranean diet has been consistently associated with 
reduced mortality risk. Few prospective studies have examined whether the benefits from 
a Mediterranean diet are equally shared by obese individuals with varying metabolic 
health.  
OBJECTIVE: To investigate the association between Mediterranean diet, 
metabolic phenotypes, and mortality risk in a representative obese U.S. population. 
DESIGN, SETTING, AND PARTICIPANTS: Data from 1,739 adults aged 20-
88 years were analyzed from participants of the National Health and Nutrition 
Examination Survey III, 1988–1994 followed up for deaths until December 31, 2011 in a 
prospective cohort analysis. Mediterranean Diet Scores (MDS) were created to assess the 
adherence to Mediterranean diet using food frequency questionnaires, supplemented by 
24-hr dietary recall data. Participants were classified as metabolically healthy obese 
(MHO) phenotype (0 or 1 metabolic abnormality) or metabolically unhealthy obese 
(MUO) phenotype (two or more metabolic abnormalities), based on high glucose, insulin 
resistance, blood pressure, triglycerides, C-reactive protein, and low high-density 
lipoprotein-cholesterol. Multivariable Cox proportional hazards regression models were 
used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) of mortality with 
increasing three MDS categories and 1-SD increments of MDS.  
MAIN OUTCOMES AND MEASURES: All-cause, cardiovascular disease 
(CVD), and cancer mortality. 
RESULTS: During a median follow-up of 18.5 years, there were 77 and 309 
deaths in 598 MHO and 1,141 MUO individuals, respectively. In MHO individuals, the 
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multivariable-adjusted HR of all-cause mortality in the highest tertile compared to the 
first tertile of MDS was 0.44 (95% CI, 0.26-0.75; P for trend <0.001), after adjustment 
for potential confounders. The corresponding HR for cancer mortality was 0.23 (95% CI, 
0.02-2.10; P trend = 0.03). A 1 SD increment in the adherence to MDS was associated 
with a 41% reduction in the risk of all-cause mortality (HR, 0.59; 95% CI, 0.37-0.94). 
Similar findings were obtained when we restricted our analyses to those with or without 
prevalent diabetes mellitus and hypertension. However, there was no mortality risk 
reduction in individuals with MUO phenotype. 
CONCLUSIONS AND RELEVANCE: Adherence to a Mediterranean dietary 
pattern appears to improve longevity in the MHO phenotype, but not among the MUO 
phenotype in an obese population.  
KEYWORDS: Mediterranean diet, metabolic health, obesity, mortality, National 
Health and Nutrition Examination Survey  
Introduction 
The Mediterranean diet, representing the traditional dietary pattern of the 
populations living around the Mediterranean Sea, is characterized by high intake of olive 
oil, legumes, grains, fish, fruits, and vegetables; moderate intake of milk, dairy products, 
and alcohol; and low intake of meat and meat products. 1 Main components of the 
Mediterranean diet have been operationalized through predefined indexes or scores to 
evaluate the adherence to the Mediterranean diet. Multiple epidemiological studies have 
demonstrated that the adherence to the Mediterranean diet is associated with lower risk of 
all-cause, cardiovascular disease (CVD), and cancer mortality, in addition to risk 
reduction of cardiometabolic disease. 2-5 
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The risk of developing obesity-related metabolic complications corresponds to the 
degree of obesity. 6 However, the existence of these obesity-related metabolic 
abnormalities varies extensively among obese individuals. 7  Despite being outwardly 
obese, a subset of obese individuals appears to be protected or more resistant to the 
development of cardiometabolic abnormalities associated with obesity. These individuals 
with a metabolically healthy obese (MHO) phenotype, namely benign or uncomplicated 
obesity, demonstrate  favorable metabolic characteristics such as high insulin sensitivity, 
relatively low visceral fat, lower liver enzyme profiles, no sign of dyslipidemia or 
hypertension 8-10 and lower risk of CVD, 11,12 compared to their metabolically unhealthy 
obese (MUO) counterparts. Thus, differentiating MHO and MUO individuals would be 
beneficial to make personalized risk assessment for prevention of obesity-related 
disease.13  
Since healthy dietary behaviors are important to reduce  obesity-related morbidity 
and mortality, 14 it would be important to understand how the beneficial effects of 
established healthy dietary patterns such as Mediterranean diet differ according to MHO 
and MUO phenotypes. A few studies examined the potential differential association of 
dietary factors between MHO and MUO phenotypes; however, many of these studies 
were cross-sectional, 15-18  without consideration of dietary pattern, 17 had small sample 
size, 19,20 or with a short follow-up. 17 19,20 21 In addition, it is unclear how dietary pattern 
may influence the natural history of these phenotypes differentially.  
Therefore, in this analysis we tested hypotheses that Mediterranean diet would 
have differential health benefit of mortality risk reduction in MHO individuals and MUO 
individuals, in a nationally representative obese US population. 
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Methods  
Study population 
Data from 1,739 adults aged 20-88 years were analyzed from participants of the 
National Health and Nutrition Examination Survey III, 1988–1994, followed up for 
deaths until December 31, 2011 in a prospective cohort analysis. In NHANES III, 
complex multi-stage stratified clustered probability sampling scheme was applied to 
achieve a nationally representative sample of the civilian, non-institutionalized US 
population. The survey included personal interviews, physical examinations, and 
laboratory measurements.  
We included 2,535 obese (a body mass index (BMI) ≥ 30 kg/m2) adults aged 20 
and older who were eligible for mortality follow-up and had complete data on food 
frequency questionnaire (FFQ) and 24-hour dietary recall, those with complete data on 
cardiometabolic parameters including fasting glucose, insulin, blood pressure (BP), 
triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and high-sensitivity C-
reactive protein (hs-CRP). We excluded those who reported a history of myocardial 
infarction, stroke, congestive heart failure, or cancer (other than skin cancer) (n=299). To 
minimize reverse causation, we excluded the participants who reported changing their 
dietary patterns during the previous 12 months because of pre-existing obesity, high 
blood pressure, high blood cholesterol, diabetes mellitus, or general health (n=415). In 
addition, we excluded those who reported implausible extreme energy intakes (<1st and 
>99th percentiles of energy intake/d in adults), those with hs-CRP >10mg/L, BMI > 60 
kg/m2, or pregnant or lactating women (n=82). Finally, a total of 1,739 individuals were 
analyzed.   
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Assessment of Mediterranean diet  
Dietary intake was assessed using the FFQ and the 24-hr dietary recall data that 
were validated by the Nutrition Methodology Working Group. 22 Adherence to the 
Mediterranean diet was assessed using the scoring methodology developed by 
Panagiotakos et al. 23,24 In this methodology, scores 0 to 5 were assigned for the weekly 
consumption of food items assumed to be contributing to Mediterranean dietary pattern, 
whereas scores on the inverse ordinal scale were assigned for the consumption of food 
items assumed to be against the Mediterranean dietary pattern. For instance, the scores 
assigned to the weekly consumption frequencies of vegetables were as follows: no 
servings, 1–6 servings, 7–12 servings, 13–20 servings, 21–32 servings and >33 servings 
were assigned scores of 0, 1, 2, 3, 4 and 5, respectively. Similar score assignments were 
used for the food items of non-refined cereals, potatoes, fruits, legumes, fish, and olive 
oil. Reverse scores were assigned for the components of red meat and meat products, 
poultry and full-fat dairy products. For alcohol consumption, a score of 5 was assigned 
for consumption of less than 300 ml (36g) of alcohol per day, and 0 for no consumption 
or for consumption of >700 ml (84g) per day.  This Mediterranean Diet Score (MDS) has 
been shown to be highly associated with prevalent cardiometabolic diseases, 10-year 
CVD risk, and inflammation and coagulation markers, in addition to capturing inherent 
characteristics of Mediterranean dietary pattern. 23-25 
The NHANES III FFQ applied a 1-month reference period without recording 
portion sizes. Thus, we calculated the MDS, assuming that the number of servings per 
week were equivalent to the number of times that a food item was consumed per week. 
Potatoes were excluded in our MDS assessment, because preparation methods for 
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potatoes in US are quite different from European countries. 26 In addition, assessment of 
alcohol consumption was modified in the present study as follows. The amount of alcohol 
consumed daily was estimated using the following assumption: 12.8g for 12-oz beer, 11g 
for 4-oz glass of wine, and 14g for an ounce of liquor based on the questionnaire 
provided. Then, gender-specific cut-offs were applied: score 5 was assigned for 
consumption of less than 28g and 14 g of alcohol per day, score 0 for no consumption or 
for consumption of  greater than 70g and 28g per day in men and women, respectively, 
and the cutoffs for subcategories between 0 and 5 were reassigned with even intervals. 27 
Olive oil consumption was not measured in the NHANES III FFQ. Thus, we 
approximated olive oil consumption by calculating the ratio of total monounsaturated 
fatty acid (MUFA) to total saturated fatty acids (SFA) using the 24-h dietary recall data, 
then dividing it into the six even intervals. The possible overall MDS score ranged from 0 
to 50, with higher values of this MDS score indicating greater adherence to the 
Mediterranean diet. 
 Assessment of Metabolic health 
Metabolic health was assessed using the metabolic parameters that were measured 
under quality control standards of Centers for Disease Control and Prevention. BMI was 
calculated as kg/m2; height was measured to the nearest 0.1cm and weight to the nearest 
0.01 kg. BP was averaged over five separate measurements. Glucose was measured in 
serum, using a modified hexokinase enzymatic method. Serum insulin was measured 
using radioimmnuoassay (Pharmacia Diagnostics). HDL-C and TG were measured using 
a Hitachi 704 analyzer (Boehringer-Mannheim Diagnostics). Serum CRP concentrations 
were measured by latex-enhanced nephlometry (Department of Laboratory Medicine, 
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Immunology Division, University of Washington, Seattle). Since NHANES III 
participants did not comply with fasting instruction strictly, six hour fasting data were 
used to increase the sample size. 28 
Metabolic health was defined when the individual had fewer than two 
cardiometabolic abnormalities [systolic/diastolic BP ≥ 130/85 mm Hg or antihypertensive 
medication use, TG ≥ 150 mg/L or on cholesterol-lowering medication, fasting glucose ≥ 
100 mg/dL or antidiabetic medication use, homoeostasis model assessment of insulin 
resistance (HOMA-IR = fasting glucose (mg/dl) x fasting insulin (lU/mL)/405) > the 90th 
percentile, hs-CRP > the 90th percentile, and HDL-C < 40 mg/dL in men or < 50 mg/dL 
in women or on cholesterol-lowering medication]. 29 
Assessment of Mortality 
To identify mortality and cause of death, the National Center for Health Statistics 
linked all participants aged 20 years and older to the National Death Index to 31 
December 2011. Therefore, for each participant follow-up extended from the date of the 
examination to the date of death or 31 December 2011. The underlying cause listed on 
the death certificate was applied to determine cause of death that was identified using the 
underlying Cause of Death-113 groups (international classification of disease (ICD), 10th 
revision). Total mortality was defined as deaths with any underlying cause of death; CVD 
and cancer mortality were defined as deaths with underlying cause of death codes for 
ICD-10 I00-I69 and C00-C97, respectively. 30 
Assessment of Covariates 
Demographic variables included age, gender, race or ethnicity (non-Hispanic 
white, non-Hispanic black, Mexican American, or others), educational attainment (<12 
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years, 12 years, or >12 years of education), living with spouse, level of income based on 
poverty income ratio (PIR) which is the ratio of household income to the appropriate 
poverty threshold (low (PIR ≤ 1.3), middle (1.3<PIR ≤ 3.5), and high (PIR>3.5)). The 
potential risk factors for CVD comprised smoking status (never, former, and current) and 
the presence of family history of CVD. Physical activity was classified based on the 
recommended levels of physical activity. 31 A group with recommended physical activity 
was defined as those who had self-reported leisure time moderate activity (3 ≤ metabolic 
equivalents (METs) <6) of five or more times per week or leisure time vigorous activity 
(METs ≥ 6) three or more times per week; physically inactive group as those with no 
reported leisure time physical activity; a group with insufficient physical activity as those 
who did not meet the criteria for recommended levels of physical activity but not inactive.  
Statistical Analysis 
The statistical analyses were performed using SAS 9.4 software (SAS Institute 
Inc., Cary, NC, USA), using the appropriate survey procedures to account for the 
complex sampling design and weights. For the subgroup analysis, domain option was 
applied in survey procedure to preserve appropriate subsample in the complex sampling 
design, and it utilized the entire samples to estimate the variance of subpopulations.  
Continuous variables were presented by mean (SE: standard error) and compared using 
linear regression analyses. Categorical variables were expressed by percentage with SE 
and were compared using Rao-Scott χ2 tests. P value of less than .05 was considered 
statistically significant.  
We used Cox proportional hazards regression to estimate the hazard ratios (HRs) 
and 95% confidence intervals (CIs) for all-cause, CVD, and cancer mortality. The 
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proportional hazards assumption of the Cox models was evaluated with log of negative 
log survival curves based on Kaplan-Meier estimates for MDS tertile group as well as 
categorical age, gender, and race/ethnicity.  In addition to crude HRs, we estimated age-, 
gender-, and race/ethnicity–adjusted HRs as well as the multivariable-adjusted HRs 
including age, BMI, and total energy intake as continuous covariates; gender, 
race/ethnicity, educational attainment, income, living with spouse, smoking status, level 
of physical activity, family history of CHD as categorical covariates. Missing values in 
the covariates were added as a dummy variable in the multivariable models. To assess 
potential differential association of MDS by age (<65 vs. ≥65 years), sex, race/ethnicity, 
smoking (ever vs. never smoked), conformity to recommended physical activity (yes vs. 
no), BMI (<35 vs ≥35), and the presence or absence of chronic disease including diabetes 
mellitus and hypertension, we also stratified our analysis and performed interaction tests 
using all-cause mortality as the outcome by including the cross-product interaction terms 
in the Cox models based on F test. In addition, we performed sensitivity analyses with an 
alternative common definition of metabolic health as metabolic syndrome, 32 and after 
exclusion of subjects who died during the first five years of follow-up. 
Results 
The MHO phenotype (n=647) was observed in 34.8 % (SE, 1.7 %) of the obese 
sample from the present study. Table 5.1 shows general characteristics according to the 
MDS tertiles between MHO and MUO individuals. MHO individuals with the highest 
MDS tertile were more likely to have a higher income, lower insulin resistance, and 
higher diastolic BP than MHO individuals in other tertiles. MUO individuals with the 
highest MDS tertile tended to be older and not non-Hispanic white; were more likely to 
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have a higher education, higher income, lower proportion of current smokers and 
recommended physical activity, lower BMI and waist circumference, lower insulin 
resistance, higher systolic BP, lower triglycerides, and higher HDL-C than MUO 
individuals with other tertiles. Comparing MHO and MUO individuals, MHO individuals 
tended to be younger, female, not non-Hispanic white, non-smokers, and have a more 
favorable metabolic status.  
The distribution of consumption frequency in each Mediterranean diet component 
according to the MDS tertile, MHO, and MUO phenotypes is shown in Table 5.2. In both 
phenotypes, consumption of grains, legumes, fruit, vegetable, fish, ratio of MUFA to 
SFA tended to increase with increasing tertile of MDS. In addition, consumption of red 
meats and dairy products tended to decrease with increasing tertile of MDS. However, 
consumption of poultry and alcohol consumption increased only in MUO individuals. 
Overall, MHO individuals consumed more MUFA (P=0.03), and less red meats and dairy 
products (P = 0.001 and 0.02, respectively), resulting in higher MDS scores for those 
components, compared to MUO individuals. 
During a median follow-up of 18.5 years, there were 77 and 309 deaths in 598 
MHO and 1,141 MUO individuals, respectively. Overall, higher mortality risk was 
observed in MUO than MHO after adjusting for potential confounders [HRs were 1.50 
(95% CI, 1.12-2.00) for all-cause mortality, 2.50 (95% CI, 1.20-5.21 for CVD mortality, 
and 1.27 (95% CI, 0.81-1.98) for cancer mortality].  
Table 5.3 shows adjusted HRs of all-cause, cardiovascular, and cancer mortality 
according to the tertile categories and a five-point increment in the MDS in MHO and 
MUO individuals. In MHO individuals, compared with the lowest tertile, HRs in the 
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second and the highest tertiles, respectively, were 0.35 (95% CI, 0.19-0.64) and 0.44 
(0.26-0.75) (P for trend <0.001) for all-cause mortality; and 0.13 (0.06-0.26) and 0.23 
(0.02-2.10) (P for trend =0.03) for cancer mortality, after multivariable adjustment. A 
five-point increment (1 SD of MDS) in the adherence to MDS was inversely associated 
with risk of all-cause mortality (HR, 0.59; 0.37-0.94). No mortality risk reduction was 
observed in MUO phenotypes with increasing MDS.  
In stratified analyses for HRs of all-cause mortality with a five-point increment of 
MDS, stronger inverse associations were observed for individuals who were aged 65 
years or older, non-Hispanic white, and with lower BMI < 35 kg/m2, especially in men 
and those with recommended physical activity (P for interaction = 0.002 and 0.008, 
respectively) (Table 5.4).  In addition, the inverse association between MDS and all-
cause mortality in MHO individuals was consistent among individuals with and without 
prevalent chronic disease including diabetes mellitus and hypertension. There was a 
positive and inverse association between MDS and all-cause mortality in MUO 
individuals with and without the recommended physical activity, respectively (P for 
interaction = 0.003).  
When data were analyzed after excluding subjects who died in the first five years 
of follow-up, the overall results were not different from those of the original dataset 
(Table 5.5). In addition, using an alternative definition of metabolic health as metabolic 
syndrome shows similar results in terms of the reduction of all-cause mortality only in 
MHO individuals (Table 5.6).  
Discussion 
In this nationally representative sample of obese U.S. adults, higher adherence to 
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Mediterranean diet was associated with a lower risk of all-cause mortality in the MHO 
phenotype, after adjustment for potential confounders. We observed a 41% reduction in 
all-cause mortality with each 1 SD increment in the MDS among MHO individuals. This 
association persisted when we restricted our analyses to those with or without prevalent 
chronic disease including diabetes mellitus and hypertension. However, the inverse 
association between the MDS and mortality was not observed in MUO phenotype. To our 
knowledge, the present study is the first to evaluate a differential beneficial effect of 
Mediterranean diet on the mortality risk reduction in MHO and MUO phenotype. 
Several epidemiologic studies have explored the association between 
Mediterranean diet and the risk of mortality in the obese population in subgroup analyses, 
showing inconsistent results. Trichopoulou et al. 1 showed inverse association of MDS 
with all-cause mortality in Greek adults who had a BMI ≥ 28.06. In contrast, George et al. 
33 showed that there was a weak association of MDS with all-cause mortality and no 
association with CVD and cancer mortality in US postmenopausal women with BMI ≥ 30. 
Mitrou et al. 34 also showed that the associations with all-cause mortality were only 
observed in ever-smoker in middle to older aged US adults with BMI ≥ 30. Based on the 
findings from these previous studies, the Mediterranean diet might not be a useful 
indicator in reducing the risk of mortality in obese population due to the possibility of 
underreporting of food intake 35 and physiological impact of obesity itself on mortality 
risk. 36 
However, these studies assumed that all obese individuals were at the same 
metabolic health and same risk of mortality. Previous studies have demonstrated that 
MHO individuals are not at increased risk of mortality and CVD compared with their 
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MUO counterparts. 37,38 The mechanisms explaining favorable cardiometabolic, 
hormonal, and inflammatory profiles in MHO individuals remain largely unknown. 
However, several potential pathophysiologic mechanisms include differences in adipose 
cell size, 39 degree of favorable gene markers’ expression reflecting adipose cell 
differentiation, 40 and the role of key genes in numerous insulin-signaling pathways 41 and 
amino acid homeostasis 42 between MHO and MUO individuals. 
Our results show that inverse associations of Mediterranean diet on risk of 
mortality were observed only in MHO individuals. These associations persisted in 
sensitivity analyses in which we analyzed the data using an alternative definition of 
metabolic health as metabolic syndrome and when we excluded the deaths at the first five 
year follow-ups. Underlying mechanisms for health benefits of Mediterranean diet are 
complex, but can be explained by the improvement of cardiometabolic profiles including 
insulin sensitivity, lipid profiles, blood pressure, endothelial dysfunction, reactive 
oxidation, and inflammatory markers. 43 44  It has been reported that individuals with 
MHO phenotype are at increased risk of unfavorable long-term outcomes compared with 
metabolically healthy normal weight individuals, even with few metabolic abnormalities. 
45  In addition, one third of MHO phenotype can be converted to MUO phenotype within 
a decade due to unhealthy life style. 46 Thus, our results suggest that there would be a 
synergistic physiological mechanism to prevent adverse health outcomes, along with 
improving the favorable cardiometabolic profiles linking MHO phenotype and the 
adherence to Mediterranean diet. Furthermore, those who reported to follow the 
recommended physical activity [moderate activity (3 ≤ METs<6) of five or more times 
per week or vigorous activity (METs ≥ 6) of three or more times per week] 31 had more 
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benefits in mortality reduction from Mediterranean diet, representing the possible 
synergistic effects of healthy life styles. Men also had more significant mortality 
reduction compared to women, which also has been shown in a randomized clinical trial 
study. 2 However, more evidence is needed to confirm gender difference in mortality risk 
reduction with Mediterranean diet in individuals with MHO phenotype.  
Based on our findings, MUO individuals might not be as responsive to diet 
because they are already metabolically overburdened. 13 Cardiometabolic co-morbidities 
might explain the lack of association between Mediterranean diet and the risk of 
mortality in MUO individuals. However, a stratified analysis with and without the 
prevalent chronic disease including diabetes mellitus and hypertension showed similar 
results. Interestingly, the risk of mortality in MUO individuals showed U shaped 
association with increasing MDS tertile in which those with the 1st and 3rd tertile of MDS 
tended to have higher mortality than those with the 2nd tertile, even though MUO 
individuals in the 3rd tertile had favorable metabolic profiles compared to those in other 
tertiles at baseline. In addition, MUO individuals who met the recommended physical 
activity tended to have a higher risk of all-cause mortality, whereas MUO individuals 
who did not meet the recommended physical activity tended to have a lower risk of all-
cause mortality in a subgroup analysis. Although we cannot completely rule out the 
possibility of reverse causality in this association, these results suggest that healthy life 
style alone might not be adequate to reverse the deleterious prognosis of MUO 
individuals. Thus, the MUO individuals may need to be prioritized for intensive weight 
loss program along with healthy dietary habit to reduce obesity related comorbidities. 
Furthermore, appropriate therapeutic approaches may be warranted to reduce the 
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mortality risk of MUO individuals. 47 
Several intervention studies have explored the impact of dietary interventions on 
cardiometabolic risk factors and whether MHO and MUO individuals had the same 
benefits. 20,21,48-51 However, the findings of these studies were inconsistent and their 
hypotheses have been focused on the short-term effect of energy-restricted diet along 
with exercise on change of cardiometabolic parameters in MHO and MUO phenotypes. 
Thus, the interpretation of these results might not be applicable to the present long-term 
prospective cohort study using a Mediterranean dietary pattern as an exposure. Therefore, 
more evidence would be necessary based on long-term follow-up studies evaluating the 
effects of healthy dietary pattern on mortality reduction, considering MHO and MUO 
phenotypes. 47 
Strengths of our study include its prospective study design with nearly 18 year 
follow-up for mortality based on the representative US population. In addition, data were 
collected based on extensive laboratory and physical examinations using standardized 
protocols to minimize the influence of measurement errors. Furthermore, we were able to 
replicate the findings using sensitivity analyses. However, our study has limitations. First, 
there was no information on “servings per week” that was applied in MDS calculation by 
Panagiotakos et al. 24 Because NHANES III FFQ did not have portion size, we used 
“times per week” in assessing the consumption frequency. This approach may cause 
exposure misclassification, but the direction would be non-differential. Second, due to a 
single measure of diet collected at baseline, we could not account for any changes in 
dietary intake over time. Third, self-assessment of food consumption may produce non-
differential measurement error, although energy adjustment would mitigate this error to 
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some degree. 52 Finally, there may be residual confounding due to not measuring the 
covariates in an objective way, such as self-reported physical activity and smoking status. 
Conclusion 
Our results suggest that higher adherence to Mediterranean diet was associated 
with a lower risk of all-cause, CVD, and cancer mortality exclusively in the MHO 
phenotype, based on a nationally representative U.S. adult population. The lack of a 
beneficial association between adherence to Mediterranean diet with the mortality 
reduction in MUO individuals may warrant the need of an aggressive prevention 
approach to reduce mortality risk in MUO individuals.  
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Table 5.1 Comparison of general characteristics according to the tertile categories of Mediterranean diet 
score between Metabolically Healthy Obese (MHO) and Metabolically Unhealthy Obese (MUO) phenotypes 
at baseline 
 
    Metabolically Healthy Obese (MHO) phenotype     
Characteristics 
Overall Tertile 1 Tertile 2 Tertile 3 P  
(n=598) (n=181) (n=240) (n=177)   
Age, years 40.7 ± 0.6 40.8 ± 0.9 40.5 ± 0.8 40.8 ± 1.3 0.76 
Men, % 33.2 ± 3.4 36.5 ± 5.4 23.8 ± 4.9 41.7 ± 7.0 0.07 
Race/ ethnicity, % 
             
 
Non-Hispanic white 68.7 ± 3.4 68.7 ± 5.6 68.8 ± 5.4 68.5 ± 3.8 0.43 
 
Non-Hispanic black 19.5 ± 2.4 21.5 ± 3.8 21.6 ± 3.8 14.9 ± 2.5 
 
 
Mexican-American 4.5 ± 0.7 2.3 ± 0.7 4.7 ± 1.0 6.4 ± 1.1 
 
 
Other 7.3 ± 1.7 7.5 ± 4.2 4.9 ± 2.8 10.3 ± 2.7 
 Educational attainment, % 
             
 
<12 years 24.3 ± 2.2 29.1 ± 4.9 24.8 ± 4.3 19.0 ± 4.5 0.39 
 
12 years 40.0 ± 3.0 39.8 ± 5.4 43.6 ± 5.7 35.6 ± 7.6 
 
 
>=13 years 35.8 ± 3.3 31.1 ± 6.0 31.7 ± 5.1 45.4 ± 5.3 
 Income, % 
             
 
PIR=<1.3 21.2 ± 2.9 21.1 ± 4.5 25.5 ± 5.3 16.0 ± 3.7 0.001 
 
PIR=<3.5 42.2 ± 3.2 60.7 ± 6.0 37.0 ± 5.6 30.5 ± 5.7 
 
 
PIR>3.5 36.5 ± 3.5 18.2 ± 5.7 37.5 ± 6.6 53.5 ± 6.1 
 Living with spouse, % 69.0 
 
2.9 68.8 
 
5.6 67.8 
 
4.5 70.7 
 
5.5 0.92 
Smoking status, % 
             
 
Never 55.1 ± 3.4 50.6 ± 5.2 60.5 ± 5.9 52.8 ± 6.1 0.58 
 
Former 21.8 ± 2.9 27.7 ± 5.0 16.7 ± 3.7 22.6 ± 5.1 
 
 
Current 23.1 ± 3.2 21.8 ± 4.7 22.8 ± 5.5 24.6 ± 6.4 
 Physical activity, % 
             
 
Inactive 14.7 ± 2.1 23.5 ± 5.2 12.0 ± 2.6 9.6 ± 2.9 0.07 
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Insufficient activity 59.5 ± 3.4 54.1 ± 4.5 63.5 ± 6.0 59.8 ± 5.0 
 
 
Recommended 
activity 25.8 ± 3.4 22.4 ± 4.7 24.4 ± 5.3 30.6 ± 5.3 
 CHD family history, % 16.9 ± 2.9 18.5 ± 4.5 15.4 ± 5.3 17.2 ± 4.8 0.89 
Diabetes mellitus, % 3.8 ± 1.1 4.5 ± 1.7 4.4 ± 1.6 2.5 ± 2.2 0.73 
Hypertension, % 23.6 ± 3.6 19.5 ± 3.2 26.0 ± 6.2 24.5 ± 5.5 0.58 
BMI, kg/m2 33.4 ± 0.1 34.0 ± 0.2 33.0 ± 0.2 33.2 ± 0.3 0.07 
Waist circumference, cm 104.0 ± 0.7 106.3 ± 0.8 101.8 ± 1.1 104.4 ± 1.2 0.16 
Fasting glucose, mg/dl 91 ± 0.4 91.0 ± 0.6 90.7 ± 0.8 90.9 ± 0.7 0.61 
HOMA-IR 2.4 ± 0.0 2.5 ± 0.1 2.4 ± 0.1 2.3 ± 0.1 <0.001 
SBP, mmHg 120 ± 0.6 120 ± 0.8 119 ± 0.9 122 ± 1.6 0.24 
DBP, mmHg 74 ± 0.5 73 ± 0.7 74 ± 0.7 77 ± 1.0 0.002 
hs-CRP, mg/dl 0.4 ± 0.02 0.4 ± 0.03 0.4 ± 0.03 0.4 ± 0.03 0.56 
Triglycerides, mg/dl 107 ± 5.0 111 ± 5.3 96 ± 3.4 117 ± 14.1 0.62 
HDL-C, mg/dl 52 ± 0.8 49 ± 0.9 54 ± 1.3 51 ± 1.6 0.06 
 
 
Table 5.1 (Continued) 
    Metabolically Unhealthy Obese (MUO) phenotype      
Characteristics 
Overall Tertile 1 Tertile 2 Tertile 3 
P  
P (MHO vs. 
MUO) 
(n=1,141) (n=340) (n=465) (n=336)     
Age, years 47.2 ± 0.7 45.9 ± 1.1 46.8 ± 1.0 49.7 ± 0.8 0.05 <0.001 
Men, % 49.9 ± 2.7 45.6 ± 3.9 53.5 ± 4.3 49.5 ± 3.9 0.29 <0.001 
Race/ ethnicity, % 
              
 
Non-Hispanic white 75.0 ± 2.6 81.9 ± 2.4 73.9 ± 3.5 67.6 ± 4.0 <0.001 <0.001 
 
Non-Hispanic black 11.2 ± 1.4 10.0 ± 1.7 11.9 ± 1.9 11.5 ± 1.7 
  
 
Mexican-American 7.1 ± 1.2 3.8 ± 0.9 6.3 ± 1.1 13.0 ± 2.5 
  
 
Other 6.7 ± 1.6 4.4 ± 1.7 7.9 ± 2.3 7.9 ± 3.0 
  
  
 
1
1
0
 
Educational attainment, % 
              
 
<12 years 27.1 ± 2.4 30.6 ± 3.8 24.3 ± 2.8 27.3 ± 4.3 0.02 0.55 
 
12 years 37.0 ± 2.5 42.0 ± 3.2 37.6 ± 4.1 29.4 ± 3.1 
  
 
>=13 years 35.9 ± 3.3 27.5 ± 3.9 38.1 ± 4.5 43.3 ± 5.1 
  Income, % 
              
 
PIR=<1.3 17.4 ± 1.9 25.4 ± 3.6 13.5 ± 2.4 13.3 ± 2.2 <0.001 0.28 
 
PIR=<3.5 48.0 ± 2.5 52.8 ± 3.7 49.4 ± 4.0 38.6 ± 5.0 
  
 
PIR>3.5 34.6 ± 3.1 21.8 ± 3.0 37.2 ± 4.9 48.1 ± 4.9 
  Living with spouse, % 30.5 
 
1.8 65.6 
 
3.5 72.2 
 
3.4 70.1 
 
3.8 0.41 0.88 
Smoking status, % 
              
 
Never 42.4 ± 2.1 40.9 ± 3.1 44.0 ± 3.2 41.7 ± 5.5 0.004 0.003 
 
Former 33.7 ± 2.1 25.0 ± 3.7 35.7 ± 2.7 41.9 ± 5.5 
  
 
Current 23.9 ± 1.7 34.1 ± 3.7 20.3 ± 3.2 16.3 ± 2.6 
  Physical activity, % 
              
 
Inactive 16.2 ± 1.7 22.6 ± 2.9 13.3 ± 2.3 12.9 ± 2.6 0.04 0.60 
 
Insufficient activity 55.8 ± 2.3 56.2 ± 4.5 56.1 ± 3.6 54.6 ± 4.2 
  
 
Recommended 
activity 28.0 ± 2.1 21.2 ± 4.1 30.6 ± 3.3 32.5 ± 3.8 
  CHD family history, % 21.6 ± 2.2 27.8 ± 3.8 18.8 ± 3.4 18.3 ± 3.7 0.13 0.28 
Diabetes mellitus, % 18.2 ± 1.5 16.9 ± 2.9 16.3 ± 2.4 23.5 ± 3.0 0.19 <0.001 
Hypertension, % 49.4 ± 2.6 46.9 ± 3.9 47.7 ± 3.9 56.0 ± 4.6 0.27 <0.001 
BMI, kg/m2 34.8 ± 0.2 35.8 ± 0.3 34.3 ± 0.2 34.3 ± 0.4 0.001 <0.001 
Waist circumference, cm 110.9 ± 0.4 113.3 ± 0.7 110.2 ± 0.7 108.9 ± 0.8 <0.001 <0.001 
Fasting glucose, mg/dl 107 ± 0.9 107.5 ± 2.5 107.5 ± 1.5 106.8 ± 1.6 0.31 <0.001 
HOMA-IR 5.0 ± 0.2 5.3 ± 0.2 5.1 ± 0.3 4.4 ± 0.2 <0.001 <0.001 
SBP, mmHg 131 ± 0.6 129 ± 0.8 130 ± 0.8 134 ± 1.1 <0.001 <0.001 
DBP, mmHg 80 ± 0.5 80 ± 0.4 80 ± 0.5 81 ± 1.2 0.21 <0.001 
hs-CRP, mg/dl 0.6 ± 0.02 0.6 ± 0.02 0.6 ± 0.03 0.6 ± 0.04 0.19 <0.001 
Triglycerides, mg/dl 195 ± 4.0 208 ± 6.0 187 ± 5.8 190 ± 9.0 0.02 <0.001 
HDL-C, mg/dl 42 ± 0.4 40 ± 0.7 41 ± 0.8 45 ± 1.3 0.003 <0.001 
  
 
1
1
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Data are presented as mean ± SE or proportion (%) ± SE. P values for continuous variables represent P for trend. 
Abbreviations: PIR, poverty income ratio; CHD, coronary heart disease; BMI, body mass index; HOMA-IR, homoeostasis model assessment of insulin 
resistance; hs-CRP, high-sensitivity C-reactive protein; HDL-C, high-density lipoprotein cholesterol. 
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Table 5.2 Comparison of consumption frequency for each component of the Mediterranean diet in 
Metabolically Healthy Obese (MHO) and Metabolically Unhealthy Obese (MUO) phenotypes at baseline  
 
  Metabolically Healthy Obese (MHO) phenotype     
 
Overall Tertile 1 Tertile 2 Tertile 3 P for 
trend   (n=598) (n=181) (n=240) (n=177) 
Score range (13 - 39) (13 - 23) (24 - 28) (29 - 39) 
 
MDS score 26.0 ± 0.2 20.8 ± 0.2 25.9 ± 0.1 31.1 ± 0.2 <0.001 
Grains (times/wk) 4.7 ± 0.4 3.8 ± 0.7 4.2 ± 0.4 6.3 ± 0.6 <0.001 
Legumes (times/wk) 2.6 ± 0.1 1.5 ± 0.1 3.0 ± 0.2 3.2 ± 0.3 <0.001 
Fruit (times/wk) 5.9 ± 0.4 4.9 ± 0.4 4.6 ± 0.3 8.4 ± 1.0 0.002 
Vegetable (times/wk) 13.1 ± 0.3 11.2 ± 0.6 12.3 ± 0.5 16.0 ± 0.9 <0.001 
Fish (times/wk) 1.4 ± 0.1 1.0 ± 0.1 1.1 ± 0.1 2.3 ± 0.3 <0.001 
MUFA:SFA 1.23 ± 0.03 1.02 ± 0.02 1.26 ± 0.02 1.41 ± 0.10 <0.001 
Red meats (times/wk) 5.2 ± 0.3 6.2 ± 0.3 5.3 ± 0.5 4.0 ± 0.2 <0.001 
Poultry (times/wk) 2.3 ± 0.1 2.1 ± 0.2 2.3 ± 0.2 2.3 ± 0.3 0.47 
Dairy products 
(times/wk) 
10.3 ± 0.4 12.3 ± 0.6 10.2 ± 0.6 8.3 ± 0.5 <0.001 
Alcohol (g/d) 2.7 ± 0.3 2.4 ± 1.0 2.3 ± 0.3 3.5 ± 0.4 0.15 
Total energy intake, 
kcal 
2032 ± 47 2121 ± 72 2016 ± 61 1966 ± 128 0.66 
 
 
Table 5.2 (Continued) 
  Metabolically Unhealthy Obese (MUO) phenotype      
 
Overall Tertile 1 Tertile 2 Tertile 3 P for 
trend 
P (MHO VS 
MUO)   (n=1,141) (n=340) (n=465) (n=336) 
Score range (12 - 40) (12 - 23) (24 - 28) (29 - 40) 
  
  
 
1
1
3
 
MDS score 25.5 ± 0.2 20.5 ± 0.1 26.0 ± 0.1 31.2 ± 0.1 <0.001 0.04 
Grains (times/wk) 5.0 ± 0.3 3.2 ± 0.3 5.3 ± 0.5 6.6 ± 0.4 <0.001 0.49 
Legumes (times/wk) 2.4 ± 0.1 1.6 ± 0.1 2.7 ± 0.2 3.2 ± 0.2 <0.001 0.14 
Fruit (times/wk) 6.1 ± 0.3 4.0 ± 0.2 5.5 ± 0.3 9.9 ± 0.5 <0.001 0.59 
Vegetable (times/wk) 13.5 ± 0.4 10.1 ± 0.4 13.8 ± 0.5 17.7 ± 0.7 <0.001 0.53 
Fish (times/wk) 1.4 ± 0.1 1.2 ± 0.3 1.2 ± 0.1 2.0 ± 0.1 0.005 0.50 
MUFA:SFA 1.19 ± 0.02 1.06 ± 0.02 1.20 ± 0.02 1.35 ± 0.05 <0.001 0.03 
Red meats (times/wk) 5.6 ± 0.2 6.7 ± 0.3 5.5 ± 0.3 4.1 ± 0.2 <0.001 0.01 
Poultry (times/wk) 2.1 ± 0.1 2.0 ± 0.1 2.1 ± 0.1 2.2 ± 0.1 0.010 0.12 
Dairy products 
(times/wk) 
11.6 ± 0.4 14.2 ± 0.8 10.9 ± 0.5 9.2 ± 0.3 <0.001 0.03 
Alcohol (g/d) 2.7 ± 0.2 2.2 ± 0.7 2.3 ± 0.3 4.0 ± 0.3 0.01 0.96 
Total energy intake, 
kcal 
2222 ± 47 2221 ± 65 2235 ± 69 2200 ± 69 0.89 <0.001 
Data are presented as mean ± SE. 
Abbreviations: MUFA, monounsaturated fatty acid; SFA, saturated fatty acid; MDS, Mediterranean Diet Score. 
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Table 5.3 Adjusted hazard ratio (HR) and 95% CI of all-cause, cardiovascular, and cancer mortality according to the tertile 
categories and a five-point increment in the Mediterranean diet score in Metabolically Healthy Obese (MHO) and 
Metabolically Unhealthy Obese (MUO) phenotypes 
 
 Metabolically Healthy Obese (MHO) phenotype 
 
Metabolically Unhealthy Obese (MUO) phenotype 
 Tertile 1  
 
Tertile 2  Tertile 3  P trend HR for  
a 1 SD 
increase in 
MDS 
Tertile 1  Tertile 2  Tertile 3  P trend HR for  
a 1 SD 
increase in 
MDS 
No. of 
participants 
181 240 177   340 465 336   
No. of 
person 
years 
3191 4394 3284   5639 8006 5625   
Deaths from 
all causes, n 
35 26 16   105 116 88   
Model 1 1.00 
(ref.) 
0.47 
(0.26-0.84) 
0.36 
(0.23-0.57) 
<0.001 0.67 
(0.56-0.81) 
1.00 
(ref.) 
0.75 
(0.56-1.01) 
0.98 
(0.56-1.74) 
0.84 1.01 
(0.83-1.22) 
Model 2 1.00 
(ref.) 
0.40 
(0.24-0.66) 
0.35 
(0.20-0.59) 
<0.001 0.59 
(0.48-0.73) 
1.00 
(ref.) 
0.69 
(0.54-0.88) 
0.77 
(0.45-1.31) 
0.28 0.91 
(0.75-1.10) 
Model 3 1.00 
(ref.) 
0.35 
(0.19-0.64) 
0.44 
(0.26-0.75) 
<0.001 0.59 
(0.37-0.94) 
1.00 
(ref.) 
0.74 
(0.58-0.95) 
0.92 
(0.48-1.76) 
0.66 0.96 
(0.78-1.17) 
CVD 
Deaths, n 
6 5 5   26 33 27   
Model 1 1.00 
(ref.) 
0.64 
(0.18-2.29) 
1.15 
(0.12-11.0) 
0.89 0.92 
(0.38-2.24) 
1.00 
(ref.) 
1.57 
(0.84-2.93) 
1.76 
(0.94-3.29) 
0.07 1.08 
(0.89-1.31) 
Model 2 1.00 
(ref.) 
0.43 
(0.12-1.49) 
1.15 
(0.12-10.7) 
0.88 0.87 
(0.28-2.67) 
1.00 
(ref.) 
1.46 
(0.75-2.83) 
1.41 
(0.79-2.50) 
0.22 1.12 
(0.93-1.35) 
Model 3 1.00 
(ref.) 
0.18 
(0.05-0.58) 
1.25 
(0.41-3.83) 
0.65 1.01 
(0.29-3.51) 
1.00 
(ref.) 
1.28 
(0.61-2.67) 
1.61 
(0.56-4.62) 
0.34 1.15 
(0.87-1.54) 
* Cancer 
Deaths, n 
11 6 3   25 25 24   
Model 1 1.00 0.12 0.19 0.03 0.45 1.00 0.58 1.07 0.99 1.13 
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(ref.) (0.07-0.22) (0.04-0.95) (0.21-0.97) (ref.) (0.19-1.72) (0.41-2.80) (0.73-1.77) 
Model 2 1.00 
(ref.) 
0.11 
(0.06-0.20) 
0.16 
(0.04-0.76) 
0.01 0.36 
(0.15-0.86) 
1.00 
(ref.) 
0.54 
(0.20-1.50) 
0.90 
(0.34-2.40) 
0.78 1.07 
(0.67-1.71) 
Model 3 1.00 
(ref.) 
0.13  
(0.06-0.26) 
0.23 
(0.02-2.10) 
0.03 0.28 
(0.04-1.79) 
1.00 
(ref.) 
0.61  
(0.34-1.09) 
1.17  
(0.41-3.33) 
0.90 1.27  
(0.77-2.10) 
Data are presented as hazard ratio (95% confidence interval). 
Abbreviations: MDS, Mediterranean diet score; CVD, cardiovascular disease. 
Model 1 represents a crude model. Model 2 adjusted for age, gender, and race/ethnicity. Model 3 further adjusted for educational attainment, income, 
living with spouse, smoking status, level of physical activity, family history of coronary heart disease, body mass index, and total calorie intakes. 
* those who had a history of skin cancer were also excluded. 
Due to small sample sizes, cautious interpretation of finding is needed for CVD and cancer deaths in MHO individuals. 
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Table 5.4 Subgroup analyses of the association between a five-point increment in the Mediterranean diet score and the 
risk of all-cause mortality in Metabolically Healthy Obese (MHO) and Metabolically Unhealthy Obese (MUO) 
phenotypes 
 
 Metabolically Healthy Obese (MHO) 
phenotype 
Metabolically Unhealthy Obese (MUO) 
phenotype 
 No. of 
participants 
(deaths) 
HR for a 1 SD 
increase in MDS 
P 
interaction 
No. of 
participants 
(deaths) 
HR for a 1 SD 
increase in MDS 
P 
interaction 
Age, y   0.55   0.79  
< 65 535 (43) 0.59 (0.32-1.06)  908 (152) 0.97 (0.68-1.37)  
≥ 65   63 (34) 0.41 (0.23-0.75)  233 (157) 1.13 (0.95-1.34)  
Gender   0.002   0.68 
Men 163 (22) 0.02 (0.01-0.67)  495 (146) 0.96 (0.76-1.21)  
Women 435 (55) 0.83 (0.50-1.38)  646 (163) 0.98 (0.70-1.38)  
Race/ ethnicity   0.29   0.52 
Non-Hispanic 
white 
175 (31) 0.39 (0.17-0.87)  432 (158) 1.02 (0.82-1.27)  
Others 423 (46) 0.76 (0.44-1.31)  709 (151) 0.84 (0.58-1.21)  
Body mass index, 
kg/m2 
  0.46   0.36 
< 35 429 (55)  0.43 (0.26-0.71)  720 (208) 1.01 (0.80-1.29)  
≥ 35 162 (22)  0.64 (0.31-1.36)  421 (101) 0.95 (0.70-1.30)  
Smoking status   0.07   0.96 
Non-smoker 378 (40) 0.54 (0.25-1.18)  589 (136) 1.08 (0.76-1.52)  
Ever-smoker 220 (37) 0.20 (0.10-0.43)  552 (173) 0.96 (0.75-1.22)  
Recommended 
physical activity  
  0.008   0.003 
Yes 148 (24) 0.30 (0.11-0.80)  278 (85) 1.29 (0.89-1.87)  
No 450 (53) 0.67 (0.45-1.00)  863 (224) 0.95 (0.75-1.20)  
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Chronic disease    0.13   0.57 
Absence  457 (35) 0.56 (0.29-0.95)  480 (61) 1.09 (0.60-1.95)  
Presence 141 (42) 0.50 (0.29-0.86)  661 (248) 0.92 (0.71-1.18)  
Models are adjusted as model 3 in Table 5.3, except for the stratifying factor.  
A group with recommended physical activity was defined as those who had self-reported leisure time moderate activity (3 ≤ metabolic equivalents 
(METs) <6) of five or more times per week or leisure time vigorous activity (METs ≥ 6) three or more times per week. 
Presence of chronic disease indicates having diabetes mellitus and hypertension.  
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Table 5.5 Multivariable adjusted hazard ratio (HR) * and 95% CI of all-cause mortality according to the tertile categories and 
a five-point increment in the Mediterranean diet score in Metabolically Healthy Obese (MHO) and Metabolically Unhealthy 
Obese (MUO) phenotypes excluding the deaths at the first five year follow-up 
 
 Metabolically Healthy Obese (MHO) phenotype Metabolically Unhealthy Obese (MUO) phenotype 
 Tertile 1  
 
Tertile 2  Tertile 3  P 
trend 
HR for  
a 1 SD 
increase in 
MDS 
Tertile 1  Tertile 2  Tertile 3  P 
trend 
HR for  
a 1 SD 
increase in 
MDS 
No. of 
participants 
189 256 184   378 502 355   
No. of 
person 
years 
3371 4663 3408   6435 8630 6017 
 
  
Deaths from 
all causes, n 
36 31 18   118 143 98   
 1.00 
(ref.) 
0.42 
(0.42-0.78) 
0.54 
(0.28-0.95) 
0.006 0.57 
(0.44-0.72) 
1.00 
(ref.) 
0.84 
(0.68-1.03) 
1.12 
(0.68-1.83) 
0.73 1.07 
(0.89-1.28) 
CVD 
deaths, n 
8 8 5   37 43 29   
 1.00 
(ref.) 
1.41 
(0.13-1.25) 
1.26 
(0.17-9.48) 
0.88 0.46 
(0.26-0.81) 
1.00 
(ref.) 
1.22 
(0.60-2.47) 
1.27 
(0.62-2.59) 
0.47 1.07 
(0.87-1.33) 
* Cancer 
deaths, n 
12 7 4   27 28 23   
 1.00 
(ref.) 
0.14 
(0.07-0.27) 
0.23 
(0.05-0.99) 
0.02 0.30 
(0.09-1.02) 
1.00 
(ref.) 
0.67 
(0.39-1.17) 
1.28 
(0.52-3.14) 
0.69 1.35 
(0.86-2.13) 
Data are presented as hazard ratio (95% confidence interval). 
Abbreviations: MDS, Mediterranean diet score; CVD, cardiovascular disease  
* : Adjusted for age, gender, and race/ethnicity, educational attainment, income, living with spouse, smoking status, level of physical activity, family 
history of coronary heart disease, body mass index, and total calories. 
* those who had a history of skin cancer were also excluded. 
Due to small sample sizes, cautious interpretation of finding is needed for CVD and cancer deaths in MHO individuals. 
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Table 5.6 Multivariable adjusted hazard ratio (HR) * and 95% CI of all-cause, cardiovascular, and cancer mortality according 
to the tertile categories and a five-point increment in the Mediterranean diet score in Metabolically Healthy Obese (MHO) and 
Metabolically Unhealthy Obese (MUO) phenotypes using metabolic syndrome† as a definition of metabolic health 
 
 Metabolically Healthy Obese (MHO) phenotype Metabolically Unhealthy Obese (MUO) phenotype 
 Tertile 1  
 
Tertile 2  Tertile 3  P 
trend 
HR for  
a 1 SD 
increase in 
MDS 
Tertile 1  Tertile 2  Tertile 3  P 
trend 
HR for  
a 1 SD 
increase in 
MDS 
No. of 
participants 
248 325 219   263 364 283   
No. of 
person 
years 
4319 5948 4002   4354 6184 4701 
 
  
Deaths from 
all causes, n 
51 41 25   83 98 78   
 1.00 
(ref.) 
0.51 
(0.31-0.85) 
0.65 
(0.40-1.06) 
0.02 0.74 
(0.60-0.90) 
1.00 
(ref.) 
0.73 
(0.56-0.94) 
1.02 
(0.50-2.08) 
0.92 0.95 
(0.73-1.24) 
CVD 
deaths, n 
7 8 9   24 30 23   
 1.00 
(ref.) 
1.35 
(0.03-25.7) 
3.98 
(0.17-62.4) 
0.66 1.39 
(0.10-22.2) 
1.00 
(ref.) 
1.15 
(0.54-2.46) 
1.34 
(0.45-4.00) 
0.56 1.04 
(0.72-1.52) 
Cancer 
deaths, n 
16 11 5   20 19 21   
 1.00 
(ref.) 
0.21 
(0.10-0.45) 
0.63 
(0.11-3.47) 
0.24 0.63 
(0.27-1.47) 
1.00 
(ref.) 
0.58 
(0.33-1.03) 
1.07 
(0.34-3.40) 
0.99 1.12 
(0.63-1.99) 
Data are presented as hazard ratio (95% confidence interval). 
Abbreviations: MDS, Mediterranean diet score; CVD, cardiovascular disease. 
Those who had a history of skin cancer were excluded in calculating HRs in cancer deaths. 
* : Adjusted for age, gender, and race/ethnicity, educational attainment, income, living with spouse, smoking status, level of physical activity, family 
history of coronary heart disease, body mass index, and total calories.  
†: Metabolic syndrome was defined when the individual had fewer than three cardiometabolic abnormalities (systolic/diastolic blood pressure ≥ 130/85 
mm Hg or antihypertensive medication use, triglycerides ≥ 150 mg/L, fasting plasma glucose ≥ 100 mg/dL or antidiabetic medication use, high density 
lipoprotein-cholesterol (HDL-C) < 40 mg/dL in men or < 50 mg/dL in women, and waist circumference ≥ 102 cm in men or ≥ 88 cm in women. 
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CHAPTER 6 
DIET QUALITY AND MORTALITY RISK IN METABOLICALLY OBESE NORMAL 
WEIGHT ADULTS1
                                                 
1 Yong-Moon Mark Park, Teresa T. Fung, Susan E. Steck, Jiajia Zhang, Linda J. Hazlett, 
Kyungdo Han, and Anwar M. Merchant. To be submitted to Diabetes Care. 
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Abstract 
Objective: To examine the association between the Dietary Approaches to Stop 
Hypertension (DASH) style diet, Healthy Eating Index (HEI), metabolic health, and 
mortality risk in a representative normal weight U.S. population.  
Research Design and Methods: Data were from normal weight (18.5 ≤ body 
mass index < 25 kg/m2) adults ≥ 40 years in the National Health and Nutrition 
Examination Survey III, 1988–1994 followed up for deaths until December 31, 2011.  A 
total of 1,333 participants without known cardiovascular disease (CVD) and cancer at 
baseline were included in this prospective cohort study. Metabolic health was defined 
based on high glucose, blood pressure, triglycerides, C-reactive protein, insulin resistance, 
and low high-density lipoprotein-cholesterol.  
Results: During a median follow-up of 17.9 years, there were 313 and 250 deaths 
in the metabolically obese normal weight (MONW) phenotype and metabolically healthy 
normal weight (MHNW) phenotype, respectively. In MONW individuals, one SD 
increment in the adherence to DASH style diet and HEI (2 points and 14 points, 
respectively) was significantly associated with 23% and 27% reductions in the risk of all-
cause mortality (Hazard ratio (HR), 0.77 [95% confidence interval (CI), 0.66-0.90]; HR, 
0.73 [95% CI, 0.63-0.85], respectively), after adjustment for potential confounders. The 
corresponding HRs for CVD mortality were 0.70 (95% CI, 0.53-0.93) and 0.74 (95% CI, 
0.61-0.91), respectively. Similar findings for all-cause mortality were observed regardless 
of diabetes or hypertension status. However, no association was observed in MHNW 
phenotype. 
Conclusions: Higher diet quality scores were associated with a lower risk of 
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mortality in MONW adults.  
Keywords: Dietary Approaches to Stop Hypertension (DASH) style diet, Health 
Eating Index, metabolic obesity, mortality, National Health and Nutrition Examination 
Survey  
Introduction 
Despite being apparently non-obese, a subset of normal weight individuals appear 
to be more susceptible to insulin resistance, type 2 diabetes mellitus (DM) and 
cardiovascular disease (CVD) (1).  These individuals display a metabolically obese 
normal weight (MONW) phenotype characterized by lower energy expenditure, higher 
visceral adiposity, impaired insulin sensitivity, and a more atherogenic lipid profile (1). 
These unfavorable characteristics of MONW phenotype contribute to an increased risk of 
cardiometabolic disease (2-4), compared to their metabolically healthy normal weight 
(MHNW) counterparts. It has been reported that the prevalence of MONW phenotype 
ranges from 7.1% to 30.1% depending on the criteria used in U.S. population (5; 6). Thus, 
identification of modifiable risk factors in MONW individuals who are apparently 
healthy, but at high risk of cardiometabolic disease would be beneficial to prevent the 
development of cardiometabolic morbidity and mortality (7).  
Healthy dietary pattern is associated with a reduced risk of CVD and cancer (8). 
In the United States, the Dietary Approaches to Stop Hypertension (DASH) score and the 
Healthy Eating Index (HEI) are diet quality indexes of substantial public health 
importance (9). The DASH style diet was developed to prevent hypertension (10),  and it 
has been reported that the adherence to the DASH style diet is related to a reduced risk of 
CVD (11) and type 2 DM (12). HEI was developed by US Department of Agriculture 
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researchers to measure the overall dietary quality in the US population, has been 
associated with lower inflammation and risk of chronic disease (13; 14). 
To date, the intervention studies on the effect of healthy dietary patterns on the 
reduced risk of chronic disease have been limited to an obese population (15-17). Even in 
observational studies, there is little evidence on the association between healthy dietary 
patterns and risk of chronic disease in normal weight population (11; 18). As the MONW 
phenotype also has risk of developing cardiometabolic disease, it would be important to 
examine the potential of high diet quality on reducing the morbidity and mortality in 
these individuals.  Furthermore, the role of the healthy dietary pattern in the natural 
history of MONW phenotype is unknown.   
Therefore, we addressed the question whether high quality diet measured by 
DASH style diet and HEI have health benefits in relation to mortality risk reduction in 
MONW individuals in a nationally representative normal weight US population. 
Methods  
Study population 
We used data from the Third National Health and Nutrition Examination Survey 
(NHANES III), 1988–1994, followed up for deaths until December 31, 2011 in this 
prospective cohort analysis. NHANES III was carried out using a complex multi-stage 
stratified clustered probability sample design to achieve a nationally representative 
sample of the civilian, non-institutionalized US population. The survey included personal 
interviews, physical examinations, and laboratory measurements.  
We included 1,786 normal weight (18.5 ≤ body mass index (BMI) < 25 kg/m2) 
adults aged 40-90 years who were eligible for mortality follow-up and had complete data 
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on food frequency questionnaire (FFQ) and 24-hour dietary recall, and cardiometabolic 
parameters including fasting glucose, insulin, triglycerides (TG), high-density lipoprotein 
cholesterol (HDL-C), blood pressure (BP), and high-sensitivity C-reactive protein (hs-
CRP). We excluded those who reported a history of myocardial infarction, stroke, 
congestive heart failure, or cancer (other than skin cancer) (n=304). To minimize reverse 
causation, we excluded the participants who reported changing  their dietary patterns 
during the previous 12 months because of pre-existing obesity, high blood pressure, high 
blood cholesterol, DM, or general health (n=129). We also excluded those who reported 
implausible extreme energy intakes (<1st and >99th percentiles of energy intake/d in 
adults), pregnant or lactating women, and those with hs-CRP >10mg/L (n=20). Finally, a 
total of 1,333 individuals were included in thess analyses and followed-up for mortality 
outcomes. Since there is a large difference in mean age between MONW and MHNW 
phenotypes (5; 19), we limited our study to subjects aged 40 and older to minimize the 
age effect in comparing the association between high quality diet and the mortality risk in 
both MONW and MHNW phenotype.  
Assessment of DASH style diet  
The DASH style diet is characterized by high intake of fruits, vegetables, nuts and 
legumes, low fat dairy products, and whole grains; and low intake of fat (total/saturated), 
sodium, sweets, and red meats (20). NHANES FFQ did not provide information on 
servings, thus, we did not use FFQ data for these analyses. Dietary intake was assessed 
using the 24-hr dietary recall data, validated by the Nutrition Methodology Working 
Group (21). We  calculated Mellen’s index which is one of the established DASH index 
scores from the 24-hr dietary recall data (22). Mellen’s index, a nutrient-based index with 
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9 components including target nutrient values used in clinical trials (23), applied absolute 
targets on the basis of a 2100-kcal diet for both men and women. Individuals satisfying 
the goal for each component received 1 point, those who meet an intermediate goal, 
defined as the midpoint between the DASH diet goal and the nutrient content of the 
DASH control diet received one-half of a point, and those who meet neither goal received 
0 points (10). The possible DASH score ranged from 0 to 9, with higher values of this 
DASH score indicating greater adherence to the DASH style diet. 
Assessment of HEI scores  
In 2000, the Centers for Disease Control and Prevention proposed the HEI as a 
measure for diet quality (24). Ten main factors used to calculate HEI include grains, 
fruits, vegetables, dairy, meats, total fat, saturated fat, cholesterol, sodium, and dietary 
variety (25). HEI scores range from 0 to 100, with a score of each component ranging 
from 0 to 10. Among the HEI components, grains, fruits, vegetables, meats and dairy 
products were based on the Food Guide Pyramid’s recommended number of servings in 
which the maximum score was given to the recommended servings. The remaining 
components complied with the Dietary Guidelines for Americans considering the 
recommended intakes of total fat, saturated fat, cholesterol and sodium (25). In addition, 
dietary variety was assessed by adding up the number of different foods eaten by an 
individual in amounts sufficient to contribute at least one-half of a serving in a food 
group (26). The data for HEI and its component scores were determined from dietary 
information collected by a single 24-h recall using an automated, interactive interview 
(27). 
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Assessment of Metabolic health 
Metabolic health was assessed using the metabolic parameters that were measured 
under quality control standards of Centers for Disease Control and Prevention. BMI was 
calculated as kg/m2; height was measured to the nearest 0.1cm and weight to the nearest 
0.01 kg. Waist circumference was measured at the level of the right iliac crest. BP was 
averaged over five separate measurements. Glucose was measured in serum, using a 
modified hexokinase enzymatic method. Serum insulin was measured using a 
radioimmnuoassay (Pharmacia Diagnostics). HDL-C and TG were measured using a 
Hitachi 704 analyzer (Boehringer-Mannheim Diagnostics). Serum CRP concentrations 
were measured by latex-enhanced nephlometry (Department of Laboratory Medicine, 
Immunology Division, University of Washington, Seattle). Since NHANES III 
participants did not comply with fasting instruction strictly, six hour fasting data were 
used to increase the sample size (28). 
Metabolic health was defined when the individual had fewer than two 
cardiometabolic abnormalities [systolic/diastolic BP ≥ 130/85 mm Hg or antihypertensive 
medication use, triglycerides ≥ 150 mg/L on cholesterol-lowering medication, fasting 
glucose ≥ 100 mg/dL or antidiabetic medication use, homoeostasis model assessment of 
insulin resistance (HOMA-IR = fasting glucose (mg/dl) x fasting insulin (lU/mL)/405) > 
the 90th percentile, hs- CRP > the 90th percentile, and HDL-C < 40 mg/dL in men or < 
50 mg/dL in women on cholesterol-lowering medication] (5). 
Assessment of Mortality 
To determine the vital status and cause of death, the National Center for Health 
Statistics linked all participants aged 20 years and older to the National Death Index 
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through 31 December 2011. Therefore, for each participant follow-up extended from the 
date of the examination to the date of death or 31 December 2011. The underlying cause 
listed on the death certificate was applied to determine cause of death that was identified 
using the underlying Cause of Death-113 groups (international classification of disease 
(ICD), 10th revision). Total mortality was defined as deaths with any underlying cause of 
death; CVD and cancer mortality were defined as deaths with underlying cause of death 
codes for ICD-10 I00-I69 and C00-C97, respectively (29). 
Assessment of Covariates 
Demographic variables included age, gender, race or ethnicity (non-Hispanic 
white, non-Hispanic black, Mexican American, or others), educational attainment (<12 
years, 12 years, or >12 years of education), living with spouse, and level of income 
measured based on poverty income ratio (PIR) which is the ratio of household income to 
the appropriate poverty threshold (low (PIR ≤ 1.3), middle (1.3<PIR ≤ 3.5), and high 
(PIR>3.5). The potential risk factors for CVD comprised smoking status (never, former, 
and current), and the presence of family history of coronary heart disease (CHD). The 
amount of alcohol consumed daily was estimated using the following assumption: 12.8g 
for 12-oz beer, 11g for 4-oz glass of wine, and 14g for an ounce of liquor based on the 
questionnaire. Then, moderate alcohol use was defined as up to 28g and 14 g of alcohol 
per day in men and women (30). Physical activity was classified based on the 
recommended levels of physical activity (31). A group with recommended physical 
activity was defined as those who had self-reported leisure time moderate activity (3 ≤ 
metabolic equivalents (METs) <6) of five or more times per week or leisure time 
vigorous activity (METs ≥ 6) three or more times per week; physically inactive group as 
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those with no reported leisure time physical activity; a group with insufficient physical 
activity as those who did not meet the criteria for recommended levels of physical 
activity but not inactive.  
Statistical Analysis 
We used the appropriate survey procedures to account for the complex sampling 
design and weights. For the subgroup analysis, domain analysis was applied to preserve 
the complex sampling design in which the entire samples were used for estimating the 
variance of subpopulations. Continuous variables were presented by mean (SE: standard 
error) and compared using linear regression analyses. Categorical variables were 
expressed by percentage with SE and were compared using Rao-Scott χ2 tests.  
Cox proportional hazards regression model was used to estimate the hazard ratios 
(HRs) and 95% confidence intervals (CIs) for all-cause, CVD, and cancer mortality. The 
proportional hazards assumption of the Cox models was evaluated with log of negative 
log survival curves based on Kaplan-Meier estimates for DASH or HEI tertile group as 
well as age, gender, and race/ethnicity. Multivariable-adjusted HRs included the 
following covariates: age, gender, race/ethnicity, educational attainment, living with 
spouse, income, smoking status, alcohol consumption, level of physical activity, family 
history of CHD, waist circumference, and total energy intake. Missing values in the 
covariates were added as a dummy variable in the multivariable models.  
To evaluate the potential effect modification of DASH index or HEI according to 
the variables with public health importance, we stratified our analysis and tested for 
interactions of DASH index and HEI with the following variables using all-cause 
mortality as the outcome by including the cross-product interaction terms in the Cox 
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models based on F test: age (<65 vs. ≥65 years), sex, race/ethnicity, smoking 
(current/former smoker vs. never smoked), physical activity (physically inactive vs. 
physically active), alcohol consumption (moderate drinker vs. non- or heavy drinker), and 
the presence or absence of chronic disease including DM and hypertension. Furthermore, 
we performed sensitivity analyses after exclusion of subjects who died during the first 
five year follow-up. All the statistical analyses were performed using SAS 9.4 software 
(SAS Institute Inc., Cary, NC, USA), and a P value of less than .05 was considered 
statistically significant.  
Results 
The MONW phenotype (n=525) was observed in 31.2 (SE, 1.7) % of the normal 
weight sample from the present study. Table 6.1 shows general characteristics according 
to the tertiles for DASH index and HEI in MONW and MHNW individuals. Overall, 
MONW individuals tended to be older and male; had less education and income; were 
less likely to be non-Hispanic whites and moderate drinkers; were more likely to be 
physically active; and had more DM, hypertension, and less favorable metabolic 
parameters, compared with MHNW individuals. In MONW individuals, those with the 
higher tertile in both DASH index and HEI were more likely to be older and female. In 
MHNW individuals, those with the higher tertile in DASH index and HEI were more 
likely to be older and physically active; had more income; were less likely to be a current 
smoker; and had a lower diastolic BP.  
The distribution of components of DASH style diet and HEI according to the each 
tertile in MONW and MHNW phenotypes is shown in Table 6.2. Overall, no difference 
of total DASH and HEI scores were found between MONW and MHNW individuals. For 
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the DASH style diet, trends of all nutrients in DASH style diet were significant with 
increasing tertile of DASH scores except sodium in MHNW individuals. Percentage of 
energy in saturated fat and total fat was lower in MONW individuals (P=0.01 and 0.001, 
respectively). For the HEI scores, trends of all components in HEI were significant with 
increasing tertile of HEI scores except HEI score for meats in both MONW and MHNW 
individuals. Total energy intake was not different between each tertile of MONW and 
MHNW individuals. HEI score for fats and dietary variety were higher and lower in 
MONW individuals (P=0.01 and 0.04, respectively). 
During a median follow-up of 17.9 years, there were 313 and 248 deaths in 
MONW and MHNW phenotypes, respectively. Overall, higher mortality risk was 
observed in MONW phenotype compared to MHNW phenotype for all-cause mortality 
(HR, 1.36 [95% CI, 1.11-1.67]), CVD mortality (HR, 2.24 [95% CI, 1.55-3.24]), and 
cancer mortality (HR, 1.47 [95% CI, 1.02-2.11]) after adjusting for potential confounders. 
Table 6.3 shows adjusted HR of all-cause, cardiovascular, and cancer mortality according 
to the tertile categories and a 1 SD increment in the DASH and HEI scores in MONW 
and MHNW individuals. Significant inverse associations of increasing DASH index and 
HEI with all-cause and CVD mortality were observed in MONW individuals after 
multivariable adjustment. For all-cause mortality, compared with the lowest tertile, HRs 
were 0.61 (0.44-0.86) (P for trend = 0.006) for DASH index and 0.50 (0.35-0.73) (P for 
trend < 0.001) for HEI in the highest tertile. For CVD mortality, HRs were 0.40 (0.24-
0.65) (P for trend < 0.001) for DASH index and 0.49 (0.26-0.93) (P for trend = 0.007) for 
HEI in the highest tertile, compared with the lowest tertile. A 1 SD increment (2 points 
for DASH index and 14 points for HEI) in the adherence to DASH style diet and HEI 
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was inversely associated with a reduction in the risk of all-cause mortality (HR, 0.77 
[0.66-0.90]; HR, 0.73 [0.63-0.85], respectively), and CVD mortality (HR, 0.70 [0.53-
0.93]; HR, 0.74 [0.61-0.91], respectively). However, no association was observed in 
MHNW phenotypes with increasing DASH score and HEI.  
In stratified analyses for HRs of all-cause mortality with a SD increment of 
DASH index and HEI, stronger inverse associations were observed for MONW 
individuals who were aged 65 years or older, non- or former smokers (for DASH index), 
or physically active, although interaction term was not significant. MONW individuals 
with or without DM or hypertension had mortality reduction in higher DASH index and 
HEI, altogether. In MHNW individuals, the inverse association was stronger among those 
who were race/ethnicity other than non-Hispanic white (P interaction <0.01 in both 
indexes) and physically inactive (P for interaction=0.002 for DASH index and 0.06 for 
HEI).   
When we analyzed the data after excluding subjects who died at follow-up during 
the first five years, the overall results are not materially different from the main analysis. 
Furthermore, the strength of association tended to increase and the significant inverse 
association was observed between the increasing HEI score and cancer mortality in 
MONW individuals (Table 6.5).  
Discussion 
Our findings suggest that high diet quality such as DASH style diet and HEI is 
associated with a lower risk of all-cause, and CVD mortality in the MONW individuals, 
independent of potential confounders, based on the nationally representative sample of 
normal weight U.S. adults. We observed a 23% and 27% reduction in all-cause mortality 
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with each 1 SD increment in the DASH score and HEI, respectively, among MONW 
individuals. This association persisted when we confined our analyses to those with or 
without prevalent DM and hypertension. We also observed greater risk reductions in 
CVD mortality for both DASH index and HEI. However, these beneficial effects of high 
quality diet on the reduction of mortality were not observed in MHNW phenotype. To 
our knowledge, this is the first study demonstrating that high diet quality such as DASH 
style and HEI may reduce the mortality risk in MONW individuals. 
The inverse associations of DASH and HEI with all-cause and CVD mortality 
were consistent with previous studies showing that higher-quality diets are associated 
with reduction in the risk of all-cause mortality (32-35) and CVD mortality (32; 33; 35; 
36) in DASH; all-cause mortality (35; 37)  and CVD mortality (35; 37; 38) in HEI. 
Among these previous studies, only one study demonstrated that the inverse association 
between the DASH diet score and all-cause mortality was obvious in non-obese subjects 
(BMI <30) in their subgroup analysis (34). 
Underlying mechanisms for the beneficial effect of the adherence to the DASH-
style diet and HEI on reducing the risk of mortality in MONW individuals might be 
complex. Those with MONW phenotype are at high risk of developing diseases in which 
proinflammatory markers such as CRP, interleukins, and tumor necrosis factor alpha play 
a major role (39; 40). In addition, it is known that the DASH-style diet reduces plasma 
CRP and fibrinogen levels (41), and that HEI score is inversely associated with serum 
CRP concentrations (14), indicating that both DASH-style diet and HEI have anti-
inflammatory effects. Thus, our results suggest that high quality dietary patterns such as 
DASH and HEI may antagonize the unfavorable cardiometabolic profiles in those with 
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MONW phenotype, resulting in lowering the risk of mortality.  
In our subgroup analysis in MONW individuals, both DASH and HEI indexes 
were associated with reduced mortality among older age individuals (≥ 65 years), 
although interaction terms were not significant. This finding might be explained by the 
potential cumulative exposure to the healthy dietary pattern with increasing age or that 
the diet measure more accurately reflected eating patterns before the event (42). An 
alternative explanation would be a reduced statistical power due to the smaller number of 
deaths in the younger age group. Although the interaction terms were not significant, the 
observation that the physically active MONW subjects had a risk reduction in mortality 
on both DASH and HEI scores reflect the possible synergistic effects of healthy life 
styles.  
The prevalence of hypertension and DM at baseline tended to increase with 
increasing DASH tertile in both MONW and MHNW phenotype, although these were not 
statistically significant. This finding indicates that there might be a reverse causation 
between DASH score, hypertension, and DM, because those with diagnosed hypertension 
and DM were more likely to follow healthy dietary habits. However, when stratified to 
those with or without hypertension and DM, there was a consistent inverse association of 
DASH and HEI score with all-cause mortality, indicating that high quality diets appear to 
have a long-term benefit on mortality reduction in MONW phenotype independent of 
prevalent hypertension and DM.  
Interestingly, high quality dietary patterns were not associated with mortality 
reduction in MHNW individuals. This finding might suggest that high quality diet does 
not operate independently in reducing the risk of mortality for those at lower risk of 
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dying. Instead, high quality diet may contribute to decreasing the mortality risk in 
MHNW individuals who had unfavorable lifestyle characteristics.  In a stratified analysis, 
the large reduction of mortality risk was observed only in physically inactive individuals 
in MHNW phenotype, in both DASH and HEI scores (P for interaction=0.002 for DASH 
index and 0.06 for HEI). Similar findings were found in current smokers although the 
interaction terms were not significant. 
Our study has several strengths. First, a prospective study design with nearly 18 
year follow-up for mortality based on the representative US population allowed us to 
evaluate a long-term effect of high diet quality on the reduction of mortality risk. Second, 
data were collected based on extensive laboratory and physical examinations using 
standardized protocols to minimize the influence of measurement errors. Finally, we were 
able to assess the potential effect modifications and replicate the findings using a 
sensitivity analysis. There are also several limitations. First, because NHANES III FFQ 
did not have portion size, we used only nutrient data from the 24-hr dietary recall data in 
calculating DASH and HEI scores, which might not be comparable to scores based on 
FFQ in other studies. Second, due to a single measure of diet collected at baseline, we 
could not account for any changes in dietary intake over time. Third, self-assessment of 
food consumption may produce non-differential measurement error, although energy 
adjustment would reduce this error to some degree (43). Finally, there may be residual 
confounding due to not measuring the covariates in an objective way, such as self-
reported physical activity and smoking status. 
To conclude, adherence to high quality diet such as DASH style diet and HEI is 
associated with a lower risk of all-cause, and CVD mortality in the MONW phenotype, 
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based on a nationally representative U.S. adult population. High quality diets may be 
particularly beneficial for normal weight individuals with metabolic abnormalities.    
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Table 6.1 Comparison of general characteristics between the lowest and highest tertile for DASH index and 
Healthy Eating Index in Metabolically Obese Normal Weight (MONW) and Metabolically Healthy Normal 
Weight (MHNW) phenotypes at baseline 
 
    Metabolically Obese Normal Weight (MONW) phenotype     
  
      DASH         HEI           
Characteristics Overall Tertile 1 Tertile 3 Tertile 1 Tertile 3 
(n=525) (n=199) (n=216) (n=232) (n=232) 
Age, years 61.4 ± 0.6 58.7 ± 1.3 64.2 ± 1.1* 57.5 ± 1.1 64.6 ± 1.3* 
Men, % 50.2 ± 3.4 58.6 ± 4.5 39.2 ± 4.8† 51.4 ± 5.0 39.9 ± 6.0‡ 
Race/ ethnicity, % 
               
 
Non-Hispanic white 78.7 ± 3.0 80.5 ± 5.3 76.8 ± 4.2 70.7 ± 5.5 86.3 ± 3.4‡ 
 
Non-Hispanic black 7.4 ± 1.2 9.3 ± 2.3 5.1 ± 1.1 13.5 ± 2.7 2.8 ± 0.7 
 
Mexican-American 3.0 ± 0.6 2.8 ± 1.0 2.6 ± 0.7 3.6 ± 1.2 2.3 ± 0.6 
 
Other 11.0 ± 2.5 7.4 ± 5.0 15.5 ± 4.0 12.2 ± 4.4 8.6 ± 3.1 
Educational attainment, % 
               
 
<12 years 33.9 ± 3.5 31.6 ± 5.0 32.9 ± 5.0 41.7 ± 5.7 30.9 ± 6.1 
 
12 years 32.4 ± 3.6 36.6 ± 6.7 31.6 ± 3.9 36.7 ± 5.4 30.1 ± 5.1 
 
>=13 years 33.7 ± 4.0 31.8 ± 6.3 35.5 ± 5.3 21.6 ± 5.7 39.0 ± 6.8 
Income, % 
               
 
PIR=<1.3 16.9 ± 2.1 18.2 ± 3.8 18.3 ± 3.6 23.5 ± 3.2 13.3 ± 3.3 
 
1.3 <PIR=<3.5 41.2 ± 3.4 38.1 ± 6.1 39.7 ± 6.2 43.4 ± 5.2 41.0 ± 6.3 
 
PIR>3.5 41.9 ± 3.9 43.7 ± 6.3 42.0 ± 6.6 33.1 ± 6.1 45.8 ± 6.6 
Living with spouse, % 68.5 ± 2.5 72.0 ± 3.9 63.6 ± 3.7 68.9 ± 4.8 69.2 ± 3.8 
Smoking status, % 
               
 
Never 42.3 ± 3.3 36.4 ± 5.2 48.0 ± 6.0 33.4 ± 5.5 54.0 ± 5.8 
 
Former 28.1 ± 2.6 27.0 ± 5.8 31.4 ± 4.7 27.0 ± 4.5 31.5 ± 4.5 
 
Current 29.7 ± 2.9 36.5 ± 6.2 20.6 ± 4.8 39.6 ± 5.4 14.5 ± 3.7 
Drinking alcohol, % 
               
 
Never 51.9 ± 4.4 44.4 ± 7.4 64.1 ± 5.8 47.5 ± 6.3 62.2 ± 6.3* 
 
Moderate 41.7 ± 4.0 48.4 ± 7.3 29.2 ± 5.5 48.9 ± 6.6 36.9 ± 6.2 
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Heavy 6.4 ± 2.1 7.3 ± 4.5 6.6 ± 2.9 3.6 ± 2.1 0.9 ± 0.6 
Physical activity, % 
               
 
Inactive  20.1 ± 2.8 22.2 ± 5.7 18.7 ± 4.1‡ 21.8 ± 4.0 15.8 ± 3.1 
 
Insufficient activity 41.0 ± 2.5 49.2 ± 6.6 28.5 ± 3.7 48.4 ± 6.2 39.1 ± 4.8 
 
Recommended activity  38.8 ± 2.6 28.7 ± 5.7 52.8 ± 5.3 29.7 ± 5.5 45.1 ± 5.5 
CHD family history, % 12.0 ± 2.1 15.6 ± 6.0 10.9 ± 3.3 15.6 ± 4.2 7.0 ± 2.3 
Diabetes mellitus, % 14.5 ± 2.1 10.2 ± 2.4 17.5 ± 3.5 16.5 ± 3.7 12.8 ± 2.8 
Hypertension, % 54.6 ± 3.3 52.5 ± 6.5 63.2 ± 3.7 52.7 ± 5.0 54.7 ± 5.8 
BMI, kg/m2 22.9 ± 0.1 23.0 ± 0.1 22.6 ± 0.1† 22.8 ± 0.1 22.9 ± 0.1 
Waist circumference, cm 87.3 ± 0.3 89.3 ± 0.8 85.3 ± 0.7* 87.2 ± 0.6 86.4 ± 0.5 
Fasting glucose, mg/dl 104 ± 1.5 99 ± 1.0 109 ± 4.5‡ 101 ± 1.6 103 ± 3.0 
HOMA-IR 2.5 ± 0.2 2.1 ± 0.1 3.1 ± 0.7 2.2 ± 0.1 3.0 ± 0.7‡ 
SBP, mmHg 137 ± 1.5 133 ± 1.4 140 ± 1.5† 136 ± 2.0 136 ± 2.3 
DBP, mmHg 77 ± 1.5 78 ± 1.0 77 ± 0.8 79 ± 1.1 75 ± 0.7 
hs-CRP, mg/dl 0.43 ± 0.03 0.42 ± 0.04 0.43 ± 0.03 0.49 ± 0.05 0.43 ± 0.04 
Triglycerides, mg/dl 172 ± 3.8 162 ± 3.4 185 ± 14.4 180 ± 9.7 174 ± 6.4 
HDL-C, mg/dl 48 ± 0.6 47 ± 1.3 50 ± 1.1 47 ± 1.4 49 ± 1.2 
 
 
Table 6.1 (Continued) 
    Metabolically Healthy Normal Weight (MHNW) phenotype       
P 
(MONW 
vs. 
MHNW) 
  
      DASH         HEI           
Characteristics Overall Tertile 1 Tertile 3 Tertile 1 Tertile 3 
(n=808) (n=408) (n=417) (n=408) (n=474) 
Age, years 52.4 ± 0.5 50.4 ± 0.7 55.8 ± 0.8* 48.6 ± 0.6 54.4 ± 1.0* <0.001 
Men, % 34.8 ± 2.4 35.1 ± 4.5 30.1 ± 3.7 38.9 ± 4.0 31.3 ± 3.6 <0.001 
Race/ ethnicity, % 
                
 
Non-Hispanic white 84.7 ± 2.2 84.9 ± 3.0 85.8 ± 3.0 79.9 ± 3.6 86.5 ± 2.1† 0.03 
 
Non-Hispanic black 6.3 ± 1.0 7.9 ± 1.7 4.5 ± 1.1 9.2 ± 1.7 4.1 ± 0.8 
 
 
Mexican-American 1.6 ± 0.3 1.5 ± 0.3 1.5 ± 0.3 1.6 ± 0.4 1.2 ± 0.3 
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Other 7.4 ± 1.8 5.7 ± 2.0 8.2 ± 2.8 9.2 ± 3.1 8.2 ± 1.6 
 
Educational attainment, % 
                
 
<12 years 15.9 ± 2.2 17.2 ± 2.9 16.5 ± 3.5 19.8 ± 3.1 11.1 ± 2.8* <0.001 
 
12 years 28.6 ± 2.7 32.0 ± 4.1 22.7 ± 4.0 32.1 ± 3.9 23.3 ± 3.4 
 
 
>=13 years 55.5 ± 3.6 50.8 ± 5.6 60.9 ± 5.3 48.1 ± 5.4 65.6 ± 3.6 
 
Income, % 
                
 
PIR=<1.3 10.0 ± 1.8 13.7 ± 2.5 6.2 ± 1.8‡ 15.2 ± 3.2 5.7 ± 1.8† 0.002 
 
1.3<PIR=<3.5 35.3 ± 3.3 37.7 ± 4.6 34.1 ± 4.9 37.1 ± 4.4 33.8 ± 4.6 
 
 
PIR>3.5 54.7 ± 3.4 48.6 ± 4.8 59.6 ± 5.0 47.7 ± 4.8 60.5 ± 4.5 
 
Living with spouse, % 68.4 ± 2.7 70.2 ± 4.2 70.2 ± 3.9 71.7 ± 3.6 66.7 ± 4.8 0.98 
Smoking status, % 
                
 
Never 45.7 ± 2.8 35.8 ± 3.4 57.9 ± 3.9* 34.1 ± 4.9 56.7 ± 4.6* 0.32 
 
Former 29.7 ± 2.2 32.5 ± 3.4 30.7 ± 4.1 27.2 ± 4.4 30.3 ± 4.0 
 
 
Current 24.5 ± 2.2 31.7 ± 4.5 11.4 ± 2.1 38.7 ± 5.1 13.0 ± 2.6 
 
Drinking alcohol, % 
                
 
Never 39.4 ± 3.7 36.6 ± 4.8 48.7 ± 5.9† 37.2 ± 5.1 40.3 ± 5.4 0.002 
 
Moderate 56.1 ± 3.7 61.2 ± 4.9 47.5 ± 6.2 58.7 ± 4.9 54.8 ± 5.8 
 
 
Heavy 4.5 ± 0.9 2.2 ± 0.9 3.9 ± 1.5 4.1 ± 2.0 4.9 ± 1.8 
 
Physical activity, % 
                
 
Inactive 9.8 ± 1.4 10.5 ± 1.8 9.5 ± 2.0† 15.5 ± 2.8 4.6 ± 1.7* <0.001 
 
Insufficient activity 51.5 ± 2.0 59.6 ± 3.1 43.2 ± 3.8 58.2 ± 4.1 48.0 ± 3.0 
 
 
Recommended activity 38.7 ± 2.3 29.9 ± 2.9 47.3 ± 4.1 26.3 ± 4.0 47.5 ± 2.8 
 
CHD family history, % 13.3 ± 1.6 16.5 ± 3.3 8.3 ± 2.1 15.6 ± 3.8 11.6 ± 2.7 0.59 
Diabetes mellitus, % 4.6 ± 0.9 3.5 ± 1.5 4.7 ± 1.5 2.1 
 
1.3 6.3 ± 1.8 <0.001 
Hypertension, % 16.0 ± 1.9 13.2 ± 2.1 17.7 ± 2.4 12.8 ± 2.7 17.7 ± 2.5 <0.001 
BMI, kg/m2 22.4 ± 0.1 22.4 ± 0.1 22.4 ± 0.1 22.3 ± 0.1 22.4 ± 0.1 <0.001 
Waist circumference, cm 81.8 ± 0.3 82.1 ± 0.6 81.4 ± 0.5 81.7 ± 0.6 81.4 ± 0.5 <0.001 
Fasting glucose, mg/dl 91 ± 0.3 91 ± 0.5 92 ± 0.6 91 ± 0.5 92 ± 0.5‡ <0.001 
HOMA-IR 1.4 ± 0.0 1.4 ± 0.0 1.4 ± 0.0 1.3 ± 0.0 1.4 ± 0.0 <0.001 
SBP, mmHg 119 ± 0.3 118 ± 1.0 120 ± 1.0 118 ± 0.9 120 ± 1.2 <0.001 
DBP, mmHg 73 ± 0.3 72 ± 0.6 71 ± 0.4† 73 ± 0.5 73 ± 0.5† <0.001 
hs-CRP, mg/dl 0.27 ± 0.01 0.29 ± 0.01 0.26 ± 0.01 0.28 ± 0.01 0.25 ± 0.01 <0.001 
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Triglycerides, mg/dl 88 ± 1.5 85 ± 2.5 93 ± 2.3† 87 ± 2.7 91 ± 2.1 <0.001 
HDL-C, mg/dl 60 ± 0.7 59 ± 1.2 60 ± 0.6 58 ± 1.4 60 ± 1.1 <0.001 
Data are presented as means ± standard error or proportion (%) ± standard error.  
* P <0.001, † P <0.01, and ‡ P <0.05 for comparison across each tertile of DASH index and HEI. P values for continuous variables represent P 
for trend. 
Abbreviations: DASH, Dietary Approaches to Stop Hypertension; HEI, Healthy Eating Index; PIR, poverty income ratio; CHD, coronary heart 
disease; BMI, waist circumference; HOMA-IR, homoeostasis model assessment of insulin resistance; SBP, systolic blood pressure; DBP, 
diastolic blood pressure; hs-CRP, high-sensitivity C-reactive protein; HDL-C, high-density lipoprotein cholesterol. 
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Table 6.2 Comparison for each component of DASH-style diet and Healthy Eating Index in Metabolically 
Obese Normal Weight (MONW) and Metabolically Healthy Normal Weight (MHNW) phenotypes at baseline 
 
  Metabolically Obese Normal Weight (MONW) phenotype 
DASH  Overall Tertile1 Tertile2 Tertile3 P for 
trend   (n=525) (n=178) (n=156) (n=191) 
Score range (0 - 8) (0 - 1.5) (2 - 3) (3.5 - 8) 
 
DASH score 2.8 ± 0.1 1.0 ± 0.1 2.5 ± 0.0 4.7 ± 0.1 <0.001 
Saturated fat, % energy 10.3 ± 0.2 13.3 ± 0.3 10.4 ± 0.5 7.4 ± 0.3 <0.001 
Total fat, % energy 31.0 ± 0.5 38.9 ± 0.4 31.3 ± 1.3 23.6 ± 0.5 <0.001 
Protein, % energy 15.2 ± 0.2 13.9 ± 0.3 15.3 ± 0.5 16.4 ± 0.4 <0.001 
Cholesterol, mg 122.4 ± 6.5 143.4 ± 8.1 129.8 ± 9.8 97.7 ± 14.6 <0.001 
Fiber, mg 9.0 ± 0.2 6.3 ± 0.1 7.8 ± 0.4 12.3 ± 0.5 <0.001 
Magnesium, mg 156.7 ± 3.0 121.8 ± 2.3 145.0 ± 6.8 197.4 ± 5.9 <0.001 
Calcium, mg 416.5 ± 11.3 356.2 ± 12.5 386.9 ± 20.0 493.7 ± 26.4 <0.001 
Potassium, mg 1520 ± 23 1230 ± 23 1407 ± 53 1870 ± 50 <0.001 
Sodium, mg 1639 ± 28 1741 ± 42 1612 ± 51 1563 ± 50 0.003 
Total energy intake, kcal 1977 ± 53 2268 ± 110 2014 ± 103 1683 ± 75 <0.001 
HEI Overall Tertile1 Tertile2 Tertile3 P for 
trend   (n=525) (n=272) (n=263) (n=273) 
Score range (21.3 - 97.7) (21.3 - 59.2) (59.3 - 72.8) (72.9 - 97.7) 
 
HEI score 67.2 ± 0.7 50.7 ± 0.5 66.4 ± 0.5 81.3 ± 0.4 <0.001 
Grains, no. of servings 6.6 ± 0.2 5.7 ± 0.3 6.6 ± 0.3 7.3 ± 0.6 0.02 
Fruits, no. of servings 1.8 ± 0.1 0.7 ± 0.1 1.2 ± 0.1 3.3 ± 0.2 <0.001 
Vegetables, no. of servings 3.3 ± 0.1 2.5 ± 0.2 3.1 ± 0.2 4.3 ± 0.3 <0.001 
Dairy, no. of servings 1.9 ± 0.1 1.8 ± 0.2 2.0 ± 0.2 1.9 ± 0.2 0.62 
Meats, no. of servings 1.9 ± 0.1 2.0 ± 0.1 1.8 ± 0.1 1.8 ± 0.2 0.47 
  
1
4
4
 
Legumes, no. of servings 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.1 ± 0.0 0.16 
Grains, HEI score 6.7 ± 0.2 6.0 ± 0.3 6.6 ± 0.2 7.4 ± 0.2 <0.001 
Fruits, HEI score 4.7 ± 0.2 2.0 ± 0.2 3.2 ± 0.3 8.2 ± 0.2 <0.001 
Vegetables, HEI score 6.3 ± 0.2 4.8 ± 0.3 6.2 ± 0.3 7.6 ± 0.3 <0.001 
Dairy, HEI score 6.2 ± 0.2 5.3 ± 0.4 6.5 ± 0.3 6.7 ± 0.4 0.01 
Meats, HEI score 6.8 ± 0.2 6.5 ± 0.4 6.7 ± 0.3 7.0 ± 0.2 0.12 
Fats, HEI score 7.1 ± 0.2 4.7 ± 0.5 7.1 ± 0.3 9.2 ± 0.1 <0.001 
Saturated fat, HEI score 7.0 ± 0.2 4.2 ± 0.4 7.2 ± 0.3 9.0 ± 0.2 <0.001 
Cholesterol, HEI score 8.3 ± 0.2 6.0 ± 0.4 8.8 ± 0.2 9.7 ± 0.1 <0.001 
Sodium, HEI score 6.4 ± 0.3 5.9 ± 0.4 6.2 ± 0.4 7.0 ± 0.3 0.001 
Dietary variety, HEI score 7.7 ± 0.2 5.4 ± 0.4 7.8 ± 0.3 9.5 ± 0.1 <0.001 
Total energy intake, kcal 1977 ± 53 1917 ± 88 2023 ± 116 1985 ± 93 0.51 
 
Table 6.2 (Continued) 
  Metabolically Healthy Normal Weight (MHNW) phenotype   
DASH  Overall Tertile1 Tertile2 Tertile3 P for 
trend 
P (MONW vs 
MHNW)   (n=808) (n=293) (n=255) (n=260) 
Score range (0 - 8.5) (0 - 1.5) (2 - 3) (3.5 - 8.5) 
  
DASH score 2.7 ± 0.1 1.0 ± 0.0 2.5 ± 0.0 4.7 ± 0.1 <0.001 0.12 
Saturated fat, % energy 10.7 ± 0.1 13.0 ± 0.2 10.9 ± 0.2 8.0 ± 0.2 <0.001 0.01 
Total fat, % energy 32.9 ± 0.4 39.4 ± 0.4 33.7 ± 0.5 25.0 ± 0.4 <0.001 0.001 
Protein, % energy 15.6 ± 0.2 14.6 ± 0.2 15.2 ± 0.3 17.0 ± 0.4 <0.001 0.12 
Cholesterol, mg 124.1 ± 3.9 156.6 ± 6.4 113.9 ± 5.8 97.9 ± 6.3 <0.001 0.78 
Fiber, mg 9.0 ± 0.2 6.3 ± 0.2 8.3 ± 0.2 12.7 ± 0.4 <0.001 0.83 
Magnesium, mg 157.4 ± 2.2 121.5 ± 1.5 147.0 ± 2.0 207.4 ± 3.6 <0.001 0.85 
Calcium, mg 390.2 ± 9.2 323.9 ± 9.0 364.0 ± 15.9 489.6 ± 17.0 <0.001 0.10 
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Potassium, mg 1514 ± 24 1210 ± 27 1432 ± 25 1931 ± 36 <0.001 0.84 
Sodium, mg 1639 ± 23 1642 ± 31 1613 ± 50 1661 ± 39 0.62 0.99 
Total energy intake, kcal 1997 ± 29 2187 ± 66 2123 ± 56 1662 ± 38 <0.001 0.70 
HEI Overall Tertile1 Tertile2 Tertile3 P for 
trend 
P (MONW vs 
MHNW)   (n=808) (n=272) (n=263) (n=273) 
Score range (23.5 - 96.7) (23.5 - 59.2) (59.3 - 72.8) (72.9 - 96.7) 
  
HEI score 66.8 ± 0.5 50.5 ± 0.5 66.2 ± 0.3 80.8 ± 0.2 <0.001 0.60 
Grains, no. of servings 6.4 ± 0.1 5.4 ± 0.2 6.5 ± 0.2 7.2 ± 0.3 <0.001 0.34 
Fruits, no. of servings 1.9 ± 0.1 0.6 ± 0.1 1.5 ± 0.1 3.3 ± 0.2 <0.001 0.56 
Vegetables, no. of servings 3.3 ± 0.1 2.6 ± 0.1 3.2 ± 0.1 3.9 ± 0.2 <0.001 0.92 
Dairy, no. of servings 2.0 ± 0.1 1.9 ± 0.2 1.8 ± 0.2 2.2 ± 0.2 0.26 0.63 
Meats, no. of servings 2.0 ± 0.0 2.4 ± 0.1 1.9 ± 0.1 1.8 ± 0.1 0.001 0.02 
Legumes, no. of servings 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.0 0.1 ± 0.0 0.69 0.62 
Grains, HEI score 6.5 ± 0.2 5.5 ± 0.2 6.4 ± 0.1 7.3 ± 0.2 <0.001 0.08 
Fruits, HEI score 4.7 ± 0.1 1.8 ± 0.1 4.2 ± 0.3 7.6 ± 0.3 <0.001 0.83 
Vegetables, HEI score 6.4 ± 0.2 4.8 ± 0.2 6.6 ± 0.2 7.7 ± 0.2 <0.001 0.53 
Dairy, HEI score 6.4 ± 0.2 5.7 ± 0.4 5.6 ± 0.3 7.6 ± 0.2 <0.001 0.43 
Meats, HEI score 6.9 ± 0.2 7.0 ± 0.2 6.8 ± 0.2 6.9 ± 0.3 0.72 0.45 
Fats, HEI score 6.6 ± 0.1 4.1 ± 0.3 6.6 ± 0.2 8.7 ± 0.2 <0.001 0.01 
Saturated fat, HEI score 6.8 ± 0.2 4.0 ± 0.3 6.8 ± 0.3 9.1 ± 0.1 <0.001 0.31 
Cholesterol, HEI score 8.0 ± 0.2 5.7 ± 0.4 8.7 ± 0.2 9.4 ± 0.1 <0.001 0.10 
Sodium, HEI score 6.4 ± 0.1 5.9 ± 0.3 6.2 ± 0.3 6.9 ± 0.3 0.002 0.89 
Dietary variety, HEI score 8.1 ± 0.1 6.1 ± 0.3 8.2 ± 0.1 9.7 ± 0.1 <0.001 0.03 
Total energy intake, kcal 1997 ± 29 2052 ± 65 1932 ± 49 1998 ± 52 0.52 0.70 
Data are presented as means ± standard error. 
Abbreviations: DASH, Dietary Approaches to Stop Hypertension; HEI, Healthy Eating Index;  
The amount of each DASH dietary components are based on a 1,000 kcal diet. 
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Table 6.3 Adjusted hazard ratio (HR)* of all-cause, cardiovascular, and cancer mortality according to the tertile categories 
and a linear increment in the DASH diet score and Healthy Eating Index in Metabolically Obese Normal Weight (MONW) 
and Metabolically Healthy Normal Weight (MHNW) phenotypes during a median follow-up of 17.9 years 
 
  
n 
No. of 
person 
years 
Deaths 
from all 
causes, 
n 
All-cause 
mortality, HR 
(95% CI) 
CVD 
deaths, 
n 
CVD mortality, 
HR (95% CI) 
Cancer 
deaths, 
n 
Cancer  
mortality, HR† 
(95% CI) 
Metabolically Obese 
Normal Weight 
(MONW) phenotype 
        
  DASH         
Tertile 1  178 2392 103 1.00 (ref.) 34 1.00 (ref.) 23 1.00 (ref.) 
Tertile 2  156 2012 95 0.84  
(0.59-1.19) 
35 0.86  
(0.54-1.38) 
16 0.94  
(0.40-2.21) 
Tertile 3  191 2617 115 0.61  
(0.44-0.86) 
37 0.40  
(0.24-0.65) 
19 0.92  
(0.56-1.49) 
P trend    0.006  <0.001  0.77 
HR for a 1 SD 
increase in DASH 
   0.77  
(0.66-0.90) 
 0.70  
(0.53-0.93) 
 0.79  
(0.62-1.01) 
  HEI         
Tertile 1  172 2268 98 1.00 (ref.) 32 1.00 (ref.) 20 1.00 (ref.) 
Tertile 2  181 2327 111 0.79 (0.56-
1.12) 
40 1.21  
(0.78-1.89) 
21 0.43  
(0.19-0.97) 
Tertile 3  172 2426 104 0.50  
(0.35-0.73) 
34 0.49  
(0.26-0.93) 
17 0.54  
(0.22-1.34) 
P trend    <0.001  0.007  0.21 
HR for a 1 SD 
increase in HEI 
   0.73  
(0.63-0.85) 
 0.74  
(0.61-0.91) 
 0.66  
(0.46-0.95) 
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Metabolically Healthy 
Normal Weight 
(MHNW) phenotype 
        
  DASH         
Tertile 1  293 4845 91 1.00 (ref.) 21 1.00 (ref.) 29 1.00 (ref.) 
Tertile 2  255 4289 69 0.77  
(0.54-1.10) 
19 0.74  
(0.35-1.58) 
18 0.42  
(0.17-1.08) 
Tertile 3  260 4195 90 0.96  
(0.68-1.35) 
25 0.99  
(0.41-2.37) 
19 0.69  
(0.39-1.24) 
P trend    0.77  0.98  0.31 
HR for a 1 SD 
increase in DASH 
   1.03  
(0.84-1.24) 
 1.06  
(0.73-1.53) 
 0.96  
(0.64-1.43) 
  HEI         
Tertile 1  272 4523 83 1.00 (ref.) 19 1.00 (ref.) 26 1.00 (ref.) 
Tertile 2  263 4226 85 0.71  
(0.44-1.15) 
24 0.72  
(0.38-1.33) 
22 0.71  
(0.27-1.89) 
Tertile 3  273 4580 82 0.66  
(0.39-1.13) 
22 0.70  
(0.40-1.22) 
18 0.51  
(0.19-1.37) 
P trend    0.14  0.22  0.18 
HR for a 1 SD 
increase in HEI 
   0.85  
(0.68-1.05) 
 0.92  
(0.70-1.21) 
 0.90  
(0.62-1.30) 
Data are presented as hazard ratio (95% confidence interval). 
Abbreviations: DASH, Mediterranean diet score; HEI, Healthy Eating Index; CVD, cardiovascular disease  
* Adjusted for age, gender, race/ethnicity, educational attainment, income, living with spouse, smoking status, alcohol consumption, level of physical 
activity, family history of coronary heart disease, waist circumference, and total calorie intakes. 
† those who had a history of skin cancer were also excluded.
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Table 6.4 Subgroup analyses of the association of one SD increment in the DASH and 
HEI score with the risk of all-cause mortality in Metabolically Obese Normal Weight 
(MONW) and Metabolically Healthy Normal Weight (MHNW) phenotypes 
 
 Metabolically Obese Normal Weight (MONW) phenotype 
 No. of 
participant
s (deaths) 
HR for a 1 SD 
increase in 
DASH 
P 
intera
ction 
HR for a 1 SD 
increase in HEI 
P 
intera
ction 
Age, y   0.28  0.09 
< 65 229 (70) 0.90 (0.63-1.28)  0.72 (0.50-1.03)  
≥ 65 273 (226) 0.69 (0.59-0.80)  0.71 (0.61-0.82)  
Gender   0.99  0.27 
Men 273 (174) 0.85 (0.64-1.11)  0.77 (0.60-0.98)  
Women 229 (122) 0.63 (0.51-0.79)  0.69 (0.55-0.86)  
Race/ ethnicity   0.41  0.16 
Non-Hispanic white 279 (182) 0.74 (0.57-0.95)  0.77 (0.64-0.93)  
Others 223 (114) 0.64 (0.48-0.85)  0.68 (0.50-0.93)  
Smoking status   0.06  0.48 
Current smoker 153 (90) 0.80 (0.45-1.41)  0.60 (0.41-0.86)  
Non- or former 
smoker 
349 (206) 0.75 (0.63-0.89)  0.76 (0.64-0.91)  
Drinking alcohol   0.25  0.84 
Moderate drinker 190 (105) 0.79 (0.53-1.20)  0.79 (0.59-1.06)  
Non- or heavy 
drinker 
312 (191) 0.82 (0.67-1.02)  0.67 (0.55-0.81)  
Physical activity    0.95  0.82 
Physically inactive 126 (78) 1.33 (0.70-2.54)  0.81 (0.64-1.04)  
Physically active 376 (218) 0.75 (0.64-0.87)  0.72 (0.62-0.85)  
Chronic disease    0.06  0.20 
Absence  162 (68) 0.65 (0.48-0.88)  0.55 (0.38-0.79)  
Presence 340 (228) 0.83 (0.69-0.99)  0.79 (0.64-0.97)  
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Table 6.4 (Continued) 
 Metabolically Healthy Normal Weight (MHNW) phenotype 
 No. of 
participan
ts 
(deaths) 
HR for a 1 SD 
increase in 
DASH 
P 
intera
ction 
HR for a 1 SD 
increase in HEI 
P 
interact
ion 
Age, y   0.61  0.29 
< 65 568 (77) 0.85 (0.56-1.27)  0.73 (0.53-1.01)  
≥ 65 218 (159) 1.12 (0.96-1.31)  0.90 (0.75-1.07)  
Gender   0.73  0.45 
Men 301 (107) 1.00 (0.74-1.34)  0.94 (0.74-1.19)  
Women 412 (97) 1.14 (0.89-1.47)  0.71 (0.48-1.05)  
Race/ ethnicity   0.001  0.005 
Non-Hispanic white 476 (157) 1.06 (0.87-1.28)  0.87 (0.72-1.05)  
Others 310 (79) 0.72 (0.44-1.16)  0.67 (0.45-0.99)  
Smoking status   0.62  0.26 
Current smoker 223 (74) 0.82 (0.56-1.22)  0.67 (0.48-0.93)  
Non- or former 
smoker 
563 (162) 1.06 (0.85-1.33)  0.88 (0.66-1.18)  
Drinking alcohol   0.22  0.14 
Moderate drinker 387 (87) 0.82 (0.56-1.22)  0.93 (0.74-1.16)  
Non- or heavy 
drinker 
399 (149) 1.06 (0.85-1.33)  0.78 (0.63-0.97)  
Physical activity    0.002  0.06 
Physically inactive 130 (53) 0.37 (0.23-0.59)  0.63 (0.46-0.85)  
Physically active 656 (183) 1.08 (0.86-1.34)  0.87 (0.66-1.13)  
Chronic disease    0.94  0.14 
Absence  582 (129) 1.00 (0.70-1.42)  0.73 (0.55-0.98)  
Presence 204 (107) 0.96 (0.77-1.18)  0.97 (0.73-1.30)  
Data are presented as hazard ratio (95% confidence interval). 
Abbreviations: SD, standard deviation; DASH, Mediterranean diet score; HEI, Healthy Eating Index; CVD, 
cardiovascular disease  
Models are adjusted as Table 6.3, except for the stratifying factor. Being physically inactive indicates no 
reported leisure time physical activity; Presence of chronic disease indicates having diabetes mellitus or 
hypertension.  
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Table 6.5 Multivariable adjusted hazard ratio (HR) of all-cause mortality according to the tertile categories and a SD 
increment in the DASH diet  and HEI scores in Metabolically Obese Normal Weight (MONW) and Metabolically Healthy 
Normal Weight (MHNW) phenotypes excluding the deaths at the first five year follow-up 
 
  
n 
No. of 
person 
years 
Deaths 
from all 
causes, 
n 
All-cause 
mortality, HR 
(95% CI) 
CVD 
deaths, 
n 
CVD mortality, 
HR (95% CI) 
Cancer 
deaths, 
n 
Cancer  
mortality, HR† 
(95% CI) 
Metabolically Obese 
Normal Weight 
(MONW) phenotype 
        
  DASH         
Tertile 1  152 2315 77 1.00 (ref.) 26 1.00 (ref.) 18 1.00 (ref.) 
Tertile 2  123 1927 62 0.72  
(0.47-1.11) 
20 0.59  
(0.33-1.05) 
10 0.71  
(0.23-2.14) 
Tertile 3  164 2550 88 0.57  
(0.42-0.77) 
24 0.35  
(0.22-0.56) 
14 0.76  
(0.34-1.71) 
P trend    <0.001  <0.001  0.37 
HR for a 1 SD 
increase in DASH 
   0.75  
(0.64-0.88) 
 0.69  
(0.49-0.96) 
 0.70  
(0.48-1.02) 
  HEI         
Tertile 1  140 2178 66 1.00 (ref.) 20 1.00 (ref.) 16 1.00 (ref.) 
Tertile 2  147 2241 77 0.66  
(0.47-0.93) 
27 1.25  
(0.76-2.05) 
12 0.19  
(0.07-0.48) 
Tertile 3  152 2373 84 0.43  
(0.31-0.60) 
23 0.49  
(0.26-0.93) 
14 0.30  
(0.12-0.79) 
P trend    <0.001  <0.001  0.04 
HR for a 1 SD 
increase in HEI 
   0.72  
(0.62-0.83) 
 0.72  
(0.59-0.88) 
 0.55  
(0.38-0.79) 
Metabolically Healthy         
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Normal Weight 
(MHNW) phenotype 
  DASH         
Tertile 1  275 4795 73 1.00 (ref.) 14 1.00 (ref.) 24 1.00 (ref.) 
Tertile 2  242 4257 56 0.73  
(0.48-1.11) 
11 0.54  
(0.19-1.54) 
16 0.54  
(0.19-1.52) 
Tertile 3  239 4133 70 0.99  
(0.66-1.49) 
14 0.83  
(0.32-2.16) 
16 0.83  
(0.43-1.56) 
P trend    0.93  0.68  0.77 
HR for a 1 SD 
increase in DASH 
   1.06  
(0.84-1.33) 
 0.93  
(0.57-1.52) 
 1.07  
(0.69-1.65) 
  HEI         
Tertile 1  256 4479 67 1.00 (ref.) 14 1.00 (ref.) 22 1.00 (ref.) 
Tertile 2  245 4168 68 0.62  
(0.36-1.06) 
14 0.39  
(0.20-0.74) 
19 0.69  
(0.24-1.97) 
Tertile 3  255 4531 64 0.54  
(0.39-0.99) 
11 0.33  
(0.15-0.73) 
15 0.50  
(0.18-1.41) 
P trend    0.05  0.01  0.19 
HR for a 1 SD 
increase in HEI 
   0.80  
(0.63-1.01) 
 0.69  
(0.50-0.96) 
 0.92  
(0.62-1.34) 
Data are presented as hazard ratio (95% confidence interval). 
Abbreviations: DASH, Mediterranean diet score; CVD, cardiovascular disease  
* Adjusted for age, gender, and race/ethnicity, educational attainment, income, smoking status, level of physical activity, family history of coronary 
heart disease, a past history of coronary heart disease or stroke, a past history of any cancer, waist circumference, and total calories. 
† those who had a history of skin cancer were also excluded. 
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CHAPTER 7 
OBESITY AS A MEDIATOR IN THE ASSOCIATION BETWEEN HEALTHY DIETARY 
PATTERNS AND INSULIN RESISTANCE AND INFLAMMATION: COMPARISON 
BETWEEN TRADITIONAL APPROACH AND CAUSAL MEDIATION APPROACH1
                                                 
1 Yong-Moon Mark Park, Jiajia Zhang, Susan E. Steck, Teresa T. Fung, Linda J. Hazlett,  
and Anwar M. Merchant. To be submitted to The American Journal of Clinical Nutrition. 
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Abstract 
Background: The association between healthy dietary patterns and efficient 
glucose metabolism or anti-inflammatory effects is well known. However, the extent to 
which obesity may act as a confounder or mediator in this association is unclear. 
Objective: We investigated whether the associations of the Mediterranean diet 
and the Dietary Approaches to Stop Hypertension (DASH) style diet with markers for 
insulin resistance and inflammation are mediated by body mass index (BMI) or waist 
circumference (WC) in a representative U.S. population.  
Design: Data from 4,700 adults aged 20-90 years without any prior diagnosis of 
cancer, cardiovascular disease, diabetes, or hypertension were analyzed from the National 
Health and Nutrition Examination Survey III, 1988–1994. Mediterranean diet scores 
(MDS) and DASH index were calculated using food frequency questionnaires and the 24-
hr dietary recall data.  Markers for insulin resistance included fasting glucose, insulin, 
homoeostasis model assessment of insulin resistance (HOMA-IR), post-load glucose, 
hemoglobin A1c (HbA1c); inflammatory markers included high-sensitivity C-reactive 
protein (hs-CRP), white blood cell (WBC), fibrinogen, homocysteine, and lipoprotein (a). 
Traditional and causal mediation analyses were applied using multiple linear regression 
models.  
Results: Higher MDS was inversely associated with BMI, WC, log insulin, log 
HOMA-IR, fasting glucose, HbA1c, WBC, and fibrinogen after adjusting for potential 
confounders. BMI mediated the association between MDS and log insulin, log HOMA-
IR, fasting glucose, and HbA1c, whereas WC mediated the association between MDS 
with log insulin, log HOMA-IR, fasting glucose, post-load glucose, HbA1c, log hs-CRP, 
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WBC, and fibrinogen. In addition, the mediated effects of WC were greater than those of 
BMI consistently in all markers in both traditional and causal mediation analysis. 
Furthermore, the association between MDS and fasting glucose was fully mediated by 
adiposity, especially by WC in younger individuals including men < 45 years and 
premenopausal women. However, no mediation effect by adiposity was observed in the 
association of DASH index with the markers for insulin resistance and inflammation. 
Conclusions:  WC mediates the association of the Mediterranean diet with insulin 
resistance and inflammation more so than BMI, suggesting that lowering abdominal 
obesity may be one of the pathways through which the Mediterranean diet reduces insulin 
resistance and inflammation. 
Keywords: waist circumference, body mass index, Mediterranean diet, insulin 
resistance, inflammation, mediation 
Introduction 
Much evidence shows that the Mediterranean diet and the Dietary Approaches to 
Stop Hypertension (DASH) style diets are associated with lower risk of cardiometabolic 
disease (1-3). Underlying mechanisms for cardiovascular health benefits of 
Mediterranean diet and DASH style diet are complex, but can be explained by the 
combined effect of improving metabolic profiles including lipid profiles, blood pressure, 
insulin resistance, and inflammatory markers (4, 5). 
The Mediterranean diet and DASH style diets appear to be independently 
associated with cardiometabolic risk after adjusting for adiposity (6). However, it is 
unclear how much the adjustment for adiposity, such as general obesity measured by 
body mass index (BMI) or abdominal obesity measured by waist circumference (WC), 
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modifies or attenuates the association of the Mediterranean diet and DASH style diet with 
cardiometabolic risk. Using mediation analysis, the role of adiposity underlying the 
relationship of the Mediterranean diet and DASH style diet with cardiometabolic risk 
could be clarified (7). Furthermore, the degree of mediation may be different between 
general obesity and abdominal obesity, because abdominal obesity affects metabolic 
disturbance to a greater extent than general obesity (8).  
Mediation analysis is a statistical procedure that can be used to explain the 
process underlying the relationship between the exposure and the outcome, and the extent 
to which this relationship can be mediated by a third variable (9). The approach to 
mediation analysis proposed by Baron and Kenny (9) focused on comparing two 
regression models in which one model was conditioned on the mediator and the other one 
was not.  The exposure coeffients in the regression models would be interpreted as a 
direct effect in the model adjusted for the mediator, and as a total effect in the model 
unadjusted for the mediator (7). This traditional approach to evaluate mediation tends to 
produce a bias by not considering mediator-outcome confounding and interaction 
between exposure and mediator. Using the counterfactual framework in causal mediation 
analysis, unbiased valid estimates of direct effect and indirect effect can be obtained (7, 
10). 
Limited data exist on the mediator role of adiposity on the relationship of the 
Mediterranean diet and DASH style diet with cardiometabolic risk, especially in a causal 
mediation analytic approach. Therefore, we aimed to examine the association of 
Mediterranean diet and DASH style diet with markers for insulin resistance and 
inflammation. In addition, we investigated whether this association is mediated by BMI 
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and WC, using both approaches in traditional mediation analysis and causal mediation 
analysis.  
Methods  
Study population 
We used data from the Third National Health and Nutrition Examination Survey 
(NHANES III), 1988–1994. NHANES III was conducted using a complex multi-stage 
stratified clustered probability sample design to attain a nationally representative sample 
of the civilian, non-institutionalized US population. The survey included personal 
interviews, physical examinations, and laboratory measurements. We included 7,871 
adults with BMI ≥ 18.5 kg/m2 aged 20-90 years who had complete data on FFQ, 24-hour 
dietary recall, BMI, and WC with at least 10 hours’ fasting. Because dietary habits might 
change due to chronic illness, we excluded those who reported a history of myocardial 
infarction, stroke, congestive heart failure, or any prior diagnosis of cancer (n=988). In 
addition, we excluded those who were diagnosed or treated for diabetes mellitus (DM) 
and hypertension, or taking cholesterol-lowering medication (n=1,485). To minimize 
reverse causation, we additionally excluded the participants who reported changing their 
dietary patterns due to any medical reason during the previous 12 months (n=547). 
Because one of the main outcomes was an inflammatory marker, we also excluded those 
with rheumatoid arthritis or hs-CRP > 10mg/L. Furthermore, we excluded pregnant or 
lactating women, those who reported implausible extreme energy intakes (<1st and >99th 
percentiles of energy intake/d in adults) or those with BMI > 60 kg/m2 (n=151). Finally, a 
total of 4,700 individuals were analyzed in the present study.  
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Assessment of Mediterranean diet  
We used 81-item food frequency questionnaires (FFQ) and the 24-hr dietary 
recall data, validated by the Nutrition Methodology Working Group (11),  to evaluate 
dietary intake. Adherence to the Mediterranean diet was assessed using the scoring 
methodology developed by Panagiotakos et al. (12, 13). In brief, scores 0 to 5 were 
assigned for the weekly consumption of food items assumed to be contributing towards 
Mediterranean dietary pattern, whereas scores on the inverse ordinal scale were assigned 
for the consumption of food items assumed to be against the Mediterranean dietary 
pattern. For instance, the scores assigned to the weekly consumption frequencies of 
legumes were as follows: no servings, less than 1 serving, 1–2 servings, 3–4 servings, 5–
6 servings, and >6 servings were assigned scores of 0, 1, 2, 3, 4 and 5, respectively. 
Similar score assignments were used for the food items of non-refined cereals, potatoes, 
fruits, vegetables, fish, and olive oil. Reverse scores were assigned for the components of 
red meat and products, poultry and full-fat dairy products. For the alcohol consumption, a 
score of 5 was assigned for consumption of less than 300 ml (36g) of alcohol per day, and 
0 for no consumption or for consumption of >700 ml (84g) per day. It has been shown 
that Mediterranean Diet Score (MDS) is highly associated with prevalent cardiometabolic 
diseases, 10-year CVD risk, and inflammation and coagulation markers, in addition to 
capturing inherent characteristics of Mediterranean dietary pattern (12-14). 
The NHANES III FFQ applied a 1-month reference period without recording 
portion sizes. Thus, we calculated the MDS, assuming that the number of servings per 
week were equivalent to the number of times that a food item was consumed per week. 
We excluded potatoes for MDS assessment, because the way potatoes are prepared in US 
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is different from European countries (15). Daily alcohol consumption was estimated 
using the following assumption: 12.8g for 12-oz beer, 11g for 4-oz glass of wine, and 14g 
for an ounce of liquor based on the questionnaire provided. Then, gender-specific cut-offs 
were applied: a score of 5 was assigned for consumption of less than 28g and 14 g of 
alcohol per day, 0 for no consumption or for consumption of  greater than 70g and 28g 
per day in men and women, respectively, and the cutoffs for subcategories between 0 and 
5 were reassigned with even intervals (16). Since olive oil consumption was not 
measured in the NHANES III FFQ, we calculated the ratio of total monounsaturated fatty 
acid to total saturated fatty acids with six even intervals using the 24-h dietary recall data 
as a proxy variable of olive oil consumption. Finally, the possible MDS score ranged 
from 0 to 50, with higher values of this MDS score indicate greater adherence to the 
Mediterranean diet. 
Assessment of DASH style diet  
One day 24-hr dietary recall data was used to calculate Mellen’s index which is 
one of established DASH index scores (17), because the serving data was not available in 
NHANES FFQ.  Mellen’s index, a nutrient-based index with 9 components including 
saturated fat, total fat, protein, cholesterol, fiber, magnesium, calcium, potassium, and 
sodium using target nutrient values used in clinical trials (18), applied absolute targets on 
the basis of a 2100-kcal diet for both men and women. One point was assigned to the 
individuals who achieved the goal for each component; one-half of a point was assigned 
to those who met an intermediate goal, defined as the midpoint between the DASH diet 
goal and the nutrient content of the DASH control diet (19); and 0 point was assigned to  
those who met neither goal.  
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Assessment of the markers for insulin resistance and inflammation  
Metabolic parameters were measured under quality control standards of Centers 
for Disease Control and Prevention. BMI was calculated as kg/m2; height was measured 
to the nearest 0.1cm and weight to the nearest 0.01 kg. Waist circumference (WC) was 
measured at the level of the right iliac crest. Blood pressure (BP) was averaged over five 
separate measurements. Mean arterial pressure was calculated using the formula of [(2 × 
diastolic BP + systolic BP) / 3]. Glucose was measured in serum, using a modified 
hexokinase enzymatic method. Serum insulin was measured using a radioimmnuoassay 
(Pharmacia Diagnostics). Homoeostasis model assessment of insulin resistance (HOMA-
IR) was calculated by the formula [fasting glucose (mg/dl) × fasting insulin (lU/mL)/405]. 
Hemoglobin A1c (HbA1c) was measured on whole blood with an ion-exchange high-
performance liquid chromatography (HPLC) method (Bio-Rad Diamat HPLC; interassay 
coefficient of variation 2.0). Post-load glucose was measured using the 2 hour oral 
glucose tolerance testing for the participants aged 40-74 years. Thus, analyses for post-
load glucose were limited to this age group. Serum high sensitivity C reactive protein (hs-
CRP) concentrations were measured by latex-enhanced nephlometry (Department of 
Laboratory Medicine, Immunology Division, University of Washington, Seattle). The 
Coagamate XC Plus automated coagulation analyzer was used to measure fibrinogen 
levels (Organon Technika, Durham, NC). The Coulter Counter Model S-PLUS JR with 
Coulter histogram differential, a quantitative, automated hematology analyzer, was used 
to determine white blood cell (WBC) (×103 cells). Serum homocysteine was measured by 
reverse phase, high-performance liquid chromatography and fluorescence detection (US 
Department of Agriculture Human Nutrition Research Center on Aging at Tufts 
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University, Boston, MA). Lipoprotein (a) was measured by enzyme-linked 
immunosorbent assay (ELISA) (Strategic Diagnostics, Newark, DE). 
Assessment of Covariates 
Participants’ sociodemographic characteristics, medical history, and lifestyle 
related characteristics were measured during the personal interview. Sociodemographic 
variables included age, gender, race or ethnicity (non-Hispanic white, non-Hispanic black, 
Mexican American, or others), educational attainment (<12 years, 12 years, or >12 years 
of education), living with spouse, and level of income measured based on poverty income 
ratio (PIR) which is the ratio of household income to the appropriate poverty threshold 
(low (PIR ≤ 1.3), middle (1.3<PIR ≤ 3.5), and high (PIR>3.5)). Family history of 
coronary heart disease (CHD) and parental history of DM were self-reported. Smoking 
status was categorized as never, former, and current. Consumption up to 28g and 14 g of 
alcohol per day in men and women was considered as moderate alcohol use (16). 
Physical activity was categorized based on the recommended levels of physical activity 
(20). A recommended physical activity was designated as a self-reported leisure time 
moderate activity (3 ≤ metabolic equivalents (METs) <6) of five or more times per week 
or leisure time vigorous activity (METs ≥ 6) three or more times per week; a physical 
inactivity as no reported leisure time physical activity; an insufficient physical activity as 
not meeting the criteria for recommended levels of physical activity but not inactive.  
Statistical Analysis 
All the statistical analyses were performed using SAS 9.4 software (SAS Institute 
Inc., Cary, NC, USA), and a P-value of less than .05 was considered statistically 
significant. Descriptive statistics were computed for the sample across tertiles of 
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Mediterranean diet and DASH style diet. Continuous variables were presented by mean 
(SE: standard error) and compared using linear regression analyses. Skewed variables 
such as fasting insulin, HOMA-IR, hs-CRP, homocysteine, and lipoprotein (a) were log-
transformed to improve their distribution towards normal. Categorical variables were 
expressed by percentages with SEs and were compared using Rao-Scott χ2 tests.  For the 
traditional mediation analysis, we used the appropriate survey procedures to account for 
the complex sampling design and weights used in NHANES III. For the subgroup 
analyses, domain analysis was applied to preserve the complex sampling design in which 
the entire samples were used for estimating the variance of subpopulations. For the 
outcome variables in our mediation analyses, fasting insulin, HOMA-IR, fasting glucose, 
post-load glucose, and HbA1c were selected as markers for insulin resistance; hs-CRP, 
WBC, fibrinogen, homocysteine, and lipoprotein (a) for inflammatory markers. 
The traditional approach for mediation analysis included the following steps. First, 
linear regression analyses were applied to examine associations of Mediterranean diet 
and DASH style diet (the highest tertile vs. the first tertile, respectively) with BMI and 
WC, after adjusting for age, gender, race/ethnicity, educational attainment, living with 
spouse, income, smoking status, level of physical activity, family history of CHD, 
parental history of DM, and total energy intake, as well as alcohol consumption for the 
association of DASH style diet with BMI and WC (the estimate a in the Figure 7.1). 
Second, linear regression analyses were applied to examine the association of BMI and 
WC with markers for insulin resistance or inflammation, using the same covariates in 
addition to adjusting for MDS or DASH (the estimate b in the Figure 7.1). In this step, we 
added covariates to the model according to the characteristics of outcome variables (mean 
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arterial pressure for markers for insulin resistance; multivitamin use for homocysteine). 
Third, the simple total effect of Mediterranean diet and DASH style diet was estimated 
by regressing the markers for insulin resistance or inflammation on MDS and DASH 
index while adjusting for the covariates used in the first step, but without adjusting for 
BMI or WC (the estimate c in the Figure 7.1). Fourth, BMI or WC was additionally 
controlled in the model to estimate the direct effect of Mediterranean diet and DASH 
style diet on the markers for insulin resistance or inflammation (the estimate c in the 
Figure 7.1). Finally, the indirect effect by BMI or WC is estimated by calculating the 
product of the beta coefficient of the first regression model and the beta coefficient of the 
second regression model (the estimate a×b in the Figure 7.1) (9, 21). This approach also 
can be presented using the two models: 𝐸 [ 𝑀 ∣ 𝐴 = 𝑎, 𝐶 = 𝑐 ] =  𝛽₀ + 𝛽₁𝑎 + 𝛽₂′𝑐; 
𝐸 [ 𝑌 ∣ 𝐴 = 𝑎, 𝑀 = 𝑚, 𝐶 = 𝑐 ] =  𝜃₀ + 𝜃₁𝑎 + 𝜃₂𝑚 + 𝜃₄′𝑐 (a represents exposure, m 
represents mediator, and c represents confounders) in which the direct effect is evaluated 
by estimating 𝜃₁; the indirect effect is evaluated by estimating 𝛽₁𝜃₂ (22). Then, we 
divided the indirect effect by its standard error and performed a z test under the null 
hypothesis that the indirect effect is equal to zero (23). In addition, proportion of 
mediation was calculated using the indirect effect as a numerator and the total effect as a 
denominator.  
BMI or WC was considered as a mediator if the estimates a and b were significant 
(9). Another criterion for determining a mediator would be whether or not the estimate c 
was significant (21). However, we did not include this criterion in the present study, 
because the effect of Mediterranean diet and DASH style diet on the markers for insulin 
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resistance or inflammation may not be significant when direct and mediated effects have 
opposite signs (22, 24). 
In the causal mediation approach, we assessed the total, direct, and indirect effects 
of Mediterranean diet and DASH style diet on markers for insulin resistance or 
inflammation with BMI or WC as a mediator, using the counterfactual framework (25, 
26). In this approach, total effect can be decomposed into direct effect (not mediated by 
BMI or WC) and indirect effect (mediated by BMI or WC). A causal directed acyclic 
graph (DAG) indicating these effects is presented in Figure 7.2. We applied the SAS 
macro developed by Valeri and VanderWeele to evaluate the natural direct effect, natural 
indirect effect, and marginal total effect of Mediterranean diet and DASH style diet on 
markers for insulin resistance or inflammation with BMI or WC as a mediator (22).  
Natural direct effect and natural indirect effects can be evaluated conceptually as 
follows. For instance, natural direct effect is the contrast between the counterfactual 
outcome if the subject were exposed at the highest tertile of Mediterranean diet, and the 
counterfactual outcome if the same subject were exposed at the lowest tertile of 
Mediterranean diet, with BMI assuming whatever value it would have taken at the 
reference value of the lowest tertile of Mediterranean diet. Natural indirect effect is the 
contrast, having set the Mediterranean diet at level of the highest tertile, between the 
counterfactual outcome if BMI assumed whatever value it would have taken at a value of 
the highest tertile of Mediterranean diet, and the counterfactual outcome if BMI assumed 
whatever value it would have taken at a reference value of the lowest tertile of 
Mediterranean diet. Based on these individual approaches, the average natural indirect 
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and direct effects at the population level were estimated (7, 10). Survey procedures were 
not applied in the causal mediation analysis.  
For this causal mediation analysis, we made four assumptions. First, there is no 
unmeasured confounding in the relation of Mediterranean diet and DASH style diet with 
the markers for insulin resistance or inflammation given confounders; second, there is no 
unmeasured confounding in the relation of BMI or WC with the markers for insulin 
resistance or inflammation; third, there is no unmeasured confounding in the relation of 
Mediterranean diet and DASH style diet with BMI and WC; fourth, there is no effect of 
Mediterranean diet and DASH style diet affecting confounders of the relationship of BMI 
and WC with the markers for insulin resistance or inflammation (25). Under these 
assumptions, natural direct effect, natural indirect effect, marginal total effect can be 
estimated using two separate linear regressions: the first regression of markers for insulin 
resistance or inflammation on the exposure (MDS or DASH index), the mediator (BMI or 
WC) and the confounding variables; and a second regression of BMI or WC on the MDS 
or DASH index and the confounding variables. Then, two regressions were combined to 
estimate natural direct and indirect effects. In this causal mediation analysis, we 
evaluated whether there is an interaction of MDS or DASH index with BMI or WC in the 
regression of the marker for insulin resistance and inflammation. When there is a 
significant interaction, controlled direct effect, natural direct effect, and natural indirect 
effect were estimated using the following models for change in MDS or DASH index 
from level a* to level a: controlled direct effect =(𝜃₁ + 𝜃₃𝑚)(𝑎 − 𝑎 ∗); natural direct 
effect = (𝜃₂𝛽₁ + 𝜃₃𝛽₁𝑎)(𝑎 − 𝑎 ∗); natural indirect effect =  (𝜃₁ + 𝜃₃ (𝛽₀ + 𝛽₁𝑎 ∗
+𝛽₂′𝑐))(𝑎 − 𝑎 ∗). When there is no significant interaction (𝜃₃ = 0), the controlled direct 
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effect is equal to natural direct effect (22). It is possible that the interaction may not be 
statistically significant due to low power. In addition, the exposure-mediator interaction 
may be important in understanding the effects of mediation even when the interaction 
terms are not significant (27). Thus, we further evaluated whether there would be any 
substantial change in the magnitude of the natural indirect effect or the power to detect 
the natural indirect effect, with or without including the interaction terms of MDS or 
DASH index with BMI or WC in the model.  
For the fair comparison between traditional and causal mediation approach, we 
additionally analyzed the data using the traditional approach without considering 
complex survey design of NAHANES III.  
In addition, we assessed whether the association of MDS or DASH index with 
markers of insulin resistance and inflammation was modified by age group (before and 
after 45 years for men; before and after menopause for women) or gender by including 
the interaction terms in the model. Only age group showed the significant interaction in 
the association between MDS and fasting glucose (P=0.03). Thus, an additional subgroup 
analysis was performed by age group for the association between MDS and fasting 
glucose.  
Results 
Table 7.1 shows general and clinical characteristics with increasing tertiles of 
MDS and DASH index. As both MDS and DASH index increased, there was an 
increased age; a lower proportion of non-Hispanic black and higher proportion of 
Mexican-American; a higher proportion of high income and recommended physical 
activity; a lower proportion of current smoker; decreased BMI, WC, and WBC. With 
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increasing MDS tertile only, there was a higher proportion of high income, moderate 
alcohol consumption, and hypertension; decreased HbA1c, fasting insulin, HOMA-IR, 
and fibrinogen. With increasing tertile of DASH index only, there was a lower proportion 
of men and a decreased homocysteine. 
Table 7.2 shows the distribution in weekly consumption of Mediterranean diet 
components and nutrient consumption of DASH style diet with increasing tertiles of 
MDS and DASH index. Overall, the consumption in each component of Mediterranean 
diet and DASH style diet tended to increase with increasing tertiles of MDS and DASH 
index. Total energy intake was not different between MDS tertiles, but increased with 
increasing tertiles of DASH index. 
Compared with the lowest tertile of MDS, highest tertile of MDS was associated 
with 0.77 kg/m2 lower BMI and 2.67 cm lower WC (P=0.004 and <0.001, respectively) 
in multivariable adjusted model. However, no significant association of DASH (highest 
tertile vs. lowest tertile) was observed with BMI and WC. In addition, when we examined 
the association of MDS and DASH index with the markers for insulin resistance or 
inflammation in multivariable model without adjusting for BMI or WC, a significant 
association representing a total effect was observed in log insulin, log HOMA, fasting 
glucose, HbA1c, WBC, and fibrinogen for MDS; only log homocysteine for DASH index 
(Table 7.3). 
With increasing BMI and WC, there was a significant increase in log insulin, log 
HOMA, fasting glucose, post-load glucose, HbA1c, log hs-CRP, WBC, and fibrinogen, 
based on the multivariable model with adjusting for MDS or DASH index. However, no 
significant association was observed in log homocysteine and log lipoprotein (a) with 
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BMI and WC (Table 7.4). Based on the results from Table 7.3 and Table 7.4, with MDS 
as an exposure; log insulin, log HOMA, fasting glucose, post-load glucose, HbA1c, log 
hs-CRP, WBC, and fibrinogen as the outcomes were included in the mediation analysis. 
Table 7.5 shows the total effect, direct effect, indirect effect, and Sobel statistics 
for testing indirect effect. Overall, the mediated effects of BMI and WC were significant 
on the association of MDS with log insulin, log HOMA, fasting glucose, HbA1c, log hs-
CRP, WBC, and fibrinogen, except post-load glucose in which BMI was a mediator. In 
addition, the mediated effects of WC were greater than those of BMI consistently in all 
markers. Although the estimates of direct effects were not significant in either marker, 
the direction of direct effect and indirect effect was opposite in log hs-CRP in which 
proportion of mediation may not be interpretable. Otherwise, the mediated effects by 
BMI were higher in log HOMA showed the highest mediated effects by adiposity. 
Among the inflammatory markers, log hs-CRP showed the highest mediated effects by 
adiposity. 
In causal mediation analysis, the overall proportion of mediated effect was 
decreased compared with traditional mediation analysis. In addition, the significance of 
mediated effect of BMI disappeared in post-load glucose, log hs-CRP, WBC and 
fibrinogen; became nearly marginal in the markers for insulin resistance including log 
insulin, log HOMA, fasting glucose, and HbA1c. However, the significance of mediated 
effect by WC remained (Table 7.6). In both traditional approach and causal mediation 
approach, the association between MDS and fasting glucose was fully mediated by BMI 
or WC. In addition, the association between MDS, post-load glucose and hs-CRP was 
fully mediated by WC (Table 7.5 and 6). 
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There was no statistically significant interaction of MDS with BMI and WC. 
When we also assessed the change in the magnitude of the natural indirect effect with or 
without including the interaction terms of MDS with BMI or WC in the model, the ratios 
of estimates in natural indirect effect ranged between 0.82 and 1.32, meaning that there 
was no remarkable change in the estimates of natural indirect effect. Furthermore, there 
was no substantial increase in the power to detect the indirect effect (Table 7.7). Taken 
together, we could not detect the significant interaction of MDS with BMI and WC. Thus, 
the controlled direct effect was equivalent to the natural indirect effect in our data. 
When we analyzed the data using the traditional approach without considering 
complex survey design of NHANES III, the proportion of mediation in the traditional 
approach approximated that of the causal mediation approach, especially in fasting 
glucose and post-load glucose with WC as a mediator (Table 7.8). 
When stratified by the age group in the association between MDS and fasting 
glucose, mediation effect by adiposity was prominent in younger age group, especially in 
WC (Table 7.9 & Figure 7.3). 
Discussion 
The present study is, to the best of our knowledge, the first to evaluate the role of 
adiposity in the relationship of Mediterranean diet with markers of insulin resistance and 
inflammation in a nationally representative sample of U.S. adults, using mediation 
analyses in both traditional and causal mediation approaches. We observed an inverse 
association of MDS with markers of insulin resistance including fasting insulin, HOMA-
IR, fasting glucose, and HbA1c; and with inflammatory markers such as WBC and 
fibrinogen. WC mediated the association of MDS with log insulin, log HOMA-IR, 
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fasting glucose, post-load glucose, HbA1c, log hs-CRP, WBC, and fibrinogen. 
Furthermore, the mediation effect in this association was greater in WC representing 
abdominal obesity than BMI representing general obesity, in both traditional and causal 
mediation approaches. However, no mediation effect by adiposity was observed in the 
association of DASH index with the markers for insulin resistance and inflammation. 
Consistent evidence shows that the Mediterranean diet has a beneficial effect on a 
reduced risk of type 2 DM (28). Several biological mechanisms may explain the inverse 
association between the Mediterranean diet and insulin resistance which is a key 
pathophysiological trait of type 2 DM. It has been shown that adherence to the 
Mediterranean diet is related to increased antioxidant capacity (29). This antioxidant 
effect of Mediterranean diet may protect oxidative stress accumulation which has been 
proposed to develop insulin resistance and beta-cell dysfunction (30). In addition, 
magnesium, abundant in Mediterranean diet, especially in vegetables, legumes, and nuts 
may promote insulin-mediated glucose uptake (31). Another potential mechanism can be 
explained by a high intake of dietary fiber through the Mediterranean diet, which 
contributes to lowering plasma glucose and insulin levels (32). Moderate alcohol 
consumption is also associated with improving insulin sensitivity and decreased basal 
insulin secretion (33). In addition, monounsaturated fats, rich in the Mediterranean diet, 
may have beneficial effects on insulin sensitivity and glucose metabolism  (34).  
Furthermore, the inverse relationship between the Mediterranean diet and insulin 
resistance can be explained by the role of the Mediterranean diet in obesity prevention 
(35). Although the epidemiological evidence on the relationship between the 
Mediterranean diet and obesity prevention has not been consistent, likely due to 
170 
 
methodological differences in previous observational studies, a potential physiological 
role of the Mediterranean diet in preventing obesity has been hypothesized (36). In 
addition, a recent meta-analysis showed that the Mediterranean diet was effective in 
reducing body weight based on clinical trials (37). It has been reported that WC 
representing abdominal obesity is a better predictor for type 2 DM than BMI representing 
general obesity (8). Under the condition of abdominal obesity, plenty of free fatty acids 
are released from expanded adipose tissue, which inhibits insulin-stimulated glucose 
metabolism in skeletal muscle and stimulates gluconeogenesis in the liver (35); increased 
flow of plasma free fatty acids aggravates altered lipid metabolism in the liver (38), all of 
which contributes to insulin resistance (39). The above mentioned beneficial health 
effects of the Mediterranean diet may play a role in protecting against obesity-induced 
insulin resistance, especially from abdominal fat. This underlying mechanism is 
supported by our findings in which higher MDS was inversely associated with fasting 
insulin and HOMA-IR, fasting glucose, and HbA1c; the mediation effect in this 
association was greater in WC than BMI in both traditional approach and causal 
mediation approach.  
In the present study, the association between MDS and fasting glucose was fully 
mediated by adiposity, because there was no significant association between the two after 
adjusting for BMI or WC (40). Despite a difference in the results from traditional 
approach and causal mediation approach, the mediation effect by WC was consistently 
observed, especially in younger individuals including men < 45 years and premenopausal 
women (Table 7.9 & Figure 7.3), suggesting that the effect of the Mediterranean diet on 
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reducing glucose level might be greater through lowering abdominal obesity than general 
obesity in men < 45 years and premenopausal women. 
It has been reported that adherence to the Mediterranean diet is associated with 
decreased inflammation which is a potential risk factor for atherosclerosis and CVD (41). 
Low-grade chronic inflammation is crucial in the initial phase of developing 
atherosclerosis, the main cause of coronary heart disease (42). In addition, inflammatory 
markers such as CRP and interleukin-6 are associated with the risk of type 2 DM (43). 
Obesity is considered to be a sub-clinical inflammatory condition to enhance the 
production of pro-inflammatory factors that contribute to insulin resistance (44), and 
abdominal obesity may play a key role in this process (45). Thus, the underlying 
mechanism on the beneficial effect of the Mediterranean diet on prevention of 
inflammation may be supported by our findings in which higher MDS was inversely 
associated with WBC and fibrinogen; the mediation effect in this association was greater 
in WC than BMI in both traditional approach and causal mediation approach.  
In the present study, the Mediterranean diet was not associated with hs-CRP with 
or without adjusting for BMI or WC. Instead, the indirect effect of hs-CRP was 
consistently highly significant in both traditional approach and causal mediation approach, 
especially in WC as a mediator, suggesting that the effect of Mediterranean diet might be 
fully mediated by adiposity, especially abdominal obesity. This finding may be supported 
by a recent study in which combining weight loss with Mediterranean diet had no impact 
on plasma CRP, but a group with substantial decrease of WC showed reduction of plasma 
CRP (46). 
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The DASH style diet was not considered for mediation analyses in the present 
study, because there was no significant association with obesity, after adjusting for 
potential confounders. Moreover, no association between DASH index and the markers 
for insulin resistance was found. These findings were consistent with the previous 
research in which the association of the DASH style diet with insulin sensitivity and 
weight control was reported to be unclear (47, 48).  
Our study has several strengths. First, we used data from a valid and reliable 
nationally representative study, based on extensive laboratory and physical examinations 
using standardized protocols to minimize the influence of measurement errors. Second, 
we assessed the mediation effect of general obesity and abdominal obesity in the 
association of healthy dietary patterns with markers for insulin resistance and 
inflammation in a comprehensive way using a traditional approach and causal mediation 
analysis as well as exploring the possible interaction effect. Finally, the present study 
adjusted for a wide range of potential confounders in multivariable analyses. There are 
also several limitations. First, this cross-sectional study cannot imply a causal and 
temporal relationship between healthy dietary pattern, adiposity, and the markers for 
insulin resistance and inflammation, although we tried to minimize reverse causality 
using strict exclusion criteria. Second, since the information on “servings per week” was 
not available on the NHANES III FFQ, we used “times per week” in assessing the 
consumption frequency for MDS calculation. This approach might cause exposure 
misclassification, but the direction would be non-differential. In addition, we used 
nutrient data from the 24-hr dietary recall data in calculating DASH score, which might 
not be comparable to DASH score based on FFQ in other studies. Third, there might be 
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residual confounding due to not measuring the covariates in an objective way. 
In conclusion, the association between Mediterranean diet, obesity, insulin 
resistance and inflammation suggest that obesity, especially abdominal obesity, may play 
a crucial role in the relationship of the Mediterranean diet with decreased insulin 
resistance and inflammation. Further prospective studies are warranted to identify the role 
of adiposity in the prevention effect of the Mediterranean diet on reducing the risk of type 
2 DM and CVD. 
References 
1. Siervo M, Lara J, Chowdhury S, Ashor A, Oggioni C, Mathers JC. Effects of the 
Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk 
factors: a systematic review and meta-analysis. The British journal of nutrition 
2014:1-15. doi: 10.1017/s0007114514003341. 
2. Kastorini C-M, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, 
Panagiotakos DB. The effect of mediterranean diet on metabolic syndrome and its 
componentsa meta-analysis of 50 studies and 534,906 individuals. Journal of the 
American College of Cardiology 2011;57(11):1299-313. 
3. Sofi F, Cesari F, Abbate R, Gensini GF, Casini A. Adherence to Mediterranean 
diet and health status: meta-analysis. Bmj 2008;337. 
4. Grosso G, Mistretta A, Frigiola A, Gruttadauria S, Biondi A, Basile F, Vitaglione 
P, D'Orazio N, Galvano F. Mediterranean diet and cardiovascular risk factors: a 
systematic review. Critical reviews in food science and nutrition 2014;54(5):593-
610. doi: 10.1080/10408398.2011.596955. 
5. Azadbakht L. Effects of Dietary Approaches to Stop Hypertension (DASH)-style 
diet on fatal or nonfatal cardiovascular diseasesdIncidence: A systematic review 
and meta-analysis on observational prospective studies. Nutrition (Burbank, Los 
Angeles County, Calif) 2013;29:611-8. 
6. Kastorini CM, Milionis HJ, Goudevenos JA, Panagiotakos DB. Mediterranean 
diet and coronary heart disease: is obesity a link? - A systematic review. Nutrition, 
metabolism, and cardiovascular diseases : NMCD 2010;20(7):536-51. doi: 
10.1016/j.numecd.2010.04.006. 
7. Richiardi L, Bellocco R, Zugna D. Mediation analysis in epidemiology: methods, 
interpretation and bias. International journal of epidemiology 2013;42(5):1511-9. 
8. Wang Y, Rimm EB, Stampfer MJ, Willett WC, Hu FB. Comparison of abdominal 
adiposity and overall obesity in predicting risk of type 2 diabetes among men. Am 
J Clin Nutr 2005;81(3):555-63. 
174 
 
9. Baron RM, Kenny DA. The moderator-mediator variable distinction in social 
psychological research: conceptual, strategic, and statistical considerations. 
Journal of personality and social psychology 1986;51(6):1173-82. 
10. Robins JM, Greenland S. Identifiability and exchangeability for direct and 
indirect effects. Epidemiology (Cambridge, Mass) 1992;3(2):143-55. 
11. United States. National Center for Health Statistics. Plan and Operation of the 
Third National Health and Nutrition Examination Survey, 1988–94. US 
Department of Health and Human Services, Public Health Service, Centers for 
Disease Control and Prevention: Hyattsville, MD, Washington, DC, 1994. 
12. Panagiotakos DB, Pitsavos C, Stefanadis C. Dietary patterns: a Mediterranean 
diet score and its relation to clinical and biological markers of cardiovascular 
disease risk. Nutrition, metabolism, and cardiovascular diseases : NMCD 
2006;16(8):559-68. doi: 10.1016/j.numecd.2005.08.006. 
13. Panagiotakos DB, Pitsavos C, Arvaniti F, Stefanadis C. Adherence to the 
Mediterranean food pattern predicts the prevalence of hypertension, 
hypercholesterolemia, diabetes and obesity, among healthy adults; the accuracy of 
the MedDietScore. Preventive medicine 2007;44(4):335-40. 
14. Carter SJ, Roberts MB, Salter J, Eaton CB. Relationship between Mediterranean 
Diet Score and atherothrombotic risk: findings from the Third National Health 
and Nutrition Examination Survey (NHANES III), 1988-1994. Atherosclerosis 
2010;210(2):630-6. doi: 10.1016/j.atherosclerosis.2009.12.035. 
15. Fung TT, McCullough ML, Newby P, Manson JE, Meigs JB, Rifai N, Willett WC, 
Hu FB. Diet-quality scores and plasma concentrations of markers of inflammation 
and endothelial dysfunction. The American journal of clinical nutrition 
2005;82(1):163-73. 
16. Liangpunsakul S, Crabb DW, Qi R. Relationship among alcohol intake, body fat, 
and physical activity: a population-based study. Annals of epidemiology 
2010;20(9):670-5. doi: 10.1016/j.annepidem.2010.05.014. 
17. Miller PE, Cross A, Subar AF, Krebs-Smith SM, Park Y, Powell-Wiley T, 
Hollenbeck A, Reedy J. Comparison of 4 established DASH diet indexes: 
examining associations of index scores and colorectal cancer. The American 
journal of clinical nutrition 2013:ajcn. 063602. 
18. Mellen PB, Gao SK, Vitolins MZ, Goff DC. Deteriorating dietary habits among 
adults with hypertension: DASH dietary accordance, NHANES 1988-1994 and 
1999-2004. Archives of Internal Medicine 2008;168(3):308-14. 
19. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray 
GA, Vogt TM, Cutler JA, Windhauser MM, et al. A clinical trial of the effects of 
dietary patterns on blood pressure. DASH Collaborative Research Group. The 
New England journal of medicine 1997;336(16):1117-24. doi: 
10.1056/nejm199704173361601. 
20. Haskell WL, Lee IM, Pate RR, Powell KE, Blair SN, Franklin BA, Macera CA, 
Heath GW, Thompson PD, Bauman A. Physical activity and public health: 
updated recommendation for adults from the American College of Sports 
Medicine and the American Heart Association. Circulation 2007;116(9):1081-93. 
doi: 10.1161/circulationaha.107.185649. 
175 
 
21. Preacher KJ, Hayes AF. SPSS and SAS procedures for estimating indirect effects 
in simple mediation models. Behavior research methods, instruments, & 
computers 2004;36(4):717-31. 
22. Valeri L, Vanderweele TJ. Mediation analysis allowing for exposure-mediator 
interactions and causal interpretation: theoretical assumptions and implementation 
with SAS and SPSS macros. Psychological methods 2013;18(2):137-50. doi: 
10.1037/a0031034. 
23. Sobel ME. Asymptotic confidence intervals for indirect effects in structural 
equation models. Sociological methodology 1982;13(1982):290-312. 
24. Rucker DD, Preacher KJ, Tormala ZL, Petty RE. Mediation analysis in social 
psychology: Current practices and new recommendations. Social and Personality 
Psychology Compass 2011;5(6):359-71. 
25. VanderWeele TJ. Mediation and mechanism. European journal of epidemiology 
2009;24(5):217-24. 
26. VanderWeele TJ. A three-way decomposition of a total effect into direct, indirect, 
and interactive effects. Epidemiology (Cambridge, Mass) 2013;24(2):224-32. doi: 
10.1097/EDE.0b013e318281a64e. 
27. VanderWeele T. Explanation in causal inference: methods for mediation and 
interaction: Oxford University Press, 2015. 
28. Koloverou E, Esposito K, Giugliano D, Panagiotakos D. The effect of 
Mediterranean diet on the development of type 2 diabetes mellitus: A meta-
analysis of 10 prospective studies and 136,846 participants. Metabolism 
2014;63(7):903-11. doi: http://dx.doi.org/10.1016/j.metabol.2014.04.010. 
29. Zamora-Ros R, Serafini M, Estruch R, Lamuela-Raventos RM, Martinez-
Gonzalez MA, Salas-Salvado J, Fiol M, Lapetra J, Aros F, Covas MI, et al. 
Mediterranean diet and non enzymatic antioxidant capacity in the PREDIMED 
study: evidence for a mechanism of antioxidant tuning. Nutrition, metabolism, 
and cardiovascular diseases : NMCD 2013;23(12):1167-74. doi: 
10.1016/j.numecd.2012.12.008. 
30. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Are oxidative stress-activated 
signaling pathways mediators of insulin resistance and beta-cell dysfunction? 
Diabetes 2003;52(1):1-8. 
31. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L, Pineo A, 
Busardo A, Paolisso G. Role of magnesium in insulin action, diabetes and cardio-
metabolic syndrome X. Molecular aspects of medicine 2003;24(1-3):39-52. 
32. Chandalia M, Garg A, Lutjohann D, von Bergmann K, Grundy SM, Brinkley LJ. 
Beneficial effects of high dietary fiber intake in patients with type 2 diabetes 
mellitus. The New England journal of medicine 2000;342(19):1392-8. doi: 
10.1056/nejm200005113421903. 
33. Bonnet F, Disse E, Laville M, Mari A, Hojlund K, Anderwald CH, Piatti P, 
Balkau B. Moderate alcohol consumption is associated with improved insulin 
sensitivity, reduced basal insulin secretion rate and lower fasting glucagon 
concentration in healthy women. Diabetologia 2012;55(12):3228-37. doi: 
10.1007/s00125-012-2701-3. 
34. Riserus U, Willett WC, Hu FB. Dietary fats and prevention of type 2 diabetes. 
Progress in lipid research 2009;48(1):44-51. doi: 10.1016/j.plipres.2008.10.002. 
176 
 
35. Schroder H. Protective mechanisms of the Mediterranean diet in obesity and type 
2 diabetes. The Journal of nutritional biochemistry 2007;18(3):149-60. doi: 
10.1016/j.jnutbio.2006.05.006. 
36. Buckland G, Bach A, Serra-Majem L. Obesity and the Mediterranean diet: a 
systematic review of observational and intervention studies. Obesity reviews : an 
official journal of the International Association for the Study of Obesity 
2008;9(6):582-93. doi: 10.1111/j.1467-789X.2008.00503.x. 
37. Nordmann AJ, Suter-Zimmermann K, Bucher HC, Shai I, Tuttle KR, Estruch R, 
Briel M. Meta-analysis comparing Mediterranean to low-fat diets for modification 
of cardiovascular risk factors. The American journal of medicine 
2011;124(9):841-51.e2. doi: 10.1016/j.amjmed.2011.04.024. 
38. Ginsberg HN, Zhang YL, Hernandez‐Ono A. Metabolic syndrome: focus on 
dyslipidemia. Obesity 2006;14(S2):41S-9S. 
39. Lebovitz HE. Insulin resistance–a common link between type 2 diabetes and 
cardiovascular disease. Diabetes, Obesity and Metabolism 2006;8(3):237-49. 
40. James LR, Brett JM. Mediators, moderators, and tests for mediation. Journal of 
Applied Psychology 1984;69(2):307. 
41. Schwingshackl L, Hoffmann G. Mediterranean dietary pattern, inflammation and 
endothelial function: a systematic review and meta-analysis of intervention trials. 
Nutrition, metabolism, and cardiovascular diseases : NMCD 2014;24(9):929-39. 
doi: 10.1016/j.numecd.2014.03.003. 
42. Hansson GK. Inflammation, Atherosclerosis, and Coronary Artery Disease. New 
England Journal of Medicine 2005;352(16):1685-95. doi: 
doi:10.1056/NEJMra043430. 
43. Wang X, Bao W, Liu J, OuYang Y-Y, Wang D, Rong S, Xiao X, Shan Z-L, 
Zhang Y, Yao P. Inflammatory Markers and Risk of Type 2 Diabetes A 
systematic review and meta-analysis. Diabetes care 2013;36(1):166-75. 
44. Bastard J-P, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B. 
Recent advances in the relationship between obesity, inflammation, and insulin 
resistance. European cytokine network 2006;17(1):4-12. 
45. Mathieu P, Lemieux I, Després JP. Obesity, inflammation, and cardiovascular risk. 
Clinical pharmacology & therapeutics 2010;87(4):407-16. 
46. Richard C, Couture P, Desroches S, Lamarche B. Effect of the Mediterranean diet 
with and without weight loss on markers of inflammation in men with metabolic 
syndrome. Obesity (Silver Spring, Md) 2013;21(1):51-7. doi: 10.1002/oby.20239. 
47. Soeliman FA, Azadbakht L. Weight loss maintenance: A review on dietary 
related strategies. Journal of research in medical sciences : the official journal of 
Isfahan University of Medical Sciences 2014;19(3):268-75. 
48. Hinderliter AL, Babyak MA, Sherwood A, Blumenthal JA. The DASH diet and 
insulin sensitivity. Current hypertension reports 2011;13(1):67-73. doi: 
10.1007/s11906-010-0168-5. 
  
 
1
7
7
 
Table 7.1 Distribution of general and clinical characteristics according to tertiles of MDS and DASH 
index 
 
          MDS                   
Characteristics Overall Tertile 1 Tertile 2 Tertile 3 P 
(n=4,700) (n=1,729) (n=1,501) (n=1,470)   
Age, years 38.5 ± 0.5 37.3 ± 0.5 38.1 ± 0.5 40.6 ± 0.8 <0.001 
Men, % 54.1 ± 0.9 54.5 ± 2.2 57.0 ± 2.2 50.6 ± 2.1 0.22 
Race/ ethnicity, % 
             
 
Non-Hispanic white 73.9 ± 1.6 77.6 ± 2.0 71.7 ± 2.4 71.1 ± 2.3 <0.001 
 
Non-Hispanic black 11.3 ± 0.7 12.0 ± 0.9 12.3 ± 1.1 9.3 ± 1.0 
 
 
Mexican-American 6.5 ± 0.6 3.9 ± 0.4 6.5 ± 0.6 10.0 ± 1.1 
 
 
Other 8.3 ± 1.2 6.5 ± 1.5 9.5 ± 1.9 9.6 ± 1.8 
 
Educational attainment, % 
             
 
<12 years 20.1 ± 1.2 23.6 ± 1.6 19.8 ± 1.8 15.6 ± 1.5 <0.001 
 
12 years 35.3 ± 1.1 41.2 ± 1.7 32.9 ± 1.8 29.5 ± 1.9 
 
 
>=13 years 44.7 ± 1.4 35.2 ± 2.0 47.3 ± 2.4 54.9 ± 2.1 
 
Income, % 
             
 
PIR=<1.3 17.9 ± 1.2 20.3 ± 2.2 17.2 ± 1.5 15.2 ± 1.7 <0.001 
 
PIR=<3.5 45.5 ± 2.0 51.3 ± 3.0 44.6 ± 2.3 38.2 ± 2.5 
 
 
PIR>3.5 36.7 ± 2.1 28.4 ± 3.3 38.3 ± 2.3 46.6 ± 2.3 
 
Smoking status, % 
             
 
Never 47.2 ± 1.2 43.4 ± 1.9 50.5 ± 1.8 49.0 ± 2.4 <0.001 
 
Former 21.4 ± 0.8 19.4 ± 1.3 19.3 ± 1.6 26.3 ± 1.8 
 
 
Current 31.4 ± 1.3 37.3 ± 1.7 30.2 ± 1.8 24.7 ± 2.2 
 
Drinking alcohol, % 
             
 
Never 38.5 ± 1.4 65.7 ± 1.9 26.4 ± 1.7 14.0 ± 1.3 <0.001 
 
Moderate 59.1 ± 1.4 31.5 ± 2.0 71.1 ± 1.8 84.2 ± 1.3 
 
 
Heavy 2.4 ± 0.2 2.8 ± 0.7 2.5 ± 0.6 1.9 ± 0.6 
 
Physical activity, % 
             
 
Inactive 12.0 ± 0.9 15.3 ± 1.5 10.3 ± 1.2 9.2 ± 1.2 <0.001 
 
Insufficient activity 55.1 ± 1.2 55.3 ± 1.8 58.4 ± 1.8 51.2 ± 2.2 
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Recommended 
Activity 
32.9 ± 1.3 29.4 ± 1.9 31.3 ± 1.8 39.6 ± 2.3 
 
CHD family history, % 15.7 ± 0.8 15.9 ± 1.5 17.2 ± 1.4 13.7 ± 1.7 0.34 
DM parental history, % 16.9 ± 0.9 15.6 ± 1.6 18.5 ± 1.4 17.2 ± 1.7 0.42 
DM, % 2.7 ± 0.3 2.5 ± 0.4 3.1 ± 0.7 2.5 ± 0.6 0.63 
Hypertension, % 9.4 ± 0.8 8.1 ± 0.9 8.2 ± 1.3 12.3 ± 1.6 0.02 
BMI, kg/m2 25.8 ± 0.1 26.0 ± 0.2 26.0 ± 0.2 25.3 ± 0.2 0.01 
WC, cm 89.1 ± 0.4 89.9 ± 0.5 90.0 ± 0.6 87.2 ± 0.5 <0.001 
Percentage body fat, % 29.0 ± 0.3 29.3 ± 0.5 29.2 ± 0.3 28.5 ± 0.3 0.32 
Fasting glucose, mg/dl 95 ± 0.3 95 ± 0.4 95 ± 0.4 94 ± 0.5 0.66 
Post load glucose, mg/dl 116 ± 1.5 116 ± 2.4 119 ± 3.5 114 ± 2.1 0.34 
HbA1c, % 5.2 ± 0.0 5.2 ± 0.0 5.2 ± 0.0 5.1 ± 0.0 0.03 
Fasting insulin, mg/dl 9.3 ± 0.2 9.8 ± 0.2 9.4 ± 0.3 8.3 ± 0.2 <0.001 
HOMA-IR 2.21 ± 0.05 2.34 ± 0.06 2.27 ± 0.08 1.98 ± 0.05 <0.001 
hs-CRP, mg/dl 0.33 ± 0.01 0.35 ± 0.01 0.32 ± 0.01 0.33 ± 0.02 0.39 
WBC (×103 cells) 6.8 ± 0.1 7.1 ± 0.1 6.8 ± 0.1 6.5 ± 0.1 <0.001 
Homocysteine, umol/L 9.4 ± 0.2 9.5 ± 0.3 9.4 ± 0.3 9.3 ± 0.4 0.94 
Fibrinogen, mg/dl 291 ± 3.2 303 ± 4.8 287 ± 5.4 282 ± 4.4 <0.001 
Lipoprotein (a), mg/dl 22 ± 1.2 24 ± 2.0 20 ± 1.4 23 ± 1.6 0.06 
 
Table 7.1 (Continued) 
    DASH index               
Characteristics Tertile 1 Tertile 2 Tertile 3 P 
(n=1,480) (n=1,770) (n=1,450)   
Age, years 36.7 ± 0.5 37.7 ± 0.5 41.3 ± 0.8 <0.001 
Men, % 56.7 ± 2.3 56.6 ± 1.5 48.1 ± 1.9 0.006 
Race/ ethnicity, % 
          
 
Non-Hispanic white 73.9 ± 1.9 73.7 ± 2.2 74.2 ± 1.9 <0.001 
 
Non-Hispanic black 15.4 ± 1.3 10.3 ± 0.7 8.1 ± 0.7 
 
 
Mexican-American 5.1 ± 0.5 6.2 ± 0.6 8.3 ± 1.0 
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Other 5.6 ± 1.1 9.8 ± 1.9 9.3 ± 1.5 
 
Educational attainment, % 
          
 
<12 years 19.0 ± 1.8 19.4 ± 1.6 22.1 ± 1.9 0.004 
 
12 years 39.6 ± 2.2 37.2 ± 1.5 28.0 ± 2.5 
 
 
>=13 years 41.4 ± 2.4 43.4 ± 2.0 49.9 ± 2.8 
 
Income, % 
          
 
PIR=<1.3 16.7 ± 2.0 18.2 ± 1.5 18.7 ± 1.7 0.05 
 
PIR=<3.5 48.6 ± 3.2 47.1 ± 2.2 39.8 ± 2.5 
 
 
PIR>3.5 34.7 ± 3.2 34.7 ± 2.1 41.5 ± 3.2 
 
Smoking status, % 
          
 
Never 44.0 ± 1.9 44.7 ± 2.3 53.9 ± 2.2 <0.001 
 
Former 19.2 ± 1.5 22.7 ± 1.5 22.0 ± 1.7 
 
 
Current 36.7 ± 2.1 32.6 ± 2.0 24.1 ± 1.9 
 
Drinking alcohol, % 
          
 
Never 37.9 ± 2.4 37.1 ± 2.0 41.1 ± 2.5 0.58 
 
Moderate 59.7 ± 2.4 60.8 ± 2.0 56.0 ± 2.6 
 
 
Heavy 2.4 ± 0.5 2.1 ± 0.4 2.8 ± 0.8 
 
Physical activity, % 
          
 
Inactive 11.4 ± 1.1 12.4 ± 1.0 12.0 ± 1.7 <0.001 
 
Insufficient activity 61.4 ± 2.0 54.9 ± 2.2 48.6 ± 2.2 
 
 
Recommended 
Activity 
27.2 ± 1.8 32.7 ± 2.2 39.4 ± 2.3 
 
CHD family history, % 16.9 ± 1.3 16.6 ± 1.5 13.2 ± 1.4 0.14 
DM parental history, % 17.9 ± 1.6 16.1 ± 1.6 17.0 ± 1.4 0.68 
DM, % 2.5 ± 0.5 2.3 ± 0.5 3.3 ± 0.9 0.55 
Hypertension, % 8.4 ± 1.2 9.7 ± 1.1 10.0 ± 1.3 0.58 
BMI, kg/m2 25.8 ± 0.2 26.1 ± 0.2 25.4 ± 0.2 0.005 
WC, cm 89.1 ± 0.5 90.2 ± 0.6 87.8 ± 0.6 0.002 
Percentage body fat, % 29.1 ± 0.4 28.9 ± 0.3 29.2 ± 0.5 0.80 
Fasting glucose, mg/dl 94 ± 0.4 95 ± 0.4 95 ± 0.6 0.66 
Post load glucose, mg/dl 115 ± 2.4 112 ± 2.2 121 ± 3.1 0.07 
HbA1c, % 5.2 ± 0.0 5.2 ± 0.0 5.2 ± 0.0 0.75 
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Fasting insulin, mg/dl 9.3 ± 0.2 9.6 ± 0.3 8.8 ± 0.2 0.05 
HOMA-IR 2.21 ± 0.06 2.29 ± 0.09 2.11 ± 0.07 0.15 
hs-CRP, mg/dl 0.32 ± 0.01 0.35 ± 0.02 0.32 ± 0.01 0.47 
WBC (×103 cells) 7.0 ± 0.1 6.9 ± 0.1 6.6 ± 0.1 0.001 
Homocysteine, umol/L 10.1 ± 0.4 9.4 ± 0.3 8.7 ± 0.2 0.009 
Fibrinogen, mg/dl 290 ± 5.3 290 ± 4.8 293 ± 5.1 0.85 
Lipoprotein (a), mg/dl 21 ± 1.7 23 ± 1.3 23 ± 1.7 0.20 
Data are presented as means ± standard error or proportion (%) ± standard error.  
P values for continuous variables represent P for trend. 
Abbreviations: MDS, Mediterranean Diet Score; DASH, Dietary Approaches to Stop Hypertension; 
PIR, poverty income ratio; CHD, coronary heart disease; DM, diabetes mellitus; BMI, body mass 
index; WC, waist circumference; HbA1c, glycated hemoglobin; HOMA-IR, homoeostasis model 
assessment of insulin resistance; hs-CRP, high-sensitivity C-reactive protein; WBC, white blood cell. 
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Table 7.2 Comparison of each component of Mediterranean diet scores and DASH index by the tertiles  
 
  MDS                         
 
Overall Tertile 1 Tertile 2 Tertile 3 P for 
trend   (n=4,700) (n=1,729) (n=1,501) (n=1,470) 
Score range (8 - 42) (8 - 24) (25 - 28) (29 - 42) 
 
MDS score 25.8 ± 0.2 21.0 ± 0.1 26.5 ± 0.0 31.5 ± 0.1 <0.001 
Grains (times/wk) 4.4 ± 0.1 3.2 ± 0.1 4.5 ± 0.2 6.2 ± 0.3 <0.001 
Legumes (times/wk) 2.6 ± 0.1 1.8 ± 0.1 2.8 ± 0.1 3.6 ± 0.2 <0.001 
Fruit (times/wk) 5.7 ± 0.2 3.9 ± 0.1 5.3 ± 0.2 8.8 ± 0.3 <0.001 
Vegetable (times/wk) 13.3 ± 0.3 10.0 ± 0.3 12.6 ± 0.3 18.4 ± 0.5 <0.001 
Fish (times/wk) 1.4 ± 0.1 1.0 ± 0.0 1.3 ± 0.1 2.2 ± 0.1 <0.001 
MUFA:SFA 1.18 ± 0.01 1.06 ± 0.01 1.16 ± 0.01 1.36 ± 0.02 <0.001 
Red meats (times/wk) 5.7 ± 0.1 7.2 ± 0.2 5.4 ± 0.1 4.0 ± 0.1 <0.001 
Poultry (times/wk) 2.0 ± 0.0 1.8 ± 0.1 2.0 ± 0.1 2.2 ± 0.1 0.001 
Dairy products (times/wk) 12.3 ± 0.3 14.5 ± 0.4 11.5 ± 0.3 10.2 ± 0.3 <0.001 
Alcohol (g/d) 3.9 ± 0.2 3.0 ± 0.4 4.3 ± 0.3 4.7 ± 0.2 0.001 
Total energy intake, kcal 2313 ± 28 2322 ± 51 2399 ± 47 2208 ± 52 0.18 
 
DASH index 
          
 
Overall Tertile 1 Tertile 2 Tertile 3 P for 
trend   (n=4,700) (n=1,480) (n=1,770) (n=1,450) 
Score range (0 - 8) (0 - 1) (1.5 - 2.5) (3 - 8) 
 
DASH score 2.1 ± 0.0 0.6 ± 0.0 1.9 ± 0.0 4.0 ± 0.0 <0.001 
Saturated fat, % energy 11.5 ± 0.1 13.6 ± 0.1 11.7 ± 0.2 8.8 ± 0.1 <0.001 
Total fat, % energy 34.2 ± 0.3 40.2 ± 0.3 35.0 ± 0.3 26.6 ± 0.4 <0.001 
Protein, % energy 15.1 ± 0.1 14.2 ± 0.2 15.0 ± 0.2 16.2 ± 0.2 <0.001 
Cholesterol, mg 129 ± 2 157 ± 3 126 ± 3 103 ± 4 <0.001 
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Fiber, mg 7.5 ± 0.1 5.5 ± 0.1 6.9 ± 0.1 10.5 ± 0.2 <0.001 
Magnesium, mg 137 ± 2 107 ± 1 128 ± 2 180 ± 3 <0.001 
Calcium, mg 371 ± 6 313 ± 5 362.1 ± 8.1 444.8 ± 12.2 <0.001 
Potassium, mg 1310 ± 14 1054 ± 10 1231 ± 16 1694 ± 30 <0.001 
Sodium, mg 1631 ± 14 1715 ± 19 1658 ± 32 1504 ± 27 <0.001 
Total energy intake, kcal 2313 ± 28 2587 ± 54 2333 ± 32 1990 ± 41 <0.001 
Data are presented as means ± standard error.  
Abbreviations: MDS, Mediterranean Diet Score; MUFA, monounsaturated fatty acid; SFA, saturated fatty acid; DASH, 
Dietary Approaches to Stop Hypertension. 
The amount of each DASH dietary component is based on a 1,000-kcal diet.
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Table 7.3 Beta-coefficients (95% CI) of the association of MDS and DASH index with body mass index, 
waist circumference, and markers for insulin resistance and inflammation in conventional analyses 
 
  MDS           DASH index       
Mediator 
Estimate 
(a) 
  
95% 
CI 
    P 
Estimate 
(a) 
  
95% 
CI 
    P 
BMI -0.770 ( -1.284 -0.256 ) 0.004 -0.285 ( -0.742 0.171 ) 0.22 
WC -2.670 ( -3.994 -1.347 ) <0.001 -0.988 ( -2.373 0.397 ) 0.16 
Outcome 
Estimate 
(c) 
  
95% 
CI 
    P 
Estimate 
(c) 
  
95% 
CI 
    P 
Log insulin -0.153 ( -0.195 -0.110 ) <0.001 -0.056 ( -0.112 0.000 ) 0.05 
Log HOMA -0.163 ( -0.210 -0.116 ) <0.001 -0.059 ( -0.121 0.003 ) 0.06 
Fasting glucose -1.416 ( -2.578 -0.253 ) 0.02 -0.337 ( -1.636 0.963 ) 0.61 
Post-load glucose -1.720 ( -6.866 3.427 ) 0.51 3.505 ( -3.37 10.38 ) 0.31 
HbA1c -0.099 ( -0.149 -0.049 ) <0.001 -0.002 ( -0.061 0.057 ) 0.94 
Log hs-CRP -0.015 ( -0.076 0.045 ) 0.61 -0.023 ( -0.078 0.032 ) 0.41 
WBC -0.323 ( -0.547 -0.098 ) 0.006 -0.267 ( -0.503 -0.031 ) 0.03 
Fibrinogen -17.44 ( -26.99 -7.88 ) 0.001 1.066 ( -14.09 16.22 ) 0.89 
Log homocysteine 0.018 ( -0.036 0.072 ) 0.50 -0.073 ( -0.143 -0.004 ) 0.04 
Log lipoprotein (a) -0.006 ( -0.251 0.239 ) 0.96 0.191 ( -0.052 0.433 ) 0.12 
Abbreviations: CI, confidence interval; MDS, Mediterranean Diet Score; DASH, Dietary Approaches to Stop Hypertension; 
BMI, body mass index; WC, waist circumference; HbA1c, glycated hemoglobin; HOMA-, homoeostasis model assessment 
of insulin resistance; hs-CRP, high-sensitivity C-reactive protein; WBC, white blood cell. 
All estimates were adjusted for age, gender, race/ethnicity, educational attainment, income, living with spouse, smoking 
status, level of physical activity, family history of coronary heart disease, parental history of diabetes mellitus, mean arterial 
pressure, and total calories (additionally adjusted for alcohol consumption in the model including DASH index; mean arterial 
pressure in the model for markers of insulin resistance; multivitamin use in the model for homocysteine). 
Paths a and c are explained in the Figure 7.1. 
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Table 7.4 Beta-coefficients (95% CI) of the association of body mass index and waist circumference on the markers 
for insulin resistance and inflammation in conventional analyses 
    MDS           DASH           
Mediator Outcomes 
Estimate 
(b) 
  
95% 
CI 
    P 
Estimate 
(b) 
  
95% 
CI 
    P 
BMI Log insulin 0.055 ( 0.050 0.060 ) <0.001 0.055 ( 0.050 0.060 ) <0.001 
 
Log HOMA 0.060 ( 0.055 0.066 ) <0.001 0.060 ( 0.055 0.066 ) <0.001 
 
Fasting glucose 0.503 ( 0.359 0.646 ) <0.001 0.505 ( 0.367 0.643 ) <0.001 
 
Post-load glucose 0.814 ( 0.112 1.517 ) 0.02 0.876 ( 0.188 1.564 ) 0.01 
 
HbA1c 0.015 ( 0.010 0.019 ) <0.001 0.015 ( 0.011 0.019 ) <0.001 
 
Log hs-CRP 0.031 ( 0.025 0.037 ) <0.001 0.031 ( 0.024 0.037 ) <0.001 
 
WBC 0.055 ( 0.036 0.074 ) <0.001 0.055 ( 0.036 0.075 ) <0.001 
 
Fibrinogen 1.732 ( 0.677 2.786 ) 0.002 1.778 ( 0.762 2.795 ) 0.001 
 
Log homocysteine 0.001 ( -0.004 0.007 ) 0.65 0.001 ( -0.004 0.007 ) 0.62 
 
Log lipoprotein (a) 0.002 ( -0.016 0.020 ) 0.81 0.001 ( -0.019 0.021 ) 0.94 
WC Log insulin 0.023 ( 0.021 0.024 ) <.0001 0.023 ( 0.021 0.025 ) <0.001 
 
Log HOMA 0.025 ( 0.023 0.027 ) <.0001 0.025 ( 0.023 0.027 ) <0.001 
 
Fasting glucose 0.229 ( 0.168 0.289 ) <.0001 0.230 ( 0.171 0.288 ) <0.001 
 
Post-load glucose 0.477 ( 0.203 0.751 ) 0.001 0.494 ( 0.228 0.759 ) 0.001 
 
HbA1c 0.006 ( 0.004 0.007 ) <.0001 0.006 ( 0.004 0.008 ) <0.001 
 
Log hs-CRP 0.012 ( 0.010 0.014 ) <.0001 0.012 ( 0.010 0.014 ) <0.001 
 
WBC 0.020 ( 0.013 0.028 ) <.0001 0.021 ( 0.013 0.028 ) <0.001 
 
Fibrinogen 0.625 ( 0.194 1.057 ) 0.005 0.657 ( 0.249 1.065 ) 0.002 
 
Log homocysteine 0.001 ( -0.002 0.003 ) 0.53 0.001 ( -0.002 0.003 ) 0.51 
  Log lipoprotein (a) -0.001 ( -0.007 0.006 ) 0.89 -0.001 ( -0.009 0.006 ) 0.76 
Abbreviations: CI, confidence interval; MDS, Mediterranean Diet Score; DASH, Dietary Approaches to Stop Hypertension; BMI, body mass 
index; WC, waist circumference; HbA1c, glycated hemoglobin; HOMA, homoeostasis model assessment of insulin resistance; hs-CRP, high-
sensitivity C-reactive protein; WBC, white blood cell. 
All estimates were adjusted for the same covariates used in Table 7.3 in addition to MDS or DASH index. 
Path b is explained in the Figure 7.1. 
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Table 7.5 Direct effect and indirect effects of the Mediterranean diet on the markers for insulin resistance and inflammation 
with BMI and waist circumference as a mediator using traditional mediation analysis 
 
    Direct effect (c')       Indirect effect (a*b)         
Proportion 
of 
mediation 
Mediator Outcomes Estimate   
95% 
CI 
    P Estimate   
95% 
CI 
    
Sobel 
test 
statistic 
P   
BMI Log insulin -0.104 ( -0.143 -0.065 ) <0.001 -0.042 ( -0.070 -0.014 ) -2.981 0.003 27.7% 
 
Log HOMA -0.110 ( -0.154 -0.065 ) <0.001 -0.046 ( -0.077 -0.016 ) -2.982 0.003 28.4% 
 
Fasting glucose -0.982 ( -2.191 0.227 ) 0.11 -0.387 ( -0.661 -0.113 ) -2.766 0.006 27.3% 
 
Post-load 
glucose 
-0.895 ( -6.183 4.393 ) 0.74 -0.627 ( -1.294 0.040 ) -1.842 0.07 36.5% 
 
HbA1c -0.086 ( -0.136 -0.037 ) 0.001 -0.011 ( -0.019 -0.003 ) -2.731 0.006 11.5% 
 
Log hs-CRP 0.007 ( -0.054 0.067 ) 0.82 -0.024 ( -0.040 -0.008 ) -2.880 0.004 NA 
 
WBC -0.282 ( -0.501 -0.062 ) 0.01 -0.042 ( -0.073 -0.011 ) -2.672 0.008 13.1% 
 
Fibrinogen -15.98 ( -25.93 -6.04 ) 0.002 -1.33 ( -2.51 -0.16 ) -2.22 0.03 7.6% 
WC Log insulin -0.085 ( -0.128 -0.043 ) <0.001 -0.061 ( -0.090 -0.031 ) -4.004 <0.001 39.8% 
 
Log HOMA -0.090 ( -0.138 -0.042 ) 0.001 -0.067 ( -0.099 -0.034 ) -4.010 <0.001 41.0% 
 
Fasting glucose -0.757 ( -1.983 0.469 ) 0.22 -0.611 ( -0.945 -0.276 ) -3.578 <0.001 43.1% 
 
Post-load 
glucose 
0.258 ( -5.288 5.804 ) 0.93 -1.273 ( -2.215 -0.331 ) -2.649 0.008 74.0% 
 
HbA1c -0.083 ( -0.132 -0.034 ) 0.001 -0.015 ( -0.024 -0.006 ) -3.408 0.001 15.3% 
 
Log hs-CRP 0.015 ( -0.044 0.074 ) 0.60 -0.032 ( -0.049 -0.016 ) -3.809 <0.001 NA 
 
WBC -0.270 ( -0.490 -0.049 ) 0.02 -0.054 ( -0.088 -0.021 ) -3.224 0.001 16.9% 
  Fibrinogen -15.21 ( -25.21 -5.21 ) 0.004 -1.67 ( -3.05 -0.29 ) -2.36 0.02 9.6% 
Abbreviations: CI, confidence interval; BMI, body mass index; WC, waist circumference; HbA1c, glycated hemoglobin; HOMA, homoeostasis model 
assessment of insulin resistance; hs-CRP, high-sensitivity C-reactive protein; WBC, white blood cell. 
All estimates for direct effect were adjusted for the same covariates used in Table 7.3. 
Paths a, b, and c’ are explained in the Figure 7.1. 
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Table 7.6 Marginal total effect, natural direct effect, and natural indirect effect on the Mediterranean diet with 
markers for insulin resistance and inflammation as BMI and waist circumference as a mediator using causal 
mediation analysis 
 
    Marginal total effect       Natural direct effect       
Mediator Outcomes Estimate   
95% 
CI 
    P Estimate   
95% 
CI 
    P 
BMI Log insulin -0.082 ( -0.118 -0.045 ) <0.001 -0.061 ( 0.000 -0.093 ) 0.02 
 
Log HOMA -0.092 ( -0.132 -0.051 ) <0.001 -0.070 ( -0.105 -0.035 ) <0.001 
 
Fasting glucose -1.571 ( -3.002 -0.139 ) 0.03 -1.346 ( -2.763 0.072 ) 0.06 
 
Post-load glucose -5.508 ( -12.46 1.45 ) 0.12 -5.156 ( -12.11 1.80 ) 0.15 
 
HbA1c -0.078 ( -0.129 -0.028 ) 0.003 -0.071 ( -0.122 -0.021 ) 0.006 
 
Log hs-CRP -0.043 ( -0.088 0.002 ) 0.06 -0.031 ( -0.074 0.012 ) 0.16 
 
WBC -0.178 ( -0.324 -0.032 ) 0.02 -0.161 ( -0.307 -0.016 ) 0.03 
 
Fibrinogen -9.61 ( -18.95 -0.27 ) 0.04 -8.66 ( -17.96 0.64 ) 0.07 
WC Log insulin -0.082 ( -0.118 -0.046 ) <0.001 -0.050 ( -0.081 -0.019 ) 0.001 
 
Log HOMA -0.093 ( -0.133 -0.052 ) <0.001 -0.057 ( -0.092 -0.023 ) 0.001 
 
Fasting glucose -1.573 ( -3.005 -0.142 ) 0.03 -1.187 ( -2.601 0.227 ) 0.10 
 
Post-load glucose -5.138 ( -12.08 1.81 ) 0.15 -4.327 ( -11.27 2.62 ) 0.22 
 
HbA1c -0.079 ( -0.130 -0.028 ) 0.002 -0.067 ( -0.117 -0.017 ) 0.009 
 
Log hs-CRP -0.043 ( -0.088 0.002 ) 0.06 -0.025 ( -0.068 0.018 ) 0.26 
 
WBC -0.179 ( -0.325 -0.032 ) 0.02 -0.153 ( -0.298 -0.008 ) 0.04 
  Fibrinogen -9.42 ( -18.77 -0.07 ) 0.05 -8.03 ( -17.36 1.30 ) 0.09 
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Table 7.6 (Continued) 
    Natural indirect effect     
Proportion 
of 
mediation 
Mediator Outcomes Estimate   
95% 
CI 
    P   
BMI Log insulin -0.020 ( -0.039 -0.002 ) 0.03 24.7% 
 
Log HOMA -0.022 ( -0.043 -0.002 ) 0.03 24.2% 
 
Fasting glucose -0.225 ( -0.437 -0.013 ) 0.04 14.3% 
 
Post-load glucose -0.352 ( -0.745 0.041 ) 0.08 6.4% 
 
HbA1c -0.007 ( -0.014 0.000 ) 0.04 9.4% 
 
Log hs-CRP -0.012 ( -0.024 0.000 ) 0.05 28.2% 
 
WBC -0.017 ( -0.034 0.000 ) 0.06 9.3% 
 
Fibrinogen -0.944 ( -1.927 0.038 ) 0.06 9.8% 
WC Log insulin -0.032 ( -0.051 -0.013 ) 0.001 39.0% 
 
Log HOMA -0.035 ( -0.057 -0.014 ) 0.001 38.3% 
 
Fasting glucose -0.386 ( -0.630 -0.143 ) 0.002 24.5% 
 
Post-load glucose -0.811 ( -1.413 -0.209 ) 0.008 15.8% 
 
HbA1c -0.012 ( -0.019 -0.004 ) 0.002 14.8% 
 
Log hs-CRP -0.018 ( -0.030 -0.006 ) 0.003 42.3% 
 
WBC -0.026 ( -0.044 -0.008 ) 0.005 14.4% 
  Fibrinogen -1.391 ( -2.392 -0.390 ) 0.006 14.8% 
Abbreviations: CI, confidence interval; BMI, body mass index; WC, waist circumference; 
HbA1c, glycated hemoglobin; HOMA, homoeostasis model assessment of insulin 
resistance; hs-CRP, high-sensitivity C-reactive protein; WBC, white blood cell. 
All estimates were adjusted for the same covariates used in Table 7.3. 
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Table 7.7 Comparison of the estimates in indirect (mediated) effects with or without the interaction 
terms of MDS with BMI and waist circumference in causal mediation analysis 
  
    With interaction   Without interaction     
Mediator Outcomes NIE 1 P PM NIE 2 P PM NIE1/NIE2 
BMI Log insulin -0.021 0.03 25.5% -0.020 0.03 24.7% 1.03 
 
Log HOMA -0.023 0.03 25.2% -0.022 0.03 24.2% 1.04 
 
Fasting glucose -0.243 0.05 15.5% -0.225 0.04 14.3% 1.08 
 
Post-load glucose -0.465 0.11 7.9% -0.352 0.08 6.4% 1.32 
 
HbA1c -0.008 0.05 10.5% -0.007 0.04 9.4% 1.11 
 
Log hs-CRP -0.010 0.06 23.8% -0.012 0.05 28.2% 0.85 
 
WBC -0.014 0.09 7.6% -0.017 0.06 9.3% 0.82 
 
Fibrinogen -0.943 0.08 9.8% -0.944 0.06 9.8% 1.00 
WC Log insulin -0.033 0.001 40.0% -0.032 0.001 39.0% 1.03 
 
Log HOMA -0.036 0.001 39.2% -0.035 0.001 38.3% 1.03 
 
Fasting glucose -0.381 0.004 24.2% -0.386 0.002 24.5% 0.99 
 
Post-load glucose -0.989 0.02 16.6% -0.811 0.008 15.8% 1.22 
 
HbA1c -0.012 0.006 14.9% -0.012 0.002 14.8% 1.00 
 
Log hs-CRP -0.015 0.004 36.3% -0.018 0.003 42.3% 0.85 
 
WBC -0.022 0.02 12.1% -0.026 0.005 14.4% 0.84 
  Fibrinogen -1.199 0.03 14.1% -1.391 0.006 14.8% 0.86 
Abbreviations: NIE, natural indirect effect; PM, Proportion of mediation; CI, confidence interval; BMI, body mass index; 
WC, waist circumference; HbA1c, glycated hemoglobin; HOMA, homoeostasis model assessment of insulin resistance; hs-
CRP, high-sensitivity C-reactive protein; WBC, white blood cell. 
All estimates were adjusted for the same covariates used in Table 7.3. 
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Table 7.8 Indirect (mediated) effect of the Mediterranean diet on the markers for insulin 
resistance and inflammation as BMI and waist circumference as a mediator using 
traditional mediation analysis without considering complex survey design of NHANES III 
 
    Indirect effect (a*b)         
Proportion 
of 
mediation 
Mediator Outcomes Estimate   
95% 
CI 
    
Sobel 
test 
statistic 
P   
BMI Log insulin -0.010 ( -0.020 0.000 ) -2.021 0.043 24.1% 
 
Log HOMA -0.011 ( -0.022 0.000 ) -1.988 0.047 23.4% 
 
Fasting glucose -0.108 ( -0.219 0.003 ) -1.914 0.056 13.9% 
 
Post-load glucose -0.308 ( -0.653 0.037 ) -1.751 0.080 10.9% 
 
HbA1c -0.004 ( -0.007 0.000 ) -1.911 0.056 9.2% 
 
Log hs-CRP -0.006 ( -0.012 0.000 ) -1.826 0.068 26.8% 
 
WBC -0.008 ( -0.016 0.001 ) -1.750 0.080 8.7% 
 
Fibrinogen -0.738 ( -1.494 0.017 ) -1.916 0.055 14.6% 
WC Log insulin -0.016 ( -0.026 -0.006 ) -3.025 0.002 37.7% 
 
Log HOMA -0.017 ( -0.029 -0.006 ) -2.963 0.003 36.7% 
 
Fasting glucose -0.186 ( -0.313 -0.058 ) -2.859 0.004 23.8% 
 
Post-load glucose -0.740 ( -1.265 -0.215 ) -2.762 0.006 26.2% 
 
HbA1c -0.006 ( -0.009 -0.002 ) -2.810 0.005 14.4% 
 
Log hs-CRP -0.006 ( -0.012 0.000 ) -1.826 0.068 26.8% 
 
WBC -0.012 ( -0.021 -0.003 ) -2.613 0.009 13.5% 
  Fibrinogen -1.059 ( -1.815 -0.303 ) -2.745 0.006 20.9% 
Abbreviations: CI, confidence interval; BMI, body mass index; WC, waist circumference; HbA1c, glycated 
hemoglobin; HOMA, homoeostasis model assessment of insulin resistance; hs-CRP, high-sensitivity C-
reactive protein; WBC, white blood cell. 
All estimates were adjusted for the same covariates used in Table 7.3. 
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Table 7.9 Marginal total effect, natural direct effect, and natural indirect effect on the association of 
Mediterranean diet score with fasting glucose as body mass index and waist circumference as a mediator 
in younger age group and older age group 
 
    Marginal total effect       Natural direct effect       
Age 
group 
Outcomes Estimate   95% CI   P Estimate   95% CI   P 
Younger BMI -1.835 ( -3.366 -0.304 ) 0.02 -1.559 ( -3.076 -0.041 ) 0.04 
 
WC -1.832 ( -3.363 -0.301 ) 0.02 -1.379 ( -2.894 0.137 ) 0.07 
Older BMI -1.530 ( -4.827 1.768 ) 0.36 -1.108 ( -4.372 2.156 ) 0.51 
  WC -1.543 ( -4.840 1.754 ) 0.36 -1.046 ( -4.297 2.206 ) 0.53 
 
 
Table 7.9 (Continued) 
    Natural indirect effect     
Proportion 
of 
mediation 
Age 
group 
Outcomes Estimate   95% CI   P   
Younger BMI -0.276 ( -0.501 -0.052 ) 0.02 15.1% 
 
WC -0.453 ( -0.711 -0.194 ) 0.001 24.7% 
Older BMI -0.422 ( -0.938 0.095 ) 0.11 27.6% 
  WC -0.497 ( -1.090 0.096 ) 0.10 32.2% 
Abbreviations: CI, confidence interval; BMI, body mass index; WC, waist circumference. 
All estimates were adjusted for age, gender, race/ethnicity, educational attainment, income, 
living with spouse, smoking status, level of physical activity, family history of coronary 
heart disease, parental history of diabetes mellitus, mean arterial pressure, and total calorie 
intakes. All estimates were adjusted for the same covariates used in Table 7.3. 
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Figure 7.1 Traditional mediation model for the association of Mediterranean diet score and DASH style diet 
score with the markers for insulin resistance and inflammation as body mass index and waist circumference 
as a mediator 
Path a represents the regression coefficient of the association of the Mediterranean diet score (MDS) 
and DASH diet score with BMI and WC. Path b represents the regression coefficient of the association of 
BMI and WC with the markers for insulin resistance and inflammation. The product of regression 
coefficients of path a and path b represents the mediated effect of BMI or WC (path a × path b). Path c’ 
represents the direct effect of MDS and DASH diet score with the markers for insulin resistance and 
inflammation, after the adjustment for BMI or WC. Path c represents the simple total effect of MDS and 
DASH diet score with the markers for insulin resistance and inflammation, without the adjustment for BMI 
or WC.   
  
 
1
9
2
 
 
 
             
Figure 7.2 Causal directed acyclic graph (DAG) describing relations of Mediterranean diet and 
DASH style diet (A) with the markers for insulin resistance and inflammation (Y) as BMI and 
waist circumference as a mediator (M) 
C1 and C2 include age, gender, race/ethnicity, educational attainment, income, living 
with spouse, smoking status, level of physical activity, family history of coronary heart disease, 
parental history of diabetes mellitus, and total calories (additionally adjusted for alcohol 
consumption in the model of DASH index). 
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Figure 7.3 Mediation model for the association of Mediterranean diet score with fasting glucose as body mass index 
(A) and waist circumference (B) as a mediator in younger age group and older age group 
a, b, c, and c’ indicate the estimates in the same way as Figure 7.1. β1 represents the beta coefficients of 
younger age group including men < 45 years and premenopausal women; β2 represents the beta coefficients of 
older age group including men ≥ 45 years and postmenopausal women. All estimates were adjusted for age, gender, 
race/ethnicity, educational attainment, income, living with spouse, smoking status, level of physical activity, family 
history of coronary heart disease, parental history of diabetes mellitus, mean arterial pressure, and total calorie 
intakes. Proportion of mediation by body mass index and waist circumference is 19.3 % and 32.1% in the younger 
age group; 10.3 % and 14.1% in the older age group, respectively (*: P < 0.05, **: P < 0.01, and ***: P < 0.001) 
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CHAPTER 8 
DISSERTATION SUMMARY 
8.1 Summary of results 
Our hypothesis for the present dissertation was as follows: 1) adherence to the 
Mediterranean diet or DASH style diet would be associated with metabolic health in both 
normal weight and obese populations; 2) adherence to the Mediterranean diet or DASH 
style diet would be associated with reduced all-cause and CVD mortality risk in 
individuals with unfavorable metabolic phenotype in both normal weight and obese 
populations; 3) adiposity would be a mediator of the influence of the Mediterranean diet 
or DASH style diet on cardiometabolic risk.  
In the cross-sectional study based on specific aim #1, the Mediterranean diet and 
DASH style diets were associated with metabolic phenotypes in the younger age group 
that included men < 45 years and premenopausal women. More specifically, MDS was 
positively associated with MHO phenotype, whereas the DASH index was inversely 
associated with the MONW phenotype, after adjustment for a wide range of potential 
confounders. MDS and DASH index were not associated with MHO and MONW 
phenotypes in the older age group that included men ≥ 45 years and postmenopausal 
women, suggesting that healthy dietary patterns may be more effective in reducing the 
cardiometabolic risk among younger adults.  
In the prospective study based on specific aim #2, higher adherence to   
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Mediterranean diet was associated with a lower risk of all-cause mortality in the MHO 
phenotype, after adjustment for potential confounders. We observed a 41% reduction in 
all-cause mortality with each 5-point increment in the MDS among MHO individuals. 
This association persisted when we restricted our analyses to those with or without 
prevalent chronic disease including diabetes mellitus and hypertension. However, the 
inverse association between the MDS and mortality was not observed among participants 
with the MUO phenotype.  
In addition, DASH style diet was associated with a lower risk of all-cause and 
CVD mortality in the MONW individuals, after adjustment for potential confounders. We 
observed a 23% reduction in all-cause mortality with each 1 SD increment in the DASH 
score among MONW individuals. This association persisted when we confined our 
analyses to those with or without prevalent diabetes mellitus and hypertension. However, 
these health benefits on the reduction of mortality were not observed in individuals with 
the MHNW phenotype.  
In the cross-sectional study based on specific aim #3, we observed an inverse 
association of MDS with the markers of insulin resistance including fasting insulin, 
HOMA-IR, fasting glucose, and HbA1c; and with inflammatory markers such as WBC 
and fibrinogen. WC mediated the association of MDS with log insulin, log HOMA-IR, 
fasting glucose, post-load glucose, HbA1c, log hs-CRP, WBC, and fibrinogen. 
Furthermore, the mediation effect of this association was greater in WC representing 
abdominal obesity than BMI representing general obesity, in both traditional and causal 
mediation approaches. However, no mediation effect by adiposity was observed in the 
association of DASH index with the markers for insulin resistance and inflammation. 
196 
 
8.2 Strengths and limitations 
Our study has several strengths. We used data from a well-characterized and 
reliable nationally representative dataset, based on extensive laboratory and physical 
examinations using standardized protocols to minimize the influence of measurement 
errors. In addition, we assessed the associations between healthy dietary patterns and 
metabolic health in a comprehensive way comprised of normal weight and obese 
populations, using MDS and DASH index. In a mediation analyses, we assessed the 
mediation effect of general obesity and abdominal obesity in the association of healthy 
dietary patterns with the markers of insulin resistance and inflammation in a 
comprehensive way using a traditional approach and causal mediation analysis; in the 
latter analysis we also explored possible interaction between dietary patterns and the 
mediator (adiposity measures). 
For the prospective study, we were able to evaluate a long-term health benefit of 
high diet quality on the reduction of mortality risk with nearly 18 years follow-up-. 
Furthermore, we were able to assess potential effect modifications and replicate the 
findings using a sensitivity analysis. Finally, the present studies adjusted for a wide range 
of potential confounders in multivariable analyses.  
There are also several limitations. First, the cross-sectional study design in 
specific aims #1 and #3 cannot imply a causal and temporal relationship between healthy 
dietary pattern, metabolic health, and cardiometabolic risk factors, although we tried to 
minimize reverse causality using strict exclusion criteria. Second, since the information 
on “servings per week” was not available at NHANES III FFQ, we used “times per week” 
in assessing the consumption frequency for MDS calculation. This approach might cause 
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exposure misclassification, but the direction would be non-differential. In addition, we 
used nutrient data from the 24-hr dietary recall data in calculating DASH index, which 
might not be comparable to DASH score based on FFQ in other studies. However, we 
were able to compare the association between metabolic health and healthy dietary 
pattern in terms of food based approach and nutrient based approach. Third, self-
assessment of food consumption may produce non-differential measurement error, 
although energy adjustment would reduce this error to some degree (Kipnis et al. 2003). 
Furthermore, there might be residual confounding due to not measuring the covariates in 
an objective way. 
8.3 Public health implications 
Adherence to the Mediterranean diet or DASH style diet is likely to be 
beneficially associated with MHO and MONW phenotypes in younger adults including 
men < 45 years and premenopausal women, suggesting that potential interventions to 
prevent cardiometabolic disease may need to be tailored by age group. Since individuals 
with unhealthy metabolic status are highly likely to develop CVD (Aung et al. 2014); 
adherence to the Mediterranean diet or DASH style diet may contribute to primary 
prevention of CVD in younger adults.  
The lack of a beneficial association between adherence to Mediterranean diet and 
mortality reduction in MUO individuals, even in those who were physically active, may 
warrant the need of an aggressive prevention approach to reduce mortality risk in MUO 
individuals. In addition, the MUO individuals may need to be prioritized for intensive 
weight loss program along with improving dietary habits to reduce obesity-related 
comorbidities. Normal weight individuals with metabolic abnormalities may benefit from 
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healthy dietary patterns such as DASH style diet for CVD prevention and mortality risk 
reduction. 
Obesity, especially abdominal obesity, may play a crucial role in the relationship 
of the Mediterranean diet with decreased insulin resistance and inflammation. In addition, 
a decrease in abdominal obesity might be considered an intermediate outcome for 
evaluating the effect of healthy dietary pattern on reducing cardiometabolic risk. 
8.4 Suggestions for future research 
Future prospective studies are warranted to establish the causal relationship 
between healthy dietary patterns and the risk of metabolic health, especially cohorts that 
may consider the change of dietary pattern of the participants. In addition to assessing the 
risk of incident unhealthy metabolic phenotype, it is necessary to evaluate whether 
healthy dietary patterns can contribute to the regression from unhealthy metabolic 
phenotype to healthy metabolic phenotype in normal weight and obese individuals. 
More evidence would be necessary based on long-term follow-up studies with 
enough power to evaluate the effects of healthy dietary pattern on mortality reduction, 
especially for cause-specific mortalities including CVD and cancer deaths. Based on the 
fact that metabolic phenotype is a dynamic state instead of being sustained for years 
(Soriguer et al. 2013), change of metabolic phenotype with advancing years should be 
considered, especially for the transition between MHO and MUO phenotypes.  
In addition, future prospective studies with multiple sequential measurements for 
dietary patterns, obesity parameters, and cardiovascular outcomes are warranted to more 
accurately clarify the degree to which adiposity mediates the beneficial association 
between the Mediterranean diet and markers of insulin resistance and inflammation. 
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Evaluating the temporal relationship between healthy dietary patterns and obesity 
together with the temporal relationship between obesity and cardiometabolic risk factors 
would confirm the causal mediated role of adiposity.  
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